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Abstract
While aging impacts most, if not all, living organisms, the molecular mechanisms behind 
this phenomenon are not completely understood. Here, I aimed to further describe the intricate 
relationship between genetics and diet in aging, focusing on touch receptor neuron aging 
processes in the model nematode, Caenorhabditis elegans. I specifically tested the hypotheses 
that (1) age-related touch receptor neuron morphological changes are associated with whole 
organism health, (2) intrinsic (i.e. genetic) and extrinsic (i.e. nutritional) factors can influence 
these morphological changes, and (3) specific cellular signaling processes underlie these 
morphological changes. To this end, this dissertation has three components: (1) the impact of 
insulin signaling disruption on neuron morphology and protein aggregation in a model of 
Huntington’s Disease; (2) establishment of Alaskan nutraceutical treatments that extend lifespan 
and offset age-related decline in neuron and whole organism health; and (3) description of 
mechanisms driving Alaskan nutraceutical treatment effects using RNA sequencing to target 
subsequent experiments. In all three of these components, I measured markers of whole 
organism health (e.g. lifespan, motility, endogenous reactive oxygen species) and markers of 
touch receptor neuron health (e.g. neuron morphology, mechanosensation). Together, this 
dissertation demonstrated that lifespan-extending interventions (e.g. decreased insulin 
signaling, Alaskan nutraceutical treatments) improved mechanosensation and, interestingly, 
differentially modulated development of age-related neuron morphological changes. That 
beneficial treatments increased the occurrence of posterior neuron process branching and/or 
decreased the occurrence of several anterior cell soma morphologies (e.g. soma outgrowths) 
suggests that some morphologies are representative of successful defense of the cell against 
age-related deterioration, while others are markers of cellular dysfunction. These results support 
the idea that multiple cellular signaling pathways are involved in aging of touch receptor 
neurons, and thus, there are multiple mechanisms for promoting health with age at the cellular 
level.
v
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Chapter 1
General Introduction
1.1 Biology of aging
Aging is a ubiquitous process affecting the health of increasing numbers of individuals 
throughout the world. Because aging impacts everyone, many of the physiological effects of 
aging are well known; including decreased sensory perception (e.g. hearing, smell, sight) and 
sarcopenia (i.e. loss of muscle tissue). At the cellular and molecular level, aging is characterized 
by genomic instability, proteostasis dysregulation, telomere shortening, epigenetic 
modifications, mitochondrial dysfunction, cellular senescence, and poor intercellular 
communication (reviewed in Lopez-Otin, 2013). Additionally, increased age is correlated with 
increased risk for development of chronic diseases (e.g. cardiovascular or neurodegenerative 
disease, cancer) and acute, life-threatening diseases (e.g. pneumonia). Thus, development of 
strategies to improve tissue, system, and organismal aging is an increasing public health 
priority.
As opposed to being a random process, aging is now known to be subject to highly 
regulated, evolutionarily-conserved processes (Kenyon, 2005). However, the exact molecular 
mechanisms that underlie the aging process (e.g. pre-programmed timetable vs. accumulation 
of too much damage) are not fully described and are often hotly disputed. Early beliefs and 
theories argued that aging was due to wear on the body and mind from the challenges of life, 
much like erosion. August Weismann (1834-1914) is one of the first theorists credited with using 
evolutionary biology concepts to predict a cellular aging theory (Gavrilov and Gavrilova, 2002). 
Weismann’s "theory of programmed cell death” posited that the number of replication cycles of a 
cell is limited, and after that limit is reached, the cell dies.
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More theories of aging were proposed in the 1950’s, based on evolutionary and 
molecular biological concepts. One such theory that has stood the test of time is the "mutation 
accumulation theory of aging,” proposed by Peter Medawar (1915-1987). This theory states that 
genes controlling aging reveal their phenotypes too late in life to be selected upon via evolution 
(i.e. after reproductive senescence), which results in passive accumulation of negative, aging- 
related phenotypes over evolutionary time (Medawar, 1946). The "antagonistic pleiotropy theory 
of aging” proposed by George Williams (1926-2010) is an alternative theory of aging that also 
has modern day supporters. This theory predicts that pleiotrophy, the phenomenon where a 
gene may be involved in more than one phenotype, is at the center of the aging process 
(Williams, 1957). Williams hypothesized that the same genes that result in negative aging 
phenotypes late in life exhibit beneficial phenotypes early in life, when they are subject to 
natural selection and, thus, propagated in a population. The "disposable soma theory of aging,” 
proposed by Thomas Kirkwood (1951- ) builds on antagonistic pleiotropy by stating that 
organisms strategically allocate resources to allow for successful reproduction, leaving fewer 
resources to maintain somatic cells throughout life.
Modern theories of aging build off of the interrelated historical theories and generally fall 
into two categories: damage/error accumulation and programmed aging/cell death (reviewed in 
Jin, 2010). One well-known damage accumulation theory of aging is the "free radical theory of 
aging”, proposed by Denham Herman (1916-2014). This theory is built on the knowledge that 
cellular nucleic acids, proteins, and lipids accumulate damage over time from exogenous and 
endogenous free radicals (i.e. molecules with an unpaired electron), such as reactive oxygen 
species (e.g. hydrogen peroxide), and predicts that this accumulation of damage underlies the 
aging process. Programmed cell death theories posit that cellular processes in the nervous, 
endocrine, and immune systems continue the biological timetable begun during growth and 
development through aging and death. These modern theories are indirectly supported by 
experimental data, but no single theory has emerged as the definitive theory of aging. The more
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we discover about molecular biology and the mechanisms behind longevity-promoting 
interventions, the more theories arise, some novel and some further explicating historical 
theories. However, the molecular, cellular, systemic, and evolutionary aspects of aging are 
indeed interrelated; thus, multiple theories (as we define them today) are likely necessary to 
describe the aging process (reviewed in Weinert and Timiras, 2003).
1.2 Brain and neuron aging
Maintaining nervous system integrity with age is critical to maintaining overall health, as 
the nervous system is the central regulator of internal and external information. Many physical 
and functional changes in the nervous system and brain are associated with the natural, non­
diseased aging process. For example, decreased cerebral cortex volume has historically been 
associated with increased age. Importantly, this loss in volume is not due to neuronal death 
(reviewed in Yankner et al., 2008). Rather, the overall volume decreases due to changes in 
neuron and dendritic morphology (Freeman et al., 2008) and a loss of white matter (i.e. 
myelination and glial cells; Bartzokis et al., 2003). In other brain regions, such as the 
hippocampus, dentritic branching increases with age (Buell and Coleman, 1979). Additionally, 
these morphological changes are correlated with poor interregional brain communication and 
cognitive performance (reviewed in Bishop et al., 2010). While numerous research groups have 
made observations of age-related physical and functional changes in the human brain, the 
molecular mechanisms driving these changes are unknown.
Neurodegenerative diseases result in additional brain phenotypes that are distinct from 
the natural, healthy aging process. Many neurodegenerative disorders are caused by genetic 
mutations and the toxic aggregation of proteins within neurons. For example, one 
neurodegenerative disease, Huntington’s disease, is caused by a polyglutamine-expansion 
mutation in the huntingtin gene leading to impairments in movement, cognitive function, and 
psychological disorders. Huntington’s disease progression results in extensive atrophy and cell
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death in the striatal putamen and caudate brain regions and the cerebral cortex, the extent of 
which is correlated with the level of polygluatmine expansion (Halliday et al., 1998). The striatal 
medium spiny neurons that do not die during disease progression exhibit drastic morphological 
changes both in moderate-grade (e.g. recurved dendrites, increased number and size of 
dendritic spines) and severe-grade (e.g. dendritic spine loss, shortened and swollen dendrites) 
Huntington’s disease (Ferrante et al., 1991). Both neurodegenerative disease and healthy aging 
phenotypes are characterized by drastic changes in the nervous system. Thus, uncovering the 
molecular mechanisms behind these nervous system changes is a pertinent approach to 
providing recommendations and therapies to improve the health of aging individuals.
Caenorhabditis elegans is a powerful in vivo model system for aging. These nematodes 
contain important neuronal components found in humans (i.e. neurotransmitters, ligand 
receptors, ion channels), are easy to genetically manipulate, and have a short wildtype lifespan 
(~3 weeks). Importantly, C. elegans experience age-related deterioration of different tissue 
types similar to humans (e.g. muscle deterioration; Herndon et al., 2002). Also similar to 
humans, the C. elegans nervous system exhibits physical and functional changes with age. C. 
elegans neurons do not die nor disintegrate in old age (Herndon et al., 2002). Instead, specific 
classes of neurons (e.g. touch receptor and GABAergic motor neurons) exhibit altered 
phenotypes with age (Toth et al., 2012; Pan et al., 2011; Tank et al., 2011). Interestingly, these 
aging neurons develop additional outgrowths from their axons and cell somas (rather than a 
loss of outgrowths) in conjunction with decreased synaptic integrity, function (i.e. touch 
response), and locomotion (Toth et al., 2012). Other molecular changes occur within aging C. 
elegans neurons as well. For example, mitochondrial density and trafficking within neurons 
decreases with age (Morsci et al., 2016). Also, decreased sensory perception, 
neurotransmission, and intercellular communication of chemosensory neurons (i.e. food 
detection) occur with age (Leinwand et al., 2015). The similarities between human and C. 
elegans neuron aging is striking and supports the use of these nematodes as experimental
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models to further our understanding of human nervous system aging and to develop novel 
therapies for neurodegenerative disease.
1.3 Genetic determinants of aging
Genetic mutations that increase lifespan are also proposed to postpone age-related 
declines in motor and cognitive function. Amazingly, the longer long-lived individuals live, the 
lower the proportion of time they spend in poor health, disabled, and with chronic disease. One 
study found that 17% of centenarians (age 100-104) "survive” with at least one chronic disease, 
53% "delay” onset of chronic disease, and 30% "escape” chronic disease altogether in their 
lifespan (Anderson et al., 2012). Compare this to 12%, 32%, and 56% of
semisupercentenarians (age 105-109) and 8%, 23%, and 69% of supercentenarians (age 
110+), respectively, for "surviving,” "delaying”, and "escaping” chronic disease in their lifetime 
(Anderson et al., 2012). These statistics indicate that increasing population lifespan has the 
potential to improve healthspan and quality of life, a very desirable outcome.
To examine the role of genetics in the aging process in living humans, very long-lived 
people (i.e. centenarians) and long-term, aging adult cohorts are studied to identify variations in 
allele frequency and gene expression that correlate with long life. Many genes and signaling 
pathways have arisen as potential determinants of longevity using these methods (reviewed in 
Newman and Murabito, 2013). However, only two such genes have been repeatedly described 
in multiple studies: apolipoprotein E (APOE; cholesterol transport and brain injury repair) and 
forkhead transcription factor (FOXO3A; insulin signaling). Genome-wide association meta­
analyses found that variations in APOE strongly associated and FOXO3A modestly associated 
with survival to more than 90 years old (Deelen et al., 2014; Beekman et al., 2013). Specific 
APOE alleles are associated with Alzheimer’s and cardiovascular disease risk, while others are 
associated with longevity, suggesting that a critical balance of APOE function must be 
maintained for improved healthspan (reviewed in Shadyab and LaCroix, 2015). In Ashkenazi
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Jewish centenarians, one common allele and two common regulatory units of APOE are 
expressed at a significantly lower level while one APOE allele is expressed at a significantly 
higher level when compared to control populations without a family history of longevity (Ryu et 
al., 2016). Additionally, males and females from diverse ethnic groups (and multiple research 
study groups) with more than one copy of the minor FOXO3A allele are consistently more likely 
to live to centenarian status (reviewed in Newman and Murabito, 2013). It will be interesting to 
see whether these genes remain relevant as new cohorts of aging individuals survive changing 
health challenges in their lifetimes (e.g. historical pre-antibiotic medical care versus the modern- 
day obesity epidemic; Newman and Murabito, 2013). Since specific gene allele frequencies are 
associated with human longevity, molecular studies exploring the specific role of these genes in 
the aging process are warranted.
The use of model organisms, including C. elegans, to study the genetic and molecular 
basis of aging is a burgeoning field with many results complementary to human genome 
studies, including FOXO3A findings (Kenyon, 2005). The longevity-associated insulin signaling 
pathway is highly conserved across multicellular organisms and is a key signaling pathway 
involved in metabolic responses to nutrient availability (Broughton and Partridge, 2009)1. A 
mutation in the C. elegans insulin receptor (DAF-2/IGFR) conferring decreased function was the 
first genetic mutation discovered to double the lifespan of an organism (Kenyon, 1993). These 
long-lived mutants also exhibit improved response to stress (Kenyon, 1993) and various 
improved molecular aging phenotypes (e.g. mitochondrial patterns, Morsci et al., 2016), 
demonstrating that lifespan extension in model organisms may also improve healthspan. 
Conversely, mutations in the C. elegans FOXO3A homolog (DAF-16/FOXO) confer decreased 
lifespan, demonstrating the negative regulation of DAF-16/FOXO (i.e. excluded from the 
nucleus) in response to insulin availability (Ogg et al., 1997). Genetically modifying insulin
1 C. elegans cholesterol transport occurs via endocytosis rather than APOE mechanisms, which is 
sufficiently different from humans to negate the utility of C. elegans as a model for this process.
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signaling in neurons (e.g. DAF-2/IGFR or DAF-16/FOXO mutations) also impacts the 
development of age-related morphological and functional changes in C. elegans 
mechanosensory and GABAergic neurons ( Toth et al., 2012; Pan et al., 2011; Tank et al.,
2011). Thus, in part because of its role in regulating lifespan and healthspan, the insulin 
signaling pathway has been heavily studied as a modulator of proteotoxicity and 
neurodegeneration (reviewed in Cohen and Dillin, 2008), again linking processes that increase 
and improve lifespan with those that drive disease development.
1.4 Nutritional aging interventions
Modifying diet, specifically consuming fruits, vegetables, nuts, and specific spices (e.g. 
tumeric, which contains curcumin), is proposed to be a practical method to lower age-related 
cognitive decline (Joseph et al., 2009). From Ancient Egypt (Ebers Papyrus from c. 1550 BC) to 
the modern-day extreme Alaskan environment (Garabaldi, 1999; Kari, 1995), people have both 
attempted to and successfully used plants and fungi as medicines. Historically, cultures 
developed pharmacopeia through instincts (e.g. smell, taste) and/or the Doctrine of Signatures 
(i.e. the shape of a plant represents the part of the body whose ailment it can treat). Today, we 
know that medicinal value is often determined, at least in part, by the plant or fungi’s molecular 
biology. Secondary metabolites, or compounds not directly involved in growth, development, 
and reproduction, are often credited with conferring medicinal properties to plant and fungal 
foods. This class of compounds includes the following: alkaloids (e.g. caffeine), terpenes (e.g. 
provide aroma and flavor of hops), glyosides (e.g. found in liquorice), and polyphenols (e.g. 
tannins, anthocyanins). The function of secondary metabolites is to increase the survival of the 
plant or fungus by defending against environmental stressors, herbivory, infection, and/or 
competition (i.e. allelopathy). Interestingly, these inherently bioactive secondary metabolites can 
confer stress resistance and even improved aging trajectories to the animals that consume 
them. This phenomenon, an inter-species hormesis principle coined "xenohormesis” (Hooper, et
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al., 2010; Howitz and Sinclair, 2008) is thought to be due to the adaptive response of the animal 
to the consumed stress response compounds in an effort to increase its own survival to the 
perceived environmental stressors. Xenohormesis is founded on the idea that the health 
benefits from secondary metabolite consumption "result not from responses to mild cellular 
damage or from their antioxidant properties, but rather from the evolutionarily adaptive 
modulation of the enzymes and receptors of stress-response pathways in mammals” (pg 389, 
Howitz and Sinclair, 2008).
Epidemiological studies consistently show that dietary patterns rich in plant food sources 
are correlated with increased lifespan, decreased incidence of age-related diseases, or both 
(reviewed in Fleming et al., 2013). For example, the Mediterranean diet, rich in fruits, 
vegetables, whole grains, fish, and legumes, is frequently heralded for its association with 
increased lifespan and decreased incidence of chronic disease when compared to modern, 
"Western” diet patterns high in sugar, processed foods, and red meat (reviewed in Jong et al., 
2014). Other place-based, traditional diet patterns appear to reduce the risk of developing age- 
related disorders. Even transitioning away from the Alaska Native traditional diet rich in meat 
and fat (90% from fish and game meat fat compared to <3% plant matter; Bersamin et al., 2007) 
to "Western” high-sugar diet patterns increases the risk of cardiovascular disease (Loring and 
Gerlach, 2009; Ebbesson et al., 2005). This observation may be due to the promotion of fatty 
acid profiles associated with cardiovascular health benefits over Western diets by Alaska Native 
diets (i.e. higher eicosapentanoic and docosahexaenoic fatty acids in red blood cells; Bersamin 
et al., 2008). These epidemiological data highlight the important role of nutrition in longevity and 
maintaining health throughout the lifespan.
There are numerous, specific examples of the interactions of plant compounds with 
cellular signaling pathways of plant consumers. For example, quercetin, a flavonol extracted 
from fruits, such as apples, interacts beneficially with insulin signaling to improve wildtype C. 
elegans health and decrease cellular oxidative damage (Youl et al., 2010). Extracts from
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roseroot, coffee, and curcumin specifically alter C. elegans DAF-16/FOXO transcription factor 
activity in models of healthy aging (Wiegant et al., 2009), Alzheimer’s disease (Dostal et al., 
2010), and various neurodegenerative diseases (Monroy et al., 2013), respectively. Even in 
human cell culture and mammalian model systems, nutraceutical and bioactive molecule 
treatments are a promising direction for improving health, aging, and neurodegeneration 
(reviewed in Seidl et al., 2014). Berries in particular have been heavily studied for their impact 
on brain signaling and neurodegeneration (Miller and Shukitt-Hale, 2012; Shukitt-Hale, 2012; 
Spencer, 2008). For example, blueberry supplementation not only increases wildtype C. 
elegans lifespan (Wilson et al., 2006) but also improves memory in aging rats (Joseph et al., 
1999), children (Whyte et al., 2015), and older adults (Krikorian et al., 2010). The specific 
molecular mechanisms behind plant compound regulation of longevity, health, and improved 
nervous system function may provide insights into the molecular mechanisms of the aging 
process itself.
Through this work, we aimed to further describe the intricate relationship between 
genetics and diet in the aging process, focusing on neuronal aging processes. We tested the 
hypothesis that the conserved, aging-related insulin signaling pathway regulates touch receptor 
neuron aging in diseased (i.e. Huntington’s disease) and nutrition supplementation models (i.e. 
Alaskan berry and fungal extract treatments) and discovered novel genetic modifiers of touch 
receptor neuron aging. Alaskan traditional knowledge holds that a diverse array of local plants 
and fungi benefit health and wellness (Garabaldi, 1999; Kari, 1995). Alaskan plant and fungus 
species have adapted to the region’s extreme environment, in part by producing a wide variety 
of secondary metabolites (Elks et al., 2013). As such, Alaskan berry species consistently 
contain higher levels of antioxidant and anti-inflammatory compounds than commercially grown 
species as well as those in lower temperate and tropical regions (Dinstel et al., 2013; Grace et 
al., 2013). By studying the in vivo biological effects of ingesting Alaskan nutraceuticals (i.e. 
interactions with cellular signaling pathways, such as insulin signaling), which are produced by
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plants and fungi adapted to a more stressful environment than other, more well-studied 
nutraceuticals, we have a unique opportunity to study the biology of aging and identify novel 
anti-aging and neurodegeneration therapies.
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Chapter 2
A Dual Role of the Insulin Signaling Pathway in the Aging of Healthy and Proteotoxically
Stressed Mechanosensory Neurons1
2.1 Abstract
Insulin signaling is central to cellular metabolism and organismal aging. However, the 
role of insulin signaling in natural and proteotoxically stressed aging neurons has yet to be fully 
described. We studied aging of Caenorbaditis elegans mechanosensory neurons expressing a 
neurotoxic expanded polyglutamine transgene (polyQ128), or lacking this proteotoxicity stressor 
(polyQ0), under conditions in which the insulin signaling pathway was disrupted by RNA 
interference (RNAi). We describe specific changes in lifespan, mechanosensory neuron 
morphologies, and mechanosensory function following RNAi treatment targeting the insulin 
signaling pathway. Overall, we confirmed that transcription factor DAF-16 is neuroprotective in 
the proteotoxically stressed model, though not strikingly in the naturally aging model. Decreased 
insulin signaling through daf-2 RNAi improved mechanosensory function in both models and 
decreased protein aggregation load in polyQ128, yet showed opposing effects on accumulation 
of neuronal aberrations in both strains. Decreased DAF-2 signaling slightly enhanced 
mechanosensation while greatly enhancing branching of the mechanosensory neuron axons 
and dendrites in polyQ0 animals, suggesting that branching is an adaptive response in natural 
aging. These effects in polyQ0 did not appear to involve DAF-16, suggesting the existence of a 
non-canonical DAF-2 pathway for the modulation of morphological adaptation. However, in 
polyQ128 animals, decreased daf-2 signaling significantly enhanced mechanosensation while 
decreasing neuronal aberrations. Unlike other interventions that reduce the strength of insulin
1 Published as Scerbak, C., Vayndorf, E., Parker, A., Neri, C., Driscoll, M., and Taylor, B. (2014). Insulin 
signaling in the aging of healthy and proteotoxically stressed mechanosensory neurons. Frontiers in 
Genetics 5. doi: 10.3389/fgene.2014.00212
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signaling, daf-2 RNAi dramatically redistributed large polyQ128 aggregates to the cell body, 
away from neuronal processes. Our results suggest that insulin signaling strength can 
differentially affect specific neurons aging naturally or under proteotoxic stress.
2.2 Introduction
The insulin/insulin-like growth factor (IGF) signaling pathway is involved in longevity and 
stress response across species (Broughton and Partridge, 2009). Signaling through this 
evolutionarily conserved pathway can promote longevity through increased expression of 
cellular stress and metabolism genes, including those encoding stress-response, chaperone, 
and antioxidant proteins (Kenyon, 1993; Cohen et al., 2009; Hsu et al., 2003; Taguchi et al., 
2007). The progression of neurodegenerative disorders, such as Huntington’s, Alzheimer’s, and 
Parkinson’s diseases, has been linked to insulin signaling in both invertebrate and mammalian 
model systems (Dillin and Cohen, 2011). In addition, decreased insulin signaling has protective 
effects against neurodegenerative-associated proteotoxicity across species (Killick et al., 2009; 
Freude et al., 2009).
The Caenorhabditis elegans insulin signaling pathway is regulated by insulin-like 
signaling ligands, INS-1 through INS-39,that modulate the activity of the DAF-2 tyrosine kinase 
receptor (Figure 2.1). DAF-2 is orthologous to the mammalian insulin/IGF receptor. This 
receptor activates a protein kinase signaling pathway, which, through phosphorylation of 
downstream transcription factor DAF-16 by AKT protein kinase, regulates functions similar to 
receptor kinases in the insulin signaling pathway in humans. Under high signaling conditions, 
DAF-16 is phosphorylated to prevent nuclear entry and hence transcription. Under low signaling 
conditions, DAF-16 is free from inhibitory phosphorylation and can regulate the expression of 
many different genes contributing to metabolism and physiological defense and homeostasis 
responses (Mukhopadhyay et al., 2006). This insulin signaling pathway has many branch points, 
including AKT, and there is some variation in the identities of proteins involved in nematodes, 
flies, and mice, three organisms in which the role of insulin signaling in aging has been
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investigated. Nevertheless, this central, conserved insulin signaling pathway is critical for 
appropriate cellular metabolism and maintenance of overall organismal health.
Various mutations in genes modulating the C. elegans insulin signaling pathway have 
been shown to directly regulate lifespan. For example, daf-2 insulin receptor mutants live twice 
as long as wildtype animals (Kenyon, 1993), age-1 PI3K mutants live longer than wildtype 
animals (Friedman and Johnson, 1988), and the lack of the daf-16 FOXO transcription factor 
gene shortens lifespan (Oh et al., 2006). Longevity effects can result from limiting insulin 
signaling in only the neurons or intestinal cells (Libina et al., 2003). In mammals, the effect of 
reduced insulin signaling on overall health and lifespan is complex, but combined evidence from 
many studies points to the potential of insulin signaling reduction to extend lifespan (Taguchi 
and White, 2008). In mice, reduced neuronal or whole animal expression of IRS2, a kinase 
activated by the insulin receptor, increases lifespan (Taguchi et al., 2007). In humans, various 
studies have detected an association between longevity and single nucleotide polymorphisms in 
genes involved in insulin signaling, including the DAF-16-related transcription factor inhibited by 
insulin signaling (FOXO3A), the insulin receptor (IGF1R), and a central protein kinase (AKT-1) 
(Newman and Murabito, 2013). Excellent reviews comparing insulin signaling in various model 
systems have been published (Taguchi and White, 2008; Broughton and Partridge, 2009; Neri, 
2012).
C. elegans exhibit many important neuronal components found in humans, including, but 
not limited to, neurotransmitters, ligand receptors, and ion channels; thus, these animals are a 
powerful model for studying neuronal aging and neurodegeneration in vivo. Neurodegenerative 
disorders, such as Huntington’s, Alzheimer’s, and Parkinson’s diseases, result in the 
progressive loss of structure and function of neurons with age. Of these protein aggregation- 
associated neurodegenerative diseases, Huntington’s disease is caused by the expansion of 
CAG trinucleotide repeats in the huntingtin gene, which results in an expansion of the length of 
polyglutamine residues at the N-terminus of the huntingtin protein. Expanded polyglutamine
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repeats in mutated huntingtin lead to neuronal protein aggregation, impairments in movement 
and cognitive function, and psychological disorders. Multiple Huntington’s disease model strains 
of C. elegans have been developed (Faber et al., 1999; Morley et al., 2002; Parker et al., 2001, 
2005). In the model strain used in this study, touch receptor neuron-specific expression of a 
transgene encoding the first 57 amino acids of human huntingtin with 128 polyglutamine repeats 
impairs function, without neuronal death (Parker et al., 2001, 2005). Thus, this model may 
feature conserved events associated with dysfunction that typify early disease stages in 
humans.
Aging is the primary risk factor for multiple neurodegenerative diseases, yet the 
intersection of natural neuronal aging and neurodegenerative states is not well understood. As a 
consequence of sensing and responding to the environment, the nervous system is known to 
play a role in physiological aging (Alcedo et al., 2013). In normal, healthy aging, C. elegans 
mechanosensory and other neuron classes develop morphological aberrations, including new 
outgrowths from the soma, novel process branching, and dendritic restructuring (Pan et al., 
2011; Tank et al., 2011; Toth et al., 2012). Neuronal insulin signaling appears to be involved in 
this natural aging process; the link between normal aging and decline under disease conditions 
is relatively unexplored. To address this relationship, we studied and compared morphological 
features of aging mechanosensory neurons with and without a neurotoxic expanded 
polyglutamine transgene, under conditions in which genes of the canonical insulin signaling 
pathway were disrupted by neuron-targeted RNA interference (RNAi). Our findings suggest that 
insulin signaling strength can differentially affect specific neurons aging naturally or under 
conditions of disrupted proteostasis. Under conditions of polyglutamine expansion stress, insulin 
receptor DAF-2 appears to act through DAF-16/FOXO. However, under conditions of normal 
aging, DAF-2 activates a non-canonical pathway that acts independently to induce 
neuroprotection.
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2.3 Materials and methods
2.3.1 Strains
The C. elegans Huntington’s disease model strain used was derived from two previously 
engineered strains. Strain ID1 (ig ls l [Pmec-7yfp, Pmec-3htt57Q128::cfp, lin-15(+)]) (polyQ128) 
contains the first 57 amino acids of human huntingtin fused to CFP-labeled expanded 
polyglutamine tract (Q128) expressed in the 6 mechanosensory neurons as well as in PVD and
FLP neurons (Parker et al., 2001). These polyQ128 animals show functional deficiencies in
touch response and accumulation of huntingtin protein aggregate in mechanosensory neurons, 
without cell death (Parker et al., 2001). Strain TU3270 (uIs57 [Punc-119SID-1, Punc-119yfp, Pmec- 
6mec-6]) overexpresses the transmembrane channel SID-1 pan-neuronally, allowing the dsRNA 
from RNAi treatment to enter all neurons (Calixto et al., 2010). TU3270 and ID1 were crossed to 
generate a polyQ128-expressing strain with neurons susceptible to RNAi (ID121). We also 
crossed a healthy transgenic model, ZB154 (zdIs5 [Pmec-4GFP]), to TU3270 to render neurons 
susceptible to RNAi treatment (ZB123; “polyQ0”).
2.3.2 Worm maintenance
Standard methods were used for strain maintenance, bacterial culturing, and animal 
manipulation (Brenner, 1974). Stock animals were cultured at room temperature (about 22°C) 
on nematode growth media (NGM) agar plates seeded with live bacteria (E. coli strain OP50-1).
2.3.3 RNA interference treatments
We prepared RNAi plates using 4X concentrated live HT115 E. coli bacteria from the 
Ahringer Library induced at room temperature for 2 days on agar plates. For each batch of RNAi 
experiments, we performed a control experiment comparing the amount of nerve ring 
fluorescence knockdown following GFP treatment to empty vector (L4440) in age-matched 
animals to confirm neuronal RNAi sensitivity of the strain used (Supplemental Figure 2.1). Only
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experiments that showed a significant (unpaired t-test, p<0.05) knockdown of GFP were used 
for further RNAi studies. We performed RNAi treatments at 25°C protected from light with age- 
synchronous populations created using timed egg lay. To perform each egg lay, adult worms 
laid eggs on each of the described RNAi treatment plates for 4 hours. Animals in all RNAi 
experiments were transferred by hand each day of adulthood to fresh RNAi plates. We 
performed and analyzed RNAi experiments “blinded” to the intervention so that the 
experimenter was not aware of the genetic identity of the RNAi treatment given to each 
population of animals. We repeated each experiment at least 3 times. We selected day 5 of 
adulthood as a time point for analysis in the following experiments based on Toth et al. (2012), 
who reported a significant difference in mechanosensory neuron morphology between day 1 
and day 5 of adulthood.
2.3.4 Lifespan analysis
Following the production of age-synchronous populations, we transferred approximately 
50 animals from each RNAi treatment group everyday of adulthood to fresh, seeded RNAi 
treatment small plates and checked for survival by visual observation or gentle prodding with a 
platinum wire. Animals with protruding intestines, those that bore live young, or that crawled off 
the plates were censored. Survival experiments always included all 6 RNAi treatment groups 
(L4440 empty vector, daf-2, age-1, daf-18, akt-1, daf-16) at once for, usually, one strain at a 
time, and were repeated at least twice. We used Kaplan-Meier log-rank survival statistics to 
analyze differences in mean survival between RNAi treatment groups and p<0.05 was noted as 
significant.
2.3.5 Mechanosensory response assay
We generated synchronous populations as described above, maintained cultures at 
25°C, and transferred each day of adulthood to fresh RNAi treatment plates. On day 5 of 
adulthood we scored individuals for motility class. Individuals were grouped into 3 classes: A
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class indicates normal, voluntary sinusoidal movement, B class indicates locomotion following 
gentle prodding, and C class indicates inability to locomote. We then tested individuals for their
ability to respond to touch by gently touching alternatively on the anterior and posterior end with
an eyelash pick, 5 times each (Figure 2.2B). Animals responded either by moving (or attempting 
to move) in the opposite direction of the touch or by showing no movement. We scored animals 
(0-5) based on the number of positive responses to touch out of 5 touches at the anterior and 5 
touches at the posterior. We also recorded the mobility of each animal. We then imaged the 
mechanosensory neurons of the tested individuals as described below.
2.3.6 Neuron morphology imaging
Following the mechanosensory response assay on day 5 of adulthood, we mounted 
animals between 2 cover slips using 2^L of 36% w/v Pluronic™ solution dissolved in water and 
imaged using the 20X objective of an Axiovert S100 inverted fluorescent microscope. Using 
constant microscope settings, we collected images of the 6 mechanosensory neurons of each 
individual and their associated huntingtin protein aggregates, if present, using FITC and CFP 
filters, respectively. We discarded animals after imaging, so data presented is cross-sectional 
rather than longitudinal. We repeated mechanosensory response assays and neuron 
morphology imaging for each strain and RNAi treatment group at least 3 times. We examined 
the images of 6 mechanosensory neurons of each individual for morphological aberrations, 
namely cell body outgrowths, cell body guidance errors, and process branching (Toth et al.,
2012).
2.3.7 Protein aggregate quantification and data analysis
For polyQ128 experiments, we analyzed huntingtin aggregates (fused with CFP) with 
ImageJ, using a custom macroinstruction that includes quantification of the total area of 
aggregates seen in each cell. For comparisons of mechanosensory response and neuron 
morphology between empty vector control polyQ0 and polyQ128 strains, we used a Mann-
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Whitney U comparison. For the mechanosensory response assays, neuron morphology 
imaging, and protein aggregate counts following RNAi treatments, we used a generalized linear 
model with a log link function (Poisson regression) and Wald tests for significance of treatment 
effects. For total aggregate area measurements, we used a one-way ANOVA with Tukey’s 
pairwise comparisons. SPSS (Version 20) statistical software was used to perform, the 
analyses. A p-value of less than 0.05 was considered statistically significant. Values presented 
in the text represent mean ± standard error.
2.4 Results
2.4.1 Neuron and systemic RNAi knockdown of insulin signaling proteins alters polyQ0
and polyQ128 C. elegans lifespan
To initiate analysis of the influence of key insulin signaling pathway genes on normal 
aging and polyQ128-induced neuronal deficits in mid-adult life, we constructed C. elegans 
strains by genetic crosses with fluorescent mechanosensory (or touch) neuron reporters that 
express the sid-1 double stranded (ds) RNA transporter pan-neuronally. This sid-1 
compensates for the lack of a neuronal dsRNA transporter, enabling genes expressed in 
neurons to be targeted by RNAi (Calixto et al., 2010). Moreover, sid-1 overexpression in 
neurons can diminish nonneuronal RNAi effects, such that the sid-1(+) neurons act as a sink for 
double stranded RNA (Calixto et al., 2010). We studied one strain that was free of proteotoxic 
stress (polyQ0), and one that expresses the first 57 amino acids of human huntingtin protein 
with expanded polyglutamines fluorescently labeled with CFP (polyQ128) (Parker et al., 2001). 
In these strains, we can measure neuronal function via mechanosensory touch response 
assays, visualize neuron morphology structures, and directly observe polyQ128 aggregates. We 
first confirmed that polyQ0 and Huntington’s disease model (polyQ128) strain neurons were 
sensitive to RNAi treatment by feeding as detected by GFP knockdown in the nerve ring 
(Supplemental Figure 2.1). Indeed, GFP knockdown was efficient in both strains, supporting that
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our intended studies on insulin signaling pathway genes could effectively target 
mechanosensory neurons.
Interestingly, healthy polyQ0 and proteotoxically stressed polyQ128 empty vector 
(L4440) treated animals exhibited similar, not significantly different, mean lifespan (Figure 2.2A). 
Thus, increased polyglutamine load in mechanosensory neurons does not confer decreased 
lifespan, consistent with previous work showing mechanosensory neurons are dispensable for 
viability and lifespan (Chalfie et al., 1985). However, empty vector treated control polyQ128 
animals do exhibit signs of abnormal function as measured by motility, touch response, and 
accumulation of mechanosensory neuronal aberrations (Table 2.1, Figure 2.2C and 2.2D), 
agreeing with previous work (Parker et al., 2001). Specifically, polyQ128 posterior touch 
response is significantly decreased (Mann-Whitney U, p<0.01) and neuronal aberrations are 
increased at the whole worm (Mann-Whitney U, p<0.01), anterior cells (Mann-Whitney U, 
p<0.01), and posterior cells level (Mann-Whitney U, p=0.04) when compared to age-matched 
polyQ0 individuals. This suggests that increased polyglutamine load in the mechanosensory 
neurons negatively affects the function and healthspan of polyQ128 animals.
Because several previously published mutant and RNAi experiments did not utilize sid-1 
enhanced neuronal RNAi targeting, and thus would not have assayed neuronal knockdown 
effects, we also confirmed RNAi effects on longevity under the conditions we used for our 
studies. We found that knockdown of insulin signaling pathway genes in neurons and other 
tissues altered healthy polyQ0 life as previously reported, with daf-2, age-1, and akt-1 RNAi 
interventions lengthening lifespan, and daf-16 RNAi shortening it (Figure 2.3A and Table 2.2). 
Insulin signaling pathway interventions in the polyQ128 strain (daf-2, age-1) similarly increased 
mean lifespan, while daf-16 RNAi treatment decreased mean lifespan (Figure 2.3B and Table 
2.2). In the 3 biological replicates of akt-1 RNAi in polyQ128 animals, lifespan impact was 
variable.
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To further address whether there might be differences in general viability between 
polyQ0 and polyQ128 strains, we compared percent change in mean lifespan between polyQ0 
and polyQ128 animals for each RNAi treatment group. We found no significant differences in 
relative percent change between healthy transgenic and polyQ128 animals for the same RNAi 
treatment (t-tests, p>0.05), except for daf-16 RNAi, which approached significance in the 
polyQ128 background (Figure 2.3C; p=0.07). We also measured endogenous reactive oxygen 
species (ROS) as detected by the membrane permeable 2’, 7’-Dichlorofluorescin diacetate 
(DCF-DA, Sigma) following RNAi treatments and found that RNAi treatment targeted at insulin 
signaling pathway proteins from embryo did not consistently significantly affect young adult (day 
1) endogenous ROS levels in both healthy transgenic and polyQ128 strains (data not shown). 
However, daf-16 RNAi treatment through mid-life in polyQ128 worms significantly increased 
endogenous ROS levels across all biological replicates.
We conclude that RNAi interventions in our polyQ0 and polyQ128 strains are efficacious 
and exert similar general influences on aging biology in polyQ0 and polyQ128 strains. 
Disruption of a small set of sensory neurons by the proteotoxic stress of polyQ128 is not 
sufficient to grossly impair whole animal function, although there are some functional 
impairment and increased morphological aberrations. However, we note that in middle-aged 
adults, daf-16 RNAi is associated with elevated ROS levels and decreased mid-life viability 
specifically in the polyQ128 strain, raising the possibility that the combination of small scale 
neuronal proteostasis disruption can influence entire organism decline when DAF-16-dependent 
defenses are impaired.
2.4.2 Decreased insulin signaling through RNAi knockdown influences healthy
mechanosensory neuron morphology and function
Previous studies on morphological aging of mechanosensory neurons indicated that 
manipulation of the insulin signaling pathway can change accumulation of neuronal aberrations
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(Pan et al., 2011; Tank et al., 2011; Toth et al., 2012). These studies differed in details of 
methods and outcomes, and did not address akt-1 or daf-18 activities. Moreover, these studies 
left open the question of how morphological features relate to function. To address these gaps 
and discrepancies, we measured neuron morphology and touch response as a surrogate for 
mechanosensory function when components of the insulin signaling pathway were knocked 
down in polyQ0 animals. We performed touch response tests (Figure 2.4A) and then imaged 
mechanosensory neurons of characterized animals for changes in morphology (Figure 2.4B and 
2.4C) at mid-life (day 5 of adulthood; described in detail in Materials and Methods). Total 
neuronal aberrations include all morphological aberrations observed in an individual or cell type, 
including soma outgrowths, abnormal cell somas, process branching, and process punctae 
(Figure 2.4B).
Our analysis of touch sensory function revealed that both anterior and posterior touch 
responses in daf-2 RNAi were better than empty vector at day 5 of adult life (Figure 2.4A; Wald 
test, p<0.01 for anterior and posterior scores). daf-16 RNAi preferentially decreased posterior 
touch (p<0.01), revealing an interesting difference between anterior and posterior 
mechanosensory neurons. We found that RNAi knockdown of age-1, daf-18, and akt-1 did not 
alter touch responses as compared to empty vector.
A striking result from our analysis of morphological aberrations at day 5 of adulthood is 
that daf-2 RNAi increased the occurrence of total neuronal aberrations as compared to control 
(from 3.2±0.23 to 4.7±0.26 per individual) in both anterior and posterior neurons (Fig. 4C). We 
found that this increase was driven exclusively by process branching, which was the only 
specific neuronal aberration observed to change with daf-2 RNAi (Fig. 4D; from 12.8±3.40% to 
32.7±3.80% in anterior cells and 14.5±3.20% to 39.4±3.70% in posterior cells). age-1 RNAi also 
increased total aberrations (from 3.2±0.23 to 4.4±0.23 per individual) (Fig. 4C) and novel 
branching in anterior neurons (Fig. 4D; from 12.8±3.40% to 25.3±3.40% in anterior cells and 
14.5±3.20% to 26.7±3.30% in posterior cells), whereas daf-18, akt-1, and daf-16 interventions
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did not induce statistically significant changes in overall aberrations or in the hyper-branching 
phenotype. Our findings suggest that daf-2 disruption, and lowered insulin signaling could 
differentially effect different morphologies, and raise the question as to whether branching might 
be an indication of a neuroprotective response (see Discussion).
2.4.3 Touch response, mechanosensory neuron morphology, and protein aggregate
accumulation are affected by insulin signaling in a model strain of Huntington’s disease 
pathogenesis
We next examined functionality and morphological aberrations in the polyQ128 strain in 
which mechanosensory neurons are exposed to a chronic proteotoxic stress that promotes early 
dysfunction (Parker et al., 2001). As previously noted, empty vector treated polyQ128 animals 
exhibit increased aberrant neuron morphology and decreased touch response compared to age- 
matched, empty vector treated wildtype animals (Figure 2.3C and 2.3D).
We tested touch response in polyQ128 animals subjected to RNAi for insulin signaling 
pathway components (Figure 2.5A). daf-2 RNAi had a neuroprotective effect on both anterior 
(Wald test, p<0.001) and posterior touch sensitivity (Wald test, p<0.001). Interestingly, however, 
all other RNAi knockdown interventions (age-1, daf-18, akt-1 and daf-16) had generally 
deleterious effects on touch sensitivity in the polyQ128 background, with a particularly 
significant change in posterior touch response in polyQ128 animals compared with empty vector 
(L4440).
We then examined neuron morphology in the polyQ128 strain following RNAi of the 
insulin signaling pathway genes (Figure 2.5B). We found that numbers of aberrations in the 
polyQ128 strain were reduced upon daf-2 RNAi when compared to empty vector (from 
4.78±0.21 to 2.94±0.15 per individual, Wald test, p<0.001). In contrast, age-1 RNAi, modestly 
increased aberrations (from 4.3±0.2 to 5.4±0.1 per individual), as did akt-1 and daf-16 
interventions in anterior mechanosensory neurons. Thus for polyQ128-expressing neurons,
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morphological aberrations generally inversely correlate with function: low abnormality 
abundance corresponds to enhanced mechanosensory function.
In polyQ128 animals, the huntingtin:polyQ128 protein is fused with CFP and can be 
visualized as aggregates in our strain (Figure 2.5C). We therefore also examined the number 
and size of fluorescent aggregates in mechanosensory neurons following RNAi knockdown of 
insulin signaling components (Figure 2.5D). Under conditions of daf-2 RNAi we found that mean 
numbers of aggregates were lowered compared to wildtype (Wald test, p<0.01 for whole 
individuals, anterior cells, and posterior cells). Mean aggregate area was unchanged for daf-2 
RNAi (Supplemental Figure 2.2), suggesting that less aggregated protein persists in mid-life 
mechanosensory neurons when DAF-2 signals are reduced. Conversely, we found modest 
increases in aggregate number and size for age-1, akt-1, and daf-16 knockdown (Figure 2.5D 
and Supplemental Figure 2.2). Importantly, Parker et al. (2005) showed no difference in 
huntingtin expression of the polyQ128 animals in age-1 and daf-16 genetic mutants. This 
suggests that our findings of altered protein aggregation in the polyQ128 strain is likely not due 
to changed huntingtin expression, but rather is more likely attributed to cellular responses of the 
expanded polyglutamine protein (Figure 2.5).
Interestingly, we noted a striking difference in the localization of polyQ128 protein 
aggregates in posterior and anterior cells for daf-2 RNAi (Figure 2.5E and 2.5F). In daf-2 RNAi 
treated animals, 80-90% of the detected aggregates localized in the cell body of anterior and 
posterior cells whereas other insulin signaling pathway knockdowns were associated with a 
majority (50-60%) of aggregates localized within the process of these cells, similar to empty 
vector controls. We also note that aggregates were never observed in outgrowths without also 
being present in the cell body. This dramatic difference of aggregate localization in daf-2 RNAi 
animals suggests that subcellular distribution of protein aggregates is regulated by a DAF-2 
non-canonical pathway.
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2.4.4 RNAi knockdown of daf-2 returns polyQ128 mechanosensory neuron
morphology to healthy levels
At the whole worm and anterior and posterior cell levels, daf-2 RNAi knockdown in the 
neurons of polyQ128 worms lowers the occurrence of total neuronal aberrations to levels 
observed in polyQ0 empty vector treated animals (Wald test, p<0.01). However, daf-2 RNAi 
polyQ128 touch response is still significantly lower than polyQ0 empty vector treated animals 
(Wald test, p<0.01).
2.5 Discussion
2.5.1 Summary of findings
To begin to address the relationship between natural and proteotoxically challenged 
neuronal aging in a physiological context, we took advantage of high resolution in vivo analyses 
of C. elegans mechanosensory neuron morphology and function. We compared mid-life 
morphological and functional features of mechanosensory neurons that aged without, or with, 
the proteotoxic stressor polyQ128, under RNAi conditions that mimic systemic, including 
neurons, low or high activation of the insulin signaling pathway. Our data suggest that insulin 
signaling plays complex roles in neuronal maintenance in both healthy (polyQ0) and degenerate 
(polyQ128) neurons, with distinct outcomes on individual neurons notable even among the 
similar group of 6 mechanosensory neurons. Our data on individual neurons highlight 
remarkable neuronal diversity of responses to cellular signaling. Comparison of how the insulin 
signaling pathway impacts natural and proteotoxic-associated decline reveals some interesting 
differences in these two processes.
We conclude that RNAi down-regulation of the daf-2 insulin receptor plays a role in 
morphological aging of mechanosensory neurons in both normally aging (polyQ0) and 
proteotoxically stressed (polyQ128) animals. Anterior and posterior neurons can be differentially 
affected by altered neuronal insulin signaling (Table 2.3). Importantly, our data suggest that
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decreased insulin signaling in normally aging systems (polyQ0) actually enhances some 
process aberrations in middle aged adults, with a focused impact on formation of ectopic 
branches on axons and dendrites. That daf-2 mechanosensory function is improved raises the 
possibility that the structural aberrations (branching) we observe actually reflect consequences 
of a defensive response that enhances or protects neuronal health during aging (Figure 2.4). 
age-1 may contribute partially to this process in polyQ0 animals, but evidence for the 
involvement of other pathway components is not compelling in our study. We also find that daf-2 
RNAi knockdown has distinctive impact on the proteotoxically stressed polyQ128 
mechanosensory neurons: morphological aberrations are lower; and aggregates are fewer in 
number and smaller in size, with a striking subcellular restriction of aggregates to the cell body, 
as compared to empty vector controls. Somewhat surprisingly, other insulin signaling pathway 
disruptions have relatively modest impact on cell function, aggregate morphology, and 
aggregate distribution in polyQ128 animals; we found that age-1 RNAi, which extends overall 
lifespan, did not confer dramatic changes in mechanosensory neurons, and often correlated 
with daf-16 RNAi in inducing modest effects. Our data raise the possibility that, under conditions 
of extreme proteotoxic stress, neurons utilize a non-canonical daf-2 pathway to enhance 
neuroprotection.
2.5.2 Extending understanding of the influence of insulin signaling on healthy aging
mechanosensory neurons
2.5.2.1 daf-2 insulin receptor
Mechanosensory neuron morphology changes with age in wildtype animals (Tank et al., 
2011; Toth et al., 2012; Pan et al., 2011). Overall, genetic mutants and systemic RNAi 
treatments have suggested that daf-2 mutants maintain youthful, aberration-free phenotypes 
longer than wildtype animals. Toth et al. (2012) distinguished among specific abnormality 
classes to measure decreases in cell body outgrowths and wavy process phenotypes, with a
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trend toward delaying branching in posterior mechanosensory neurons. Tank et al. (2011) 
showed that 10 day old daf-2(e1370) mutants had decreased process branching. Using a 
neuron-targeted daf-2 RNAi approach, we measured an increase in neuronal aberrations at day 
5 of adulthood, the vast majority of which are novel branches (Figure 2.4D and 2.4E). Because 
we find increased aberrations in daf-2 RNAi coincident with a period of enhanced function 
(Figure 2.4A), we raise the question of whether mid-life branching might be a manifestation of a 
normal neuronal defense mechanism that actually improves sensory capacity, although this 
issue remains to be resolved with single animal functional imaging. This finding is also 
significant in that it suggests that all changes in morphology seen with age or treatments are not 
the same mechanistically and that some phenotypes, such as process branching, may be 
protective to neurons. Differences from other studies (Toth et al., 2012; Tank et al., 2011; Pan et 
al., 2011) could arise from differences in methods for reducing daf-2 expression (with RNAi 
knockdown being distinct from modulation of specific amino acid resides in receptor reduction- 
of-function mutants) and different timing of scoring during adult life.
2.5.2.2 age-1 PI3 kinase and other insulin signaling molecules
We found that age-1 RNAi modestly increased branching of mechanosensory neuron 
processes at day 5 of adult life, but did not alter touch sensitivity. The latter observation 
establishes that morphological phenotype and function are not always linked. akt-1, daf-18, and 
daf-16 RNAi interventions did not alter the trajectory of age-related morphological change in 
otherwise healthy neurons. The role of age-1, akt-1, and daf-18 in morphological aging of the 
mechanosensory neurons has not been previously reported. Overall, age-1 knockdown can 
have an effect on mechanosensory neuron morphological aging (Figure 2.4D and 2.4E) but 
impact on function is not large at mid-life. Other pathways that run in parallel may be important 
in mid-adult life (Tank et al., 2011).
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2.5.2.3 daf-16
For natural aging of mechanosensory neurons, we find that daf-16 RNAi exerts a small 
but statistically significant effect on day 5 adult posterior touch response, but not on aberrations. 
Tank et al. (2011) also came to the conclusion that aberrations for day 10 branching in a daf-16 
deletion mutant were similar to wildtype; whereas Pan et al. (2011) and Toth et al. (2012) noted 
a small increase in aberrations in daf-16 mutants at days 9 and 10 (note the latter study, like 
ours, found no change at adult day 5). Still, time course studies do not support a profound 
impact of daf-16 disruption on morphological aging of the mechanosensory neurons. daf-16 
appears to be needed for daf-2(rf)-mediated suppression of excess branching, though cell 
autonomy of this activity is disputed (Pan et al., 2011; Tank et al., 2011).
Overall, although compelling data support that insulin signaling a factor in natural aging 
of mechanosensory neurons, with reduced signaling correlating with reduced function, other 
pathways likely influence the process as well (Tank et al., 2011).
2.5.3 Distinctive outcomes of daf-2 RNAi in the proteotoxically stressed Huntington’s 
disease model strain
2.5.3.1 daf-2
In middle-aged polyQ128 animals, we found that daf-2 RNAi improved mechanosensory 
function, limited the number of morphological aberrations, and decreased overall aggregate 
number and size, compared to empty vector controls (Figure 2.5). Thus, reduced insulin 
receptor signaling through DAF-2 confers neuroprotection that is associated with diminished 
polyQ128 aggregate load in this model. Our data are consistent with studies in other disease 
models (Cohen et al., 2010) implicating daf-2 in enhanced proteostasis during toxic protein 
challenge.
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2.5.3.2 age-1 PI3 kinase and other insulin signaling molecules
We found that age-1 RNAi modestly impairs touch sensitivity at a time point at which the 
mean number of aberrations and of aggregates are elevated relative to empty vector controls 
(Figure 2.4). Unexpectedly, akt-1 and daf-16 RNAi, which should have opposing impacts on the 
signal transduction pathway, induce similar outcomes in these proteotoxically challenged 
mechanosensory neurons. Because age-1 RNAi (and sometimes akt-1 (Hertweck et al., 2004)) 
extend lifespan (Table 2.2), dysfunction is not the anticipated outcome of such interventions. We 
emphasize two points here: first, our data raise the possibility that the most commonly outlined 
downstream pathway for DAF-2 signaling may not be the operative signaling pathway for the 
mechanosensory neuron proteotoxicity pathway; and second, as it has previously been noted 
that other healthspan phenotypes differentially affected by daf-2 vs age-1 mutations. For 
example, in age-1 mutants the biphasic profile for rate of increase in lipofuscin/age pigments 
during adulthood shows a temporal shift (delay in onset without change in time course), 
whereas for daf-2 mutants the rate of lipofuscin accumulation remains low across adulthood 
(Gerstbrein et al., 2005). In other words, daf-2 is more effective in preventing long term 
elevation in age pigment accumulation, while age-1 delays onset of accumulation. This anomaly 
is a precedent for differential health outcomes following closely related insulin signaling pathway 
interventions.
In previous work, Morley et al. (2002) found that C. elegans expressing polyQ82 in body 
wall muscle show slower development of aggregates and motility defects with age-1 RNAi and 
age-1 mutants. While those authors showed the opposite effect of age-1 RNAi on polyQ 
accumulation and toxicity compared to our study using a different cell type, they stressed the 
importance of threshold stresses in their interpretation. We note that our model carries an 
elevated polyglutamine load (polyQ128) as compared to polyQ82. In humans, longer 
polyglutamine expansion in huntingtin is well known to result in earlier onset of Huntington’s 
disease and lower life expectancy.
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2.5.3.3 daf-16
As expected, we observed daf-16 RNAi confers diminished mechanosensory function 
together with increased anterior aberration and increased number and size of aggregates. Our 
results are consistent with previous studies showing that daf-16 deficiency is associated with 
exacerbated polyQ128 proteotoxicity in young adult mechanosensory neurons (Parker et al., 
2005, 2012; Lejeune et al., 2012) and with enhanced proteotoxicity in a polyQ82 model (Morley 
et al., 2002) and an Alzheimer’s disease model (Cohen et al., 2009).
Overall, changes in anterior and posterior cell function, morphology, and protein 
aggregation load and localization (Figures 2.4 and 2.5) correlate with whole animal observations 
(Figure 2.3) in both polyQ0 and polyQ128 strains. However, with polyQ128 daf-16 RNAi we 
observed decreased anterior and posterior mechanosensory function (Figure 2.5A) and 
increased protein aggregate area and number in whole animal and both cell types (Figure 2.5D 
and Supplemental Figure 2.2), while only anterior mechanosensory neurons (ALML or ALMR) 
increased significantly in total neuronal aberrations (Figure 2.5B). This maintenance of neuron 
morphology with worsened function and protein aggregation suggests other mechanisms can 
mediate these endpoints.
2.5.4 daf-2 RNAi uniquely changes distribution of polyQ128 aggregate load
A striking observation of daf-2 RNAi animals is a profound difference in the distribution of 
polyQ128 aggregates (Figure 2.5E and 2.5F). daf-2 RNAi is the only intervention we tested that 
induces localization of CFP-labeled polyQ128 aggregates nearly exclusively to the neuron cell 
body. Most aggregates we concentrated in only a few dots, which resembled perinuclear 
lysosomes. Although this subcellular domain restriction remains to be definitively identified, our 
observations suggest that for both anterior and posterior mechanosensory neurons, daf-2 may 
exert neuroprotection by sequestering aggregates to prevent them from interfering with other 
cellular functions. The lower aggregate size suggests that enhanced degradation may occur
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when DAF-2 signaling is low. Our data also suggest that DAF-2 signaling could influence axonal 
transport of aggregate proteins or their retention in the cell body. Since we did not observe the 
cell body restricted pattern of age-1 RNAi, a non-canonical downstream signaling pathway 
might be responsible for the observed effect.
2.5.5 Neurons aging under extreme aggregate challenge exhibit differences from
natural aging
It is striking that the daf-2 RNAi polyQ128 neuronal aberration level is below that of 
polyQ128 empty vector controls (Figure 2.5B), and similar to that of polyQ0 empty vector 
controls (Figure 2.4C), while polyQ0 daf-2 RNAi increases aberrations. Together with stresses 
induced by polyQ128, low insulin signaling (daf-2 and age-1 RNAi treatment) is associated both 
with protection from and an increase in morphological restructuring. Without extreme proteotoxic 
challenge at mid-life (as in polyQ0), however, neuronal aberrations are more apparent when 
insulin signaling is low. One possibility to explain these differences between daf-2 RNAi in the 
naturally aging (polyQ0) and proteotoxically stressed (polyQ128) models is that hormetic 
consequences induced by polyQ128 are involved in suppression of aberrations. Alternatively, 
the aberrations in polyQ0 may be a manifestation of cellular maintenance that cannot be 
executed in the face of extreme polyQ128 challenge. An interesting question is whether 
additional neuron classes in the polyQ128 animals are affected by the expression of polyQ 
aggregates in the mechanosensory neurons or whether these effects are cell autonomous.
A second striking difference between natural aging and aging under extreme proteotoxic 
stress resides in daf-16 RNAi treatment effects. In polyQ0 animals, daf-16 RNAi impairs 
posterior touch sensation, but does not markedly alter neuron morphology (only affecting 
anterior touch sensitivity). In contrast, in polyQ128 animals, daf-16 RNAi results in both impaired 
touch response and increased neuronal aberrations. Also, daf-16 RNAi in polyQ128, aggregate 
load increases and lifespan decreases proportionally more than in polyQ0. This suggests that
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polyQ128 expression in mechanosensory neurons induces stress signaling to other body 
tissues to disrupt the overall health of the animal.
A potential mechanism for the differences in effects of manipulating insulin signaling in 
polyQ0 and polyQ128 is increased basal insulin signaling in polyQ128 as a result of its protein 
load. However, we propose this is unlikely to be the mechanism underlying the observed 
differences. We see no difference in lifespan between empty vector control (L4440) treated 
polyQ0 and polyQ128 lifespan (Figure 2.2A). This is not surprising given that mechanosensory 
neurons do not seem to modulate lifespan (Chalfie et al., 1985). Further, microarray analysis of 
polyQ128 FACS-purified Pmec-3 cells (mechanosensory neurons) showed no apparent 
dysregulation of genes in the insulin signaling pathway compared to non-toxic 
huntingtin:polyglutamine-expressing controls (Tourette and Neri, personal communication). 
Thus, the differences in neuron morphology and function seen in empty vector control treated 
polyQ0 and polyQ128 animals are likely due to some mechanism other than insulin signaling.
We have seen that with age, the effects on touch response and mechanosensory 
morphology are negatively correlated in polyQ0 and polyQ128 models (Vayndorf et al., 2016). 
We showed that this correlation between increased morphological aberrations and decreased 
function remains in all RNAi treated polyQ128 animals (Figure 2.5). However, when polyQ0 
animals receive RNAi treatment targeting components of the insulin signaling pathway, touch 
response and accumulation of aberrant morphology are no longer negatively correlated (Figure 
2.4). Interestingly, while only daf-2 RNAi showed overall significant effects on mechanosensory 
morphology and function in polyQ0 animals, RNAi treatment of polyQ128 animals yielded a 
higher number of significant changes. Also, we observed empty vector control polyQ128 
animals decreased touch response and increased changes in neuron morphology when 
compared to polyQ0 animals. Perhaps the decreased baseline neuronal function and worsened 
baseline neuron morphology of the polyQ128 animals makes them more susceptible to changes 
in expression of insulin signaling pathway proteins, whereas naturally aging animals have more
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ability to compensate with other signaling pathways when there are changes in insulin signaling 
protein expression.
Overall, our findings suggest that improving neuronal aging outcomes and neuronal 
dysfunction associated with elevated protein aggregate stress may not be as simple as 
decreasing classical insulin signaling. This is not surprising because there are 40 insulin ligands 
with different expression levels in various cell types all vying for binding sites at the C. elegans 
insulin receptor, DAF-2. Others have shown that this insulin network is complex and works 
together to respond to varying stresses (Ritter et al., 2013), including protein misfolding and 
dysfunction as in our polyQ128 model. In addition, in mammalian and cell culture models, 
huntingtin is a phosphorylation substrate for AKT/PKB (Humbert et al., 2002; Dong et al., 2012). 
AKT can be modified and even cleaved into an inactive form in a rat model of Huntington’s 
disease (Colin et al., 2005). Thus, in systems with endogenous huntingtin, unlike C. elegans, 
complex interactions between insulin signaling, expanded polyglutamine huntingtin aggregation, 
and neuron morphology and function may be operative. Further genetic studies of the huntingtin 
polyQ128 model in C. elegans have the potential to elucidate mechanisms that influence 
morphological changes during neuronal aging.
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Figure 2.1 The insulin signaling pathway in Caenorhabditis elegans.
Upon insulin ligand binding to the DAF-2 insulin receptor in C. elegans, AGE-1 (homolog to 
mammalian PI3-K) is activated and converts PIP2 to PIP3 at the cellular membrane. PIP3 
activates the central kinase AKT-1 (ortholog to mammalian PKB), which phosphorylates DAF- 
16, the C. elegans FOXO transcription factor, preventing its entry into the nucleus where it 
would otherwise regulate the expression of genes contributing to longevity, stress response, 
and metabolism. The DAF-18 (homolog to mammalian PTEN) phosphatase negatively regulates 
the system by decreasing the amount of PIP3 present at the membrane by reconverting it to 
PIP2.
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Figure 2.2 PolyQ0 and polyQ128 exhibit basal differences in mechanosensory neuron 
morphology and function without altered lifespan.
(A) Kaplan-Meier survival curves for one representative survival experiment shown for empty 
vector (L4440) treated polyQ0 and polyQ128 animals. Mean and median lifespan do not differ 
between the two strains. (B) Schematic of posterior touch test; an animal is touched at the tail 
and normally moves forward, gaining 1 positive response to touch (out of 5). For anterior touch 
test, animals are touched at the head and scored for backwards movement. Mechanosensory 
neurons (PLMs and ALMs) and pharynx shown. (C) Anterior and posterior touch test scores for 
empty vector control individuals. Each bar represents the mean number of positive responses 
out of 5 to soft touch. (D) Total number of aberrations (e.g. number of outgrowths and branches 
and presence of abnormal cell body and punctae) per worm and cell type for each empty vector 
control group. Whole worm bars represent the mean values of the sum of all 4 neurons scored 
(ALML, ALMR, PLML, and PLMR) for each individual. Anterior and posterior bars represent the 
mean values for individual anterior (ALML or ALMR) or posterior (PLML or PLMR) neurons. * 
denotes significance of p<0.01 and # denotes significance of p<0.10 following Mann-Whitney U 
comparison. Each bar shows mean ± SE for N=69 (polyQ0) and N=84 (polyQ128) animals.
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Figure 2.3 Neuronal and systemic insulin signaling mediates lifespan of both healthy (polyQ0) 
and proteotoxically stressed (polyQ128) animals.
Kaplan-Meier survival curves for one representative survival experiment shown for polyQ0 (A) 
and polyQ128 (B) animals with RNAi knockdown of the indicated insulin signaling pathway 
gene. Mean lifespan, sample size, and significance reported as Replicate 1 for each strain in 
Table 2.2. (C) Mean percent change in lifespan with RNAi treatment for polyQ0 and polyQ128 
animals pooled across biological replicates. Only daf-16 RNAi showed a significant impact on 
lifespan for polyQ128 animals when compared to polyQ128 empty vector controls (23.3±4.1% 
for 3 replicates of 45-50 animals). Each bar represents mean ± SE.
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(A) Anterior and posterior touch test scores of polyQ0 animals following RNAi treatment. Each 
bar represents the mean number of positive responses to 5 soft touches. (B) Representative 
examples of outgrowths (a), branching (b), punctae (c), and abnormal cell body (d) phenotypes 
seen in aging mechanosensory neurons of polyQ0 and polyQ128 individuals. (C) Mean number 
of neuronal aberrations per whole animal (sum of all 4 neurons scored in an individual) and 
individual cell type (anterior [ALML or ALMR] and posterior [PLML or PLMR]). (D) Percentage of 
neurons with branching phenotype for each RNAi treatment. Neurons with this phenotype may 
have more than one branch (data not shown). (E) Representative images of mechanosensory 
neuron processes and process branching (white arrows) in polyQ0 animals. * denotes 
significance of p<0.01 and # denotes significance of p<0.10 relative to appropriate empty vector 
control following a generalized linear model with a log link function (Poisson regression) and 
Wald tests for significance of treatment effects. Each bar represents mean ± SE for N=49-70 
animals.
Figure 2.4 d af-2  RNAi mediates mechanosensory neuron morphology and function in polyQ0
animals.
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(A) Anterior and posterior touch test scores, representing the number of positive responses to 5 
soft touches, following RNAi treatment for indicated insulin signaling pathway gene of polyQ128 
animals. (B) Mean number of neuronal aberrations per whole animal (sum of all 4 neurons 
scored in an individual) and individual cell type (anterior [ALML or ALMR] and posterior [PLML 
or PLMR]). (C) Representative image of polyQ128 aggregate (CFP, blue panels) accumulation 
within anterior (ALM) and posterior neurons (PLM) (YFP, green panels). White arrows in YFP 
panels indicate the location of the cell body of each neuron. (D) The effect of RNAi treatment on 
the number of distinct CFP-labeled extended polyglutatmine huntingtin protein aggregates in 
whole animal and anterior and posterior neurons of polyQ128 animals. (E) Sub-cellular 
localization of poyQ128 aggregates within anterior neurons of polyQ128 animals that contained 
aggregates. (F) Location of polyQ128 aggregates in posterior neurons of polyQ128 animals. * 
denotes significance of p<0.01 and # denotes significance of p<0.10 relative to appropriate 
empty vector control following generalized linear model analysis with a log link function (Poisson 
regression) and Wald tests for significance of treatment effects. Each bar represents mean ± 
SE.
Figure 2.5 The insulin signaling pathway mediates mechanosensory neuron morphology and
function in polyQ128 animals.
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Supplemental Figure 2.1 polyQ0 and polyQ128 neurons are sensitive to RNAi treatments.
Representative data and images of both polyQ0 and polyQ128 embryos treated with GFP RNAi 
treatment compared to empty vector controls. * denotes p<0.001 when compared to empty 
vector control following unpaired t-test. This experiment was repeated with similar results for 
each replicate of each RNAi experiment. Each bar represents mean relative fluorescence in 
arbitrary units (RFU) ± SE.
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Supplemental Figure 2.2 Insulin signaling mediates poly128 aggregate area.
Mean aggregate area per cell type and whole animal for each RNAi treatment. 
Aggregate area calculated using ImageJ. * denotes significance of <0.01 and # denotes 
significance of <0.10 relative to appropriate empty vector control following ANOVA and 
Tukey post-hoc analysis. Each bar represents mean ± SE.
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Table 2.1 Effect of RNAi treatment on polyQO and polyQ128 motility.
Number of individuals falling into A, B, or C class motility for each treatment group is shown. A 
class indicates normal, voluntary sinusoidal movement, B class indicates locomotion following 
gentle prodding, and C class indicates inability to locomote. Overall, polyQ128 animals have 
higher incidence of B class motility than polyQO. Only polyQ128 daf-18(RNAi) results in a 
significant difference in motility compared to control.
Strain RNAi Treatment
Number per Motility Class
Total NA B C
polyQO
Empty Vector 65 4 0 69
daf-2 53 0 0 53
age-1 67 4 0 71
daf-18 47 2 0 49
akt-1 50 1 0 51
daf-16 48 3 0 51
polyQ128
Empty Vector 69 15 0 84
daf-2 87 6 0 93
age-1 77 18 0 95
daf-18 47 0 0 47
akt-1 31 15 1 47
daf-16 51 20 1 72
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Table 2.2 Effects of RNAi treatment targeting insulin signaling on polyQ0 and polyQ128 animals’ 
mean lifespan.
Mean lifespan in days ± SE of each RNAi treatment replicate for the polyQ0 and polyQ128 
strains are shown. Each replicate of 6 treatments (empty vector control, DAF-2, AGE-1, DAF- 
18, AKT-1, and DAF-16) was run one strain at a time. Entries with * are significantly different 
(p<0.05) from the strain- and replicate-matched empty vector control following Kaplan Meier log- 
rank survival statistics. Replicate with missing data (N/A) was censored from experiment.
Strain
RNAi
Treatment N
Replicate 1 
Mean 
Lifespan 
days ± SE
Replicate 2 
Mean 
Lifespan 
N days ± SE
Replicate 3 
Mean 
Lifespan 
N days ± SE
Empty
Vector 50 13.7 ± 0.56 60 14.3 ± 0.58 55 13.5 ± 0.66
polyQ0 daf-2 40 16.8 ± 0.83* N/A N/A 48 16.3 ± 1.04*
age-1 51 16.3 ± 0.82* 59 16.9 ± 0.61* N/A N/A
daf-18 30 11.7 ± 0.70 60 14.8 ± 0.57 50 13.5 ± 0.62
akt-1 40 15.8 ± 0.79* 60 16.2 ± 0.52* 48 13.4 ± 0.50
daf-16 46 11.0 ± 0.61* 60 12.1 ± 0.53* 51 12.9 ± 0.68
polyQ128
Empty
Vector 50 15.2 ± 0.71 50 15.1 ± 0.61 56 13.4 ± 0.55
daf-2 51 16.1 ± 0.94 50 16.2 ± 0.89* N/A N/A
age-1 40 17.9 ± 1.01* N/A N/A 59 15.0 ± 0.89*
daf-18 38 15.6 ± 0.79 50 14.5 ± 0.66 59 11.4 ± 0.42*
akt-1 47 15.8 ± 0.79 25 14.4 ± 1.15 56 11.4 ± 0.44*
daf-16 48 10.9 ± 0.60* 50 12.8 ± 0.63* 61 10.4 ± 0.39*
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Table 2.3 RNAi treatments targeting the insulin signaling pathway differentially effect polyQ128 specific mechanosensory neuron 
aberrations.
Table depicts mean number and significant difference for anterior (ALML or ALMR) and posterior (PLML or PLMR) mechanosensory 
neurons following RNAi treatment for each specific neuronal aberration observed (i.e. cell body outgrowths, process branching, 
presence of process punctae, and cell body abnormality). p values indicate significance compared to appropriate empty vector 
control following generalized linear model analysis. Sample sizes for anterior (Nanterior) and posterior (Nposterior) neurons of each RNAi 
treatment are shown. Example outgrowths (A), branching (B), punctae (C), and abnormal cell body (D) are shown in Figure 2.4B.
RNAi Treatment on polyQ128 animals
Specific 
Types of 
Aberrations 
per
Cell
Type
Empty
Vector
(Nanterior = 226, 
Nposterior _ 217)
Mean±SE
daf-2
(Nanterior _ 
Nposterior _
Mean±SE
199;
202)
p
value
age-1
(Nanterior _ 185, 
Nposterior _ 185)
P
Mean±SE value
daf-18
(Nanterior _ 92, 
Nposterior _ 94)
P
Mean±SE value
akt-1
(Nanterior _ 
Nposterior _
Mean ±SE
93;
92)
P
value
daf-16
(Nanterior _ 143, 
Nposterior _ 140)
P
Mean±SE value
Number of 
Cell Body anterior 1.11±0.05 0.86±0.04 *0.00 1.32±0.06 *0.01 1.21±0.08 n.s. 1.24±0.08 n.s. 1.29±0.06 *0.03
Outgrowths
posterior 0.01±0.01 0.01±0.03 n.s. 0.03±0.03 n.s. 0.01±0.01 n.s. 0.00±0.00 n.s. 0.01±0.01 n.s.
Number of 
Branches anterior 0.15±0.03 0.09±0.02 *0.05 0.16±0.03 n.s. 0.23±0.05 n.s. 0.10±0.03 n.s. 0.13±0.03 n.s.
posterior 0.07±0.02 0.05±0.02 n.s. 0.08±0.02 n.s. 0.05±0.02 n.s. 0.03±0.02 n.s. 0.05±0.02 n.s.
Presence of 
Punctae anterior 0.14±0.02 0.04±0.02 *0.00 0.37±0.02 *0.00 0.27±0.03 *0.02 0.39±0.03 *0.00 0.33± 0.02 *0.00
posterior 0.71±0.03 0.90±0.03 *0.00 0.59±0.04 *0.02 0.65±0.05 n.s. 0.55±0.05 *0.01 0.58±0.04 *0.01
Presence of 
Abnormal Cell 
Body anterior 0.13±0.01 0.03±0.01 *0.00 0.19±0.01 n.s. 0.10±0.02 n.s. 0.15±0.02 n.s. 0.11±0.01 n.s.
posterior 0.00±0.01 0.02±0.01 *0.02 0.03±0.01 *0.01 0.02±0.02 n.s. 0.00 ±0.02 n.s. 0.03±0.01 *0.02
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Chapter 3
Differential Mechanosensory Neuron Aging Trajectories and Lifespan Extension Following 
Medicinal Alaskan Berry and Fungal Treatments in Caenorhabditis elegans2
3.1 Abstract
Many nutritional interventions that increase lifespan are also proposed to postpone age- 
related declines in motor and cognitive function. Potential sources of anti-aging compounds are 
the plants and fungi that have adapted to extreme environments. We studied the effects of four 
commonly consumed and culturally relevant Interior Alaska berry and fungus species (bog 
blueberry, lowbush cranberry, crowberry, and chaga) on the decline in overall health and neuron 
function and changes in touch receptor neuron morphology associated with aging. We observed 
increased wildtype Caenorhabditis elegans lifespan and improved markers of healthspan upon 
treatment with Alaskan blueberry, lowbush cranberry, and chaga extracts. Interestingly, 
although all three treatments increased lifespan, they differentially affected the development of 
aberrant morphologies in touch receptor neurons. Blueberry treatments decreased anterior 
mechanosensory neuron (ALM) aberrations (i.e. extended outgrowths and abnormal cell bodies) 
while lowbush cranberry treatment increased posterior mechanosensory neuron (PLM) 
aberrations, namely process branching. Chaga treatment both decreased ALM aberrations (i.e. 
extended outgrowths) and increased PLM aberrations (i.e. process branching and loops). These 
results support the large body of knowledge positing that there are multiple cellular strategies 
and mechanisms for promoting health with age. Importantly, these results also demonstrate 
that although an accumulation of abnormal neuron morphologies is associated with aging and
2 Authorship for this chapter is as follows: Courtney Scerbak, Elena Vayndorf, Alicia Hernandez, Colin 
McGill, and Barbara Taylor. In preparation for submission.
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decreased health, not all of these morphologies are detrimental to neuronal and organismal 
health.
3.2 Introduction
Aging is a ubiquitous process affecting the health of increasing numbers of aged 
individuals throughout the world. Gradual declines in many physiological functions accompany 
increased chronological age and are associated with increased mortality. Thus, development of 
strategies to improve tissue, system, and organismal function during aging is an increasing 
public health priority. Alaskan traditional ecological knowledge holds that a diverse array of local 
berries, plants, and fungi benefit health and wellness. While plant matter consists of a low 
proportion of total energy intake in traditional Alaska Native diets (<3% compared to 90% from 
fish and game meat and fat; (Bersamin et al., 2007), plants and fungi historically were and 
currently are highly valued by Alaska Native traditional healers (Loring and Gerlach, 2009). 
Various berries, plant greens, and fungi are consumed as part of a standard subsistence diet 
and used by traditional healers and contemporary herbalists to combat health problems ranging 
from stomach and muscle pain to bleeding and snow blindness. An increasing number of 
studies show that transitioning away from Alaska Native traditional diets and lifestyles is 
associated with increased incidence of age-associated disorders, including cardiovascular 
disease (Loring and Gerlach, 2009; Ebbesson et al., 2005). Importantly, cultures throughout the 
world value plants and fungi related to Alaskan species in traditional foods and medicines (Kim 
and Song, 2014; Iriti et al., 2010).
Modifying diet, specifically consuming fruits, vegetables, nuts, and specific spices (e.g. 
tumeric, which contains curcumin), is proposed to be a practical method to lower age-related 
cognitive decline (Joseph et al., 2009). Alaskan plant and fungus species have adapted to 
extreme environments, in part by producing a wide variety of secondary metabolites, bioactive 
molecules not required for plant growth and development (Elks et al., 2013; Wink, 2003).
58
Various plant and fungal extracts composed of secondary metabolites interact with specific 
molecular targets to improve health and to slow the progression of aging and age-related 
disease damage (Youl et al., 2010; Wiegant et al., 2008; Liu et al., 2005). For example, a large 
body of research describes the anti-inflammatory and antioxidant activity of polyphenolic 
compounds, such as anthocyanins (Zafra-Stone et al., 2007). Berries in particular have been 
heavily studied for their impact on brain signaling and neurodegeneration (Miller and Shukitt- 
Hale, 2012; Shukitt-Hale, 2012; Spencer, 2008).
Alaskan berry species consistently contain higher levels and activity of antioxidant and 
anti-inflammatory compounds (e.g. phenolic, flavonoid, and anthocyanin compounds) than other 
commercially grown, temperate species (Grace et al., 2014; Dinstel et al., 2013; Kalt et al., 
2001). The selected berries in this study, bog blueberry (Vaccinium uliginosum, also known as 
bog bilberry), lowbush cranberry (Vaccinium vitis-idaea, also known as lingonberry), and 
crowberry (Empetrum nigrum, also known as blackberry or mossberry), are found throughout 
Alaska and the circumpolar north in bogs, woodlands, and spruce stands. Non-Alaskan species 
of lowbush blueberries (Vaccinium angustifolium) prevent and reverse object-recognition 
memory loss in aging rats (Joseph et al., 1999) and improve memory in both children (Whyte et 
al., 2015) and older humans (Krikorian et al., 2010). Blueberry polyphenols (V. angustifolium) 
also extend wildtype Caenorhabditis elegans lifespan (Wilson et al., 2006). The American 
cranberry (Vaccinium macrocarpon) extends C. elegans lifespan in a dose-dependent manner 
(Guha et al., 2012). Crowberry contains higher total anthocyanins than other well-studied 
berries, such as blueberries, raspberries, and cranberries (Ogawa et al., 2008), but little is 
known about its biological actions. Thus, it is logical to suspect and investigate the benefits of 
consuming Alaskan berries.
Chaga (Inonotus obliquus, also known as cinder conk) is a parasitic fungus found on 
birch trees; it has a long history of a wide variety of medicinal uses in Asia and Eastern Europe, 
as well as in Alaska. Chaga extracts exhibit high antioxidant activity (Cui et al., 2005) and
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protect rat neuronal cells against oxidative stress (Giridharan et al., 2011). Korean traditional 
knowledge heralds chaga for its anti-cancer effects (Kim and Song, 2014) and ergosterol 
peroxide extracted from chaga was recently shown to inhibit cell growth by promoting apoptosis 
in a colorectal cancer cell model (Kang et al., 2015). Taken together, consumption of plants and 
fungi, especially those biochemically adapted to life in the Arctic, is a promising approach to 
combating age-related declines in function and development of disease.
The nematode C. elegans has homologous neuronal features to humans that are vital 
for nervous system function, which makes these animals a powerful model for studying neuronal 
aging in vivo. Healthy brain and neuron aging in humans and C. elegans is not characterized by 
cell death (Yankner et al., 2008; Herndon et al., 2002). Instead, age-related cognitive and 
functional decline in the human brain is associated with neuroanatomical changes, such as 
decreased white matter (i.e. myelinated neuron axons, glial cells), altered dendritic branching, 
and decreased synapse density (Yankner et al., 2008). Recently, certain classes of C. elegans 
neurons were also shown to change morphologically with age (Toth et al., 2012; Pan et al., 
2011; Tank et al., 2011). Specifically, aging touch receptor neurons develop novel outgrowths 
from the soma, axon, and dendrites and deteriorated synapses when observed with fluorescent 
(GFP transgenes) and electron microscopy (Toth et al., 2012; Pan et al., 2011; Tank et al., 
2011). By assessing neuron function and phenotypes within an individual, we have a powerful 
model for exploring mechanisms of neuronal aging and neurological effects of medicinal 
Alaskan berries and fungus.
The current study aims to describe the influence of Alaskan medicinal berry and fungal 
treatments on the aging process. We tested the hypothesis that treatments with blueberry, 
lowbush cranberry, crowberry, and chaga increase wildtype C. elegans lifespan and alter touch 
receptor neuron aging, potentially through different cellular mechanisms. Specifically, we tested 
the impact of specific treatments on lifespan and healthspan (i.e. motility, touch response, 
endogenous ROS). By examining the six C. elegans touch receptor neurons throughout
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adulthood using fluorescence microscopy, we also described the effects of the treatments on 
age-related morphological changes. Studying the impact of these culturally relevant foods on 
aging not only provides further support for their ethnomedicinal use, but also gives unique 
insights into the mechanisms of whole organism and neuronal aging.
3.3 Materials and methods
3.3.1 C. elegans strains and maintenance
The following strains were used in this study: N2 (Bristol), ZB154 (zdIs5 [Pmec-4GFP; 
lin-15(+)]), and TJ375 (gp/s7[hsp-16.2::GFP]). We used standard methods to maintain and 
manipulate C. elegans populations (Brenner, 1974). Stock populations were cultured at room 
temperature (about 22°C) on Nematode Growth Media agar plates (1L NGM: 2.5g peptone, 17g 
agar, 3g NaCl, 975mL double distilled water, 1mL 5mg/mL cholesterol, 1mL 1M CaCl2, 1mL 1M 
MgSO4, 25mL 1M KHPO4, and 0.5mL 100mg/mL streptomycin) seeded with live bacteria (E. coli 
strain OP50-1 cultured in Luria Broth) that were allowed to form a lawn for 48h at room 
temperature and then stored at 4°C until use.
3.3.2 Berry and fungus extract preparation
We collected wild specimens of the selected species of natural berries and fungus from 
Fairbanks, Alaska in late summer and early fall 2012. A local Alaskan fungi expert verified the 
identity of the chaga (/nonotus obliquus) specimen. We prepared crude berry extracts by 
blending and homogenizing a known mass of berries with a known volume of chilled 80% 
aqueous acetone (~4°C) for 10min and removing the acetone with a rotary evaporator (~90min). 
We prepared crude chaga extract by steeping the fungus in boiling water and straining out 
leftover particulates, to mimic common consumption of the fungus as a tea-like infusion. We 
determined the stock concentrations of extracts using a ratio of the starting mass berry or 
fungus to the final volume of extract. Extracts were then aliquoted and stored at -80°C. Freeze
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thaw cycles were limited to one (thawed from -80°C then aliquoted and frozen at -20°C until 
use) to ensure maximal preservation of bioactive components (Lohachoompol et al., 2004). 
Because seasonal weather patterns and location (e.g. bog versus mountain) have been shown 
to influence the chemical makeup of various botanicals (Howell et al., 2001), all experiments 
were conducted using extracts prepared from the same extraction batch to eliminate the 
potential for differences in the chemical properties of the extracts.
3.3.3 Biochemical quantification of extracts
We quantified total phenolic content of each of the Alaskan berry and fungus extracts 
using a Folin-Ciocalteu assay with a gallic acid standard curve adapted for 96-well plate 
analysis (Herald et al., 2012). We also measured flavonoid content with a NaNO2/Al/NaOH 
assay with a catechin standard curve (Herald et al., 2012). The gallic acid and catechin 
standard curves used for comparison had R2 values of 0.98 and 0.96, respectively. We 
quantified anthocyanin content by pH-differential assay with cyanidin-3-glucoside equivalent 
(Song et al., 2013). Each measurement included at least 3 technical replicates.
3.3.4 Berry and fungus treatment administration
To administer Alaskan berry and fungus treatments, we created treatment agar plates by 
mixing the appropriate concentration of extract into NGM after the agar cooled but prior to it 
solidifying. Control plates consisted of NGM plates with no extract. We seeded all plates with 
live OP50-1 E. coli. During all experiments, we ensured that the experimenter was blinded to the 
treatment groups. In the following described experiments (unless otherwise mentioned), 
synchronous populations of the appropriate C. elegans strains were created on standard, 
untreated NGM agar plates using the egg lay method (i.e. allow 30 gravid adults to lay eggs for 
4h, then removing the adults), fed standard live OP50-1 E. coli, and cultured at 25°C. We 
transferred experimental populations by hand to treatment plates at the late L4 larval stage, just
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before adulthood (48h at 25°C after egg lay), allowing the animals to ingest the extract after 
normal larval development.
3.3.5 Lifespan analysis
Following the production of age-synchronous L4 populations via egg lay, we transferred 
2 replicates of 25 animals onto plates for each berry and fungus treatment. We continued to 
transfer animals at least every other day of adulthood to fresh, seeded agar plates with the 
appropriate treatment. After all treatment groups stopped producing eggs, we continued to 
determine survival at least every other day by visual observation or gentle prodding with a 
platinum wire. At any point during the experiment, animals with protruding intestines, internal 
live young, or that crawled off the plates were censored. Survival experiments always included 
an untreated control in parallel with berry and fungus treatments and were repeated at least 3 
times. For lifespan experiments using UV irradiated bacteria, berry and fungus treatment 
administration and agar plate preparation were performed in the same manner as all other 
experiments with the additional step of exposing prepared OP50-1 lawns to 9999J/m2 254nm 
UV light using a UV Stratalinker 1800 and testing for survival before use. We used Kaplan-Meier 
log-rank survival statistics to analyze differences in mean survival between treatment groups. 
For this and all other statistical analyses described, we used the statistical software SPSS 
(version 20) and considered a p-value of less than 0.05 statistically significant.
3.3.6 Motility measurement
We divided aging individuals’ motility into 3 classes: A, B, and C, following the methods 
of Herndon et al. (2002). Class A individuals moved spontaneously in a normal, sinusoidal 
pattern. Class B individuals moved in markedly non-sinusoidal movements and may have 
required prodding to encourage movement. Class C individuals moved their head and/or tail in 
response to prodding, but were unable to move across the agar. Treatment effects were 
compared to their age-matched no treatment control using an ordinal logistic statistics model.
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3.3.7 Reactive oxygen species quantification
To begin treatment on large age-matched populations, we washed late L4 populations 
(48h after bleaching at 25°C) onto treatment plates with M9 (autoclaved 3g KH2PO4, 5g NaCl, 
6g Na2HPO4*7H2O and sterile 1mL 1M MgSO4 in 1L H2O). On test day (48h after treatment, day 
3 of adulthood), we isolated 300-500 adult worms from each treatment group by washing 
populations through a 50 jm  filter with M9. We then quantified reactive oxygen species (ROS) 
using H2DCF-DA (Halliwell and Whiteman, 2004). To do this, we: transferred the live adults into 
labeled 2mL tubes using 1.5mL M9 buffer; allowed them to settle by gravity; removed the 
supernatant such that 500 | j L of M9 was left in the tube; and pipetted 3 aliquots of 50j L of the 
well-mixed M9-worm solution to the appropriate 96-well plate well. Immediately before loading 
the plate into the Biotek Synergy™ HT Multi-Mode Microplate Reader, we added 50j L of 
100mM 2’, 7’-Dichlorofluorescin diacetate (DCF-DA, Sigma) in M9 to each well. We recorded 
basal fluorescence (excitation 485nm, emission 520nm), stored the plate in the dark at room 
temperature on a shaker for 1h, and recorded final fluorescence. We normalized fluorescence 
results to basal worm and basal DCF-DA fluorescence (50j M DCF-DA in M9 buffer). Results 
were also normalized to total protein in each tube (using the leftover 200j L of M9-worm solution 
in the 2mL tube, described above) using the Pierce BCA Protein Assay on the supernatant 
following worm lysis (20j L 1M NaOH to each tube incubated for 25min at 70°C). This ROS 
quantification protocol was performed 3 times and was adapted from other published protocols 
(Braeckman et al., 2002; Schulz et al., 2006).
3.3.8 Fecundity measurement
To determine whether fecundity, specifically the number of viable progeny produced, 
was affected by treatments, we performed progeny count assays. We individually plated and 
transferred age-matched adults each day to fresh plates until the end of their reproductive 
phase or death. We allowed embryos left behind by the adults each day to develop for 48h at
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25°C and then manually counted the number of progeny produced by each individual on each 
day. We compared the total number of progeny produced per treatment and control using one­
way ANOVA and Tukey post-hoc comparisons. We tested for treatment effects on each day of 
adulthood using a Poisson log linear statistical model.
3.3.9 Mechanosensory neuron aging assay
We performed neuron aging assays (i.e. soft touch response and mechanosensory 
neuron imaging) using the C. elegans strain zdIs5, which expresses green fluorescent protein 
(GFP) in each of the 6 touch receptor neurons (Figure 3.5A). On days 5, 7, 9, and 11 of 
adulthood, we randomly selected individuals from a synchronous population, tested for touch 
sensitivity, and imaged the number and type of specific neuronal aberrations seen in the 6 
fluorescently labeled neurons. We measured soft touch sensitivity and observed 
mechanosensory neuron aberrations as established by Toth et al. (2012), by counting the 
number of positive responses an individual had to 5 alternating touches at each the anterior and 
posterior ends (10 total touches). To image the fluorescently labeled neurons, we then mounted 
that individual on a labeled coverslip with 36% Pluronic solution and quantified neuron 
morphology with an Olympus FSX100 inverted fluorescent microscope at 20x magnification. 
Neuron morphologies observed included those previously described (Scerbak et al., 2014; Toth 
et al., 2012; Pan et al., 2011; Tank et al., 2011), such as various lengths of outgrowths from the 
soma, branches from the process, abnormally shaped soma, punctae on the process, and soma 
in the wrong location. This assay of mechanosensory neuron form and function was repeated at 
least 3 times for each selected Alaskan berry and fungus lifespan-extending treatment and each 
replicate contained its own distinct untreated control group. We performed Poisson log linear 
(for count data, i.e. number of outgrowths) or logistic regression (for bimodal data, i.e. presence 
of abnormal cell soma) statistical models to test for treatment and age effects on touch
65
sensitivity and neuron morphologies. Pairwise comparisons with p<0.05 were considered 
significant.
3.3.10 hsp16-2::GFP gene expression assay
hsp-16.2::GFP gene expression assays were performed on age-matched day 3 adults 
cultured on appropriate berry and fungus treatment plates at 20°C using 8x magnification and 
constant exposure. Positive control animals were heat shocked at 37°C for 90min, 20h before 
imaging (Rea et al., 2005). To detect treatment effects, we used an ordinal logistic statistics 
model.
3.4 Results
3.4.1 Standardization of Alaskan plant and fungus extracts
Polyphenolic compounds, including flavonoids and anthocyanins, exhibit potent 
antioxidant and anti-inflammatory properties (Joseph et al., 2014). We quantified three 
measures of phenolic content to compare our extracts with others shown to have bioactive 
properties and other Alaskan berry extracts shown to contain high phenolic content. Total 
phenolic content (Folin-Ciocalteu assay with gallic acid equivalent), flavonoid content 
(NaNO2/Al/NaOH assay with catechin equivalent), and anthocyanin content (pH-differential with 
cyanidin-3-glucoside) of each extract were measured using established methods (Table 3.1; 
Song et al., 2013; Herald et al., 2012). The relative abundance of total phenolics and 
anthocyanins of blueberry compared to lowbush cranberry levels was the same as previously 
reported for Alaskan blueberry and lowbush cranberry (Grace et al., 2014); total phenolic 
content was 443% higher in lowbush cranberry than blueberry while anthocyanin content was 
137% higher in blueberry than cranberry (Table 3.1). Our crowberry extract contained the
highest levels of total phenolics and anthocyanins of all our extracts. In contrast, our chaga
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extract contained the lowest levels of total phenolics, flavonoids, and anthocyanins of all our 
extracts.
3.4.2 Alaskan berry and fungus treatments extend C. elegans lifespan
Under our laboratory culture conditions (i.e. 25°C, solid media, live OP50-1 E. coli food 
source), C. elegans untreated control mean lifespan was 10.2±0.4 days. Three of the four tested 
Alaskan berry and fungus treatments resulted in wildtype C. elegans lifespan extension: 
blueberry, lowbush cranberry, and chaga treatments extended lifespan at varying doses and to 
different extents when compared to untreated control populations (Figure 3.1 and Table 3.2). 
Blueberry treatment elicited the highest increase in lifespan of all tested Alaskan berries and 
fungus; an average of 30% and up to 47% (200|jg/mL treatment) when compared to untreated 
control. Blueberry was also the only treatment for which an entire range of doses tested (60- 
400jg/mL) resulted in lifespan extension (Figure 3.1D). In a representative trial, mean lifespan 
significantly increased over the no treatment control to 12.4±0.6, 11.2±0.6, 12.4±0.7, and 
11.2±0.6 days upon treatment with 60, 100, 200, and 400jg/m L Alaskan blueberry extract, 
respectively (p<0.05, Kaplan-Meier log-rank test). Treatment with 800jg/m L blueberry did not 
consistently, statistically increase lifespan.
Both lowbush cranberry (Figure 3.1E) and chaga (Figure 3.1F) treatments resulted in a 
bimodal response in lifespan extension. Two of the five selected lowbush cranberry treatment 
doses significantly increased lifespan: 50 and 400jg/mL. Both 50 and 400jg/m L lowbush 
cranberry treatments reliably, statistically increased lifespan up to 22% when compared to 
control. Treatment with 50, 200, and 800jg/m L chaga extract significantly increased mean 
lifespan to 13.1±0.6, 12.9±0.5, and 12.9±0.6 days, respectively, compared to a control of 
10.7±0.5 days in a representative trial (p<0.05, Kaplan-Meier log-rank test). In addition to the 
effective chaga treatments doses shown in Figure 3.1C, we observed no significant change in 
mean or median lifespan at several additional doses (10, 20, and 100jg/mL; Figure 3.1F).
67
Crowberry treatment was also tested for lifespan extension at similar treatment doses as 
blueberry, but no significant effect was observed (Supplemental Figure 3.1).
Next, we investigated whether the lifespan-extending effects of blueberry, lowbush 
cranberry, and chaga were primarily due to secondary responses in C. elegans to an altered 
food source, OP50-1 E. coli exposed to the same treatment. OP50-1 E. coli growth in liquid 
culture was unaffected by the presence of Alaskan nutraceuticals at C. elegans lifespan- 
extending doses (data not shown). We also measured C. elegans lifespan on Alaskan berry 
and fungus treatments with UV irradiated OP50-1 E. coli. Both blueberry and lowbush cranberry 
treatments resulted in extended wildtype lifespan when compared to untreated control, even 
with UV-killed bacteria (p<0.05; Kaplan Meier log-rank test; Supplemental Figure 3.2). However, 
chaga treatment did not extend lifespan when C. elegans were fed UV-killed bacteria 
(0.09<p<0.4; Kaplan Meier log-rank test).
3.4.3 Alaskan berry and fungus treatments improve healthspan
Interventions that increase lifespan do not necessarily increase health with age nor 
decrease the proportion of time spent living in a frail state (Bansal et al., 2015). To address this 
possibility with our Alaskan berry and fungus treatments that extended lifespan (Figure 3.1), we 
studied several measures of healthspan. In C. elegans, the ability to move spontaneously and 
actively (i.e. motility) declines stochastically (Herndon et al., 2002). At mid-life (day 5 of 
adulthood), both control and lifespan-extending Alaskan berry and fungus treatments tested had 
nearly 100% normal motility, as expected (Figure 3.2A-C). However, all of the lifespan- 
extending Alaskan berry and fungus treatments maintained healthy motility well into late 
adulthood (day 11) by significantly increasing the ratio of normally, spontaneously moving adults 
(Class A) to abnormally, non-spontaneously moving (Class B) and frail, immobile (Class C) 
adults (p<0.01 ordinal logistic model; Figure 3.2D-F). There were no dose-dependent effects on 
motility within blueberry and lowbush cranberry treatments (p>0.2, ordinal logistic model).
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800^g/mL chaga treatment significantly decreased the incidence of Class C adults at Day 11 of 
adulthood when compared to control, 50, and 200^g/mL chaga (p<0.001, ordinal logistic 
model).
The ability to sense and respond to touch (i.e. touch response) also decreases with age 
in C. elegans. We observed a significant age-related decrease in both anterior and posterior 
touch response (i.e. the number of positive responses to 5 touches at the anterior or posterior 
end of the animal) in all control groups, as expected (Figure 3.3, black bars). Overall, lifespan- 
extending Alaskan berry and fungus treatments slowed this decline in mechanosensation by 
late adulthood (day 9 or day 11; Figure 3.3). Both blueberry treatments robustly improved 
anterior (1.75±0.15 control vs. 2.5±0.15 60^g/mL and 2.4±0.16 200^g/mL; p<0.02) and 
posterior touch response (2.7±0.14 control vs. 3.4±0.13 60^g/mL and 3.2±0.14 200^g/mL; 
p<0.02) at day 11 when compared to age-matched control. Low dose lowbush cranberry 
treatment (50^g/mL) improved both anterior and posterior touch response over control at day 11 
of adulthood (anterior: 1.7±0.14 vs. 2.2±0.18; posterior: 3.1±0.11 vs. 3.3±0.11; p<0.05). The 
higher lowbush cranberry treatment (400^g/mL) improved posterior touch response at day 9 of 
adulthood (3.75±0.11 vs. 3.9±0.11; p<0.02), then dropped to control levels at day 11 (3.1±0.11 
vs. 3.26±0.11; Figure 3.3E). Two of the three lifespan-extending chaga treatments improved 
touch response: both 50 (2.63±0.18) and 200^g/mL (2.82±0.21) chaga treatments significantly 
improved anterior (but not posterior) touch response compared to control (2.0±0.16) at day 11 
(p<0.05).
Reactive oxygen species (ROS) are considered a biomarker of overall health and are 
associated with aging (Campos et al., 2014; Stuart et al., 2014; Kregel and Zhang, 2007). To 
test the hypothesis that lifespan-extending berry and fungus treatments decrease damaging 
ROS early in life, we measured ROS within whole, live young adult (day 2) C. elegans 
populations using H2DCF-DA. Blueberry, lowbush cranberry, and chaga treatments differentially 
influenced endogenous management of ROS (Figure 3.4A). Treatment with blueberry trended
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toward increasing ROS levels (113.7% of control; p=0.085; One-way ANOVA) while chaga 
treatment strikingly decreased ROS (53.5% of control; p=0.06; One-way ANOVA). Lowbush 
cranberry treatment had no effect on ROS early in adulthood when compared to control (p=1.0; 
One-way ANOVA), although lowbush cranberry-mediated ROS levels were not significantly 
different from chaga treatments. Increased expression of the heat shock protein HSP-16.2 is a 
marker for ROS stress within C. elegans. To further describe ROS stress in young adults 
treated with lifespan-extending Alaskan berry and fungus treatments, we measured the hsp- 
16.2::GFP gene reporter fluorescence in the pharynx (Figure 3.4B-G). These results generally 
align with the H2DCF-DA ROS measurements (Figure 3.4A). Blueberry treatment significantly 
increased hsp-16.2::GFP expression (146% of control; p<0.05; One-way ANOVA). Both chaga 
and lowbush cranberry treatments did not significantly alter hsp-16.2::GFP gene expression 
(p>0.2; One-way ANOVA).
Interventions that increase aging are often associated with a decrease in fecundity 
(Jafari and Rose, 2006). We found that lifespan-extending Alaskan berry and fungus treatments 
did not influence total progeny produced per individual (p>0.7; One-way ANOVA; N=24 per 
treatment; Table 3.3). When we considered the number of progeny produced per individual on 
specific days of adulthood, several treatment doses had numerically small (<15 progeny) but 
significant effects (p<0.05; One-way ANOVA with Tukey post-hoc analysis). However, no 
treatments extend the number of days individuals produced viable progeny (Supplementary 
Figure 3.3).
3.4.4 Alaskan berry and fungus treatments differentially alter mechanosensory neuron
aging
C. elegans mechanosensory neurons sense soft touch and exhibit changes in 
morphology with age and with modifications in cellular signaling (Toth et al., 2012; Pan et al., 
2011; Tank et al., 2011). To visualize these morphological changes with age, we used a C.
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elegans strain with GFP-labeled touch receptor neurons (zdIs5 [mec-4p::GFP]). There are six C. 
elegans touch receptor neurons: two anterior lateral (ALML, ALMR), one anterior ventral (AVM), 
two posterior lateral (PLML, PLMR), and one posterior ventral (PVM), which are illustrated in 
Figure 3.5A. This study focused on the two pairs of lateral neurons because they are the most 
sensitive to change with age. The four lateral neurons (ALML, ALMR, PLML, PLMR) are typified 
by a circular cell body (soma) and a single, straight process (representing the axon and 
dendrites) extending towards the anterior end of the animal. Posterior neurons have an 
additional outgrowth from the soma towards the posterior of the animal. We considered any 
morphological deviations from this norm to be "neuronal aberrations,” but did not assume that 
these aberrations were functionally deleterious.
In all treatments, we observed similar morphological changes with age in the untreated 
control groups, as expected (Figures 3.5-7; black bars). Notably, as they aged, all control 
populations exhibited significantly increased numbers of total aberrations per anterior cell (day 
11 is 179% of day 5 levels; p<0.05; Poisson log linear model; Figure 3.5B; black bars) and total 
aberrations per posterior cell (day 11 is 3154% of day 5 levels; p<0.05; Poisson log linear 
model; Figure 3.6A; black bars). In anterior cells, the total number of extended outgrowths 
increased with age (day 11 is 469% of day 5 levels; p<0.05; Poisson log linear model; Figures 
3.5D and 3.7B; black bars). In posterior cells, an increase in process branching was the primary 
driver for the increased total aberrations per cell (increased from no occurrences at day 5 to 
23.2% occurrence at day 11; p<0.05; Poisson log linear model; Figure 3.6B; black bars). These 
findings generally align with previously described age-related morphological changes observed 
in touch receptor neurons (Toth et al., 2012; Pan et al., 2011; Tank et al., 2011).
Blueberry treatments that significantly extended lifespan (60 and 200^g/mL) decreased 
the total number of aberrations observed per animal relative to control by day 11 of adulthood 
(79.2% and 71.8% of control; p<0.05; Poisson log linear model). At the cellular level, only 
anterior lateral neuron morphology was altered with blueberry treatment (86.2% and 76.2% of
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control; p<0.05; Poisson log linear model; Figure 3.5B). The primary aberration driving this 
difference in anterior neuron morphology with blueberry treatment was soma outgrowths (90.9% 
and 77.6% of control levels; p<0.05; Poisson log linear model; Figure 3.5C), specifically 
extended soma outgrowths (<2x soma diameter; Figure 3.5D). The percent of anterior cell 
somas with an abnormal shape or location significantly decreased with 200^g/mL blueberry 
treatment day 11 of adulthood (67.4% and 56.5% of control; p<0.05 Poisson log linear model; 
Figure 3.5G) and was the only other specific aberration significantly altered with blueberry 
treatment. Conversely, on day 5 of adulthood, low dose blueberry (60^g/mL) treatment 
significantly increased extended outgrowths and significantly decreased percent cells with 
abnormal cell bodies (p<0.05; Poisson log linear model), suggesting that a relationship between 
these two aberrations exists early in life. Posterior touch receptor neuron aging was unaffected 
by blueberry treatment (p>0.8; Poisson log linear model).
In contrast to blueberry treatment, lowbush cranberry treatment increased only posterior 
cell aberrations (Figure 3.6A). Treatment with low dose lowbush cranberry (50^g/mL) 
significantly increased total posterior cell aberrations both at mid-life (day 5; 719% of control) 
and old age (day 11; 177% of control; p<0.01; Poisson log linear model). This increase in total 
aberrations was due solely to increased posterior cell process branching compared to control by 
day 11 of adulthood (Figure 3.6B). Anterior cell aberration development with age was unaffected 
by 50^g/mL lowbush cranberry treatment (p>0.8; Poisson log linear model). The higher lowbush 
cranberry treatment (400^g/mL), which also increased lifespan, had no effect on age-related 
development of posterior cell aberrations (p>0.1; Poisson log linear model). 400^g/mL lowbush 
cranberry treatment significantly decreased the number of anterior cell aberrations by day 11 of 
adulthood, similar to 200^g/mL blueberry treatment (83.1% of control; p<0.05; Poisson log 
linear model), but we are unable to relate this decrease to any specific type of neuronal 
aberration.
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Treatment with lifespan-extending chaga doses elicited effects similar to both blueberry 
and lowbush cranberry treatments: both anterior cell soma outgrowths and posterior cell 
process outgrowth events were impacted (Figure 3.7). While chaga treatment did not 
significantly alter the accumulation of total anterior cell outgrowths with age (p>0.8; Poisson log 
linear model; Figure 3.7A), these treatments did affect the lengths of the soma outgrowths 
observed. In all three chaga treatments, the occurrence of extended outgrowths (>2x soma 
diameter) significantly decreased compared to control at day 11 of adulthood (43.3%-52.8% of 
control; p<0.05; Poisson log linear model; Figure 3.7B). Conversely, short soma outgrowths 
(<1x soma diameter) increased by day 11 with chaga treatment (153-210% of control; p<0.05; 
Poisson log linear model; Figure 3.7C). Posterior cell process outgrowths, which consist of both 
straight branches pointing away from the process and branches that loop back to the process 
(i.e. loops), were affected by all three chaga treatments later in life (166-403% of control; 
p<0.05; Poisson log linear model; Figure 3.7D). Branching events were the primary driver of 
these posterior cell process outgrowths, but the unique presence of loops in the process 
warrants consideration. Specifically, treatment with low dose chaga (50^g/mL) significantly 
reduced posterior cell process outgrowths at day 9 of adulthood (8.3% of control; p<0.05; 
Poisson log linear model), but these aberrations rose to control levels at day 11 (p>0.2; Poisson 
log linear model). Treatment with 200^g/mL chaga quadruples the occurrence of posterior cell 
process outgrowths at day 11 of adulthood compared to control (403% of control; p<0.05; 
Poisson log linear model). High dose chaga treatment (800^g/mL) caused a significant 
decrease in posterior cell process outgrowths at day 9 of adulthood compared to control and a 
significant increase by day 11 (241% of control; p<0.05; Poisson log linear model).
3.5 Discussion
Compared to the modern "Western” lifestyle, traditional North American Native and 
subsistence lifestyles are associated with lower incidence of age-related and chronic disorders,
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particularly cardiovascular disease (Mohatt et al., 2007; Ebbesson et al., 2005). Differences in 
the diet of these two lifestyles are proposed factors for the improved health. To further explore 
the influence of traditional food sources on the functional aging process, we tested the effects of 
Alaskan berry and fungus extracts on C. elegans lifespan, healthspan, and markers of touch 
receptor neuron aging. Alaskan blueberry, lowbush cranberry, and chaga treatment increased 
lifespan at varying doses (i.e. 50 to 800|jg/mL; Figure 3.1 and Table 3.2). Increased lifespan 
may be uncoupled from improved health in old age (e.g. healthspan), thus measuring length of 
life alone does not necessarily provide an accurate portrayal of aging (Bansal et al., 2015). We 
find that measures of healthspan are either improved (i.e. motility, touch response; Figure 3.2­
3.3) or not affected (i.e. total viable progeny produced; Table 3.3) throughout the lifespan of 
animals treated with Alaskan berries and fungus. Each of the Alaskan berry and fungus 
treatments resulted in varied touch receptor neuron aging trajectories, with both decreased 
incidence of anterior neuron (ALM) soma outgrowths and increased incidence of posterior 
neuron (PLM) process branching (Figure 3.8). Nonetheless, both changes correlated with 
improved touch response (Figures 3.3 and 3.5-3.8). Importantly, this suggests that the 
development of specific touch receptor neuron morphologies impact neuronal and organismal 
function differently and reflects the importance of examining multiple healthspan markers in 
aging studies. Our findings demonstrate that beneficial nutritional lifespan interventions 
differentially impact touch receptor neuron aging and, thus, support the body of research 
describing numerous cellular strategies leading to increased lifespan and improved health 
(reviewed in Lopez-Otin et al., 2013).
Alaskan blueberry treatment effects are distinct from the other treatments; blueberry 
elicited the greatest increase in lifespan (up to 47%) and improved both anterior and posterior 
touch response late in life, while only impacting ALM morphology (i.e. decreased extended 
soma outgrowths and incidence of abnormal cell bodies; Figure 3.5). There is also a time- 
dependent and dose-dependent response to blueberry treatment that is unique from the other
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Alaskan nutraceutical treatments. First, middle-aged adults (day 5) treated with 60^g/mL 
blueberry exhibit a touch receptor neuron phenotype associated with decreased health later in 
life (i.e. increased incidence of extended outgrowths from anterior cell somas; Figure 3.5D) and 
no improvement in other markers of healthspan (i.e. motility, Figure 3.2A; touch response, 
Figure 3.3A and 3.3D). Second, the higher 200^g/mL treatment elicited a significant decrease in 
extended outgrowths by late life (day 11), while 60^g/mL did not (Figure 3.5D). Also, in young 
adults (day 2) treated with 200^g/mL blueberry, we observed increased levels of damaging 
ROS within live animals and increased hsp-16.2::GFP expression, a marker of ROS stress 
when compared to controls (Figure 3.4). Importantly, heat-shock treatments, which induce hsp- 
16.2::GFP expression, are known to result in improved stress response via hormetic 
mechanisms (Link et al., 2009). Blueberry treatment (200^g/mL) also slightly, but significantly, 
decreased the number of progeny produced on day 2 of adulthood (27±13.1 fewer progeny than 
control; Supplemental Figure 3.3) but did not impact total progeny produced over reproductive 
lifespan; again suggesting that early in life, blueberry treatment induces stress-response 
signaling.
These dose- and time-dependent results indicate an involvement of two interesting 
biological phenomenon in the blueberry treatment effects: hormesis and xenohormesis. 
Hormesis describes the dose-dependent effect wherein low doses of a treatment elicit a 
beneficial response while high doses of the same treatment are elicit a negative response or are 
toxic. Xenohormesis is the adaptive, defensive response of animals to consuming secondary 
metabolites produced by environmentally stressed plants (e.g. polyphenols; Howitz and Sinclair, 
2008). Xenohormesis may also be described as one organism (i.e. the consumer) benefiting 
from the stress response, or hormesis, of another organism (i.e. the plant). This intra-species 
signaling is proposed to activate stress-response signaling in animals via interactions with 
signaling molecules (as opposed to general antioxidant effects), which improves the health and 
survival of the consumer (Howitz and Sinclair, 2008). Xenohormesis may be involved in the
75
blueberry treatment effects because of the increased C. elegans lifespan following the 
consumption of Alaskan blueberry extract, which is known to have elevated polyphenolic 
content relative to other blueberry species (Grace et al., 2014), indicative of UV-stress. 
Additionally, our observation of a detrimental neuronal phenotype coupled with increased 
markers of ROS stress and decreased progeny early in life followed by improved lifespan, 
healthspan, and touch receptor neuron health late in life suggests that hormesis within the worm 
is likely also occurring.
Others have proposed that polyphenols, including extracts from blueberry, exert their 
effects on stress-response and longevity through mechanisms other than antioxidant activity, 
such as hormesis and xenohormesis. For example, Elks et al. (2011) observed that feeding a 
hypertensive rat model a blueberry-enriched diet improved renoprotection and oxidative stress 
markers in the long term (6 or 12 weeks) but increased oxidative stress in the short term (2 
days). These authors also proposed xenohormesis as a mechanism of blueberry treatment 
effects. Additionally, Wilson et al. (2006) found that treatment with non-Alaskan, wild lowbush 
blueberry polyphenols not only increased lifespan but also improved response to heat stress 
and thermotolerance, processes that are markers of an adaptive response to a stressor (Gems 
and Partridge, 2008). Blueberry extracts have also been shown to modulate biological 
responses (e.g. inhibition of inflammation) at treatment doses low enough to preclude the action 
of antioxidants as ROS scavengers as the sole explanation of their effects in neuronal cell 
culture (Gustafson et al., 2012). Interactions of specific polyphenolic compounds with diverse 
cellular signaling pathways outside of antioxidant signaling involved in aging have also been 
described (e.g. quercitin from apples and insulin signaling; Youl et al., 2010). Our results and 
these previous examples suggest that blueberry treatment elicits health benefits through 
signaling mechanisms outside, or at least in addition to, antioxidant signaling and scavenging.
Lowbush cranberry treatment increased lifespan to a lower extent than blueberry (22% 
compared to 30-47%), improved both anterior and posterior touch response late in life, and only
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impacted PLM neuron aging (i.e. increased posterior process branching). Chaga treatment 
resulted in bimodal lifespan extension to a similar magnitude as lowbush cranberry (up to 24%), 
only improved anterior touch response, and both decreased extended ALM soma outgrowths 
and increased PLM process branching and loop events late in life. Interestingly, there is not a 
clear relationship between total phenolic, flavonoid, and anthocyanin contents and these 
lifespan, healthspan, and neuron aging results (Table 3.1), suggesting that the concentrations of 
these compounds alone is not enough to predict anti-aging bioactivity. Although both lowbush 
cranberry and chaga treatments resulted in a similar magnitude of lifespan extension, the 
lowbush cranberry extract contained nearly 3x, 7x, and 29x more total phenolic, flavonoid, and 
anthocyanin content, respectively, than the chaga extract. Also, the extract containing the 
highest levels of all three polyphenols, crowberry, did not extend the lifespan of wildtype animals 
at the doses tested. This lack of lifespan extension may be due to either testing doses with too 
high of polyphenolic content or the presence of competing, non-beneficial molecules in the 
crowberry extract that are not in the blueberry or lowbush cranberry extracts.
Chaga extract contained the lowest polyphenolic compound levels of the studied 
extracts, yet, our ROS results support previous studies demonstrating that extracts from chaga 
exert potent antioxidant effects (Figure 3.4; Giridharan et al., 2011; Cui et al., 2005). While 
chaga contains novel polyphenolic compounds (Lee et al., 2007), it is interesting to note that the 
fungus also contains unique non-polyphenolic bioactive secondary compounds, such as steroid 
derivatives. Ergosterol peroxide, a steroid derivative unique to fungi, lichens, yeast, and 
sponges, was recently shown to have anti-cancer activity in a model of colorectal cancer (Kang 
et al., 2015). The low polyphenolic content in our chaga extract when compared to berry 
extracts coupled with the observed beneficial effects on aging (e.g. decreased ROS and 
increased lifespan) suggest that such a compound may be central to the health properties of 
chaga. The lack of correlation between the polyphenolic content in our extracts and ROS levels 
with the observed effects on whole animal and neuron aging suggests that the general
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antioxidant effect (i.e. removal of ROS) by these compounds may not be central to their 
involvement in healthy neuron aging. Rather, chaga-induced healthy neuron aging may be due 
to the interaction of polyphenolic and non-polyphenolic compounds with cellular signaling 
pathways distinct from antioxidant signaling pathways, another potential example of 
xenohormesis.
Anterior and posterior mechanosensory neurons respond to aging with different 
morphological changes: ALM neurons exhibit increased soma outgrowths and abnormal soma 
shapes while PLM neurons exhibit increased process outgrowths with age (i.e. branching, 
loops; Vayndorf et al., 2016; Toth et al., 2012; Pan et al., 2011; Tank et al., 2011). Our 
association of distinctly different mechanosensory neuron morphologies with improved health is 
novel. We found that both decreased outgrowth from anterior neuron somas (i.e. soma 
outgrowths) and increased outgrowth from posterior neuron axons (i.e. process branching) late 
in life are associated with improved mechanosensory neuron function (i.e. touch response), 
improved motility, and increased lifespan (Figure 3.8). Thus, increased incidence of these age- 
related morphologies is not directly correlated with poorer health: both decreased incidence of 
ALM aberrations (i.e. soma outgrowths, abnormal soma shape) and increased incidence of PLM 
aberrations (i.e. process branching and loops) correlate with increased lifespan, improved 
motility, and improved touch response. Others have shown that specific genetic mutations 
known to be involved in aging (e.g. insulin signaling) seem to regulate specific mechanosensory 
neuron morphologies (Scerbak et al., 2014; Toth et al., 2012; Tank et al., 2011; Pan et al., 
2011). Because of the apparent different cellular controls of these morphological changes, a 
synergy in maintaining organismal health with age may exist between the anterior and posterior 
neurons. Aspects of this potential synergy are evident in the treatment effects of chaga, which 
impacted both ALM and PLM neurons: although chaga treatment was not the most effective at 
extending lifespan at the doses tested (Figure 3.1), it maintained motility the best out of 
treatments tested (Figure 3.2) and maintained anterior touch response better than cranberry
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(Figure 3.3). What remains to be determined is whether increased incidence of morphological 
aberrations (e.g. PLM process branching) is a stimulatory response that actively promotes 
healthy aging or whether this phenotype occurs as a consequence of good health and aging. 
The ALM and PLM pairs of touch receptor neurons consistently respond to the aging process 
different manners; reflecting the multifaceted controls of aging at the cellular level.
These data and conclusions also bring up an exciting aspect of studying the impacts of 
medicinal foods on aging: the opportunity to study biological complexities that can rarely be fully 
recapitulated by single genetic manipulations. Studying the impact of culturally valued foods, 
such as Alaskan berries and fungi, not only supports the traditional ecological knowledge that 
these foods are beneficial to health, but provides novel insights into the mechanisms of 
neuronal aging and aging in general.
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Figure 3.1 Alaskan berry and fungus treatments extend wildtype C. elegans lifespan.
Representative survival curves for each berry and fungus treatment (A-C) and induced percent change in lifespan relative to control 
for all replicates (D-F) are shown (N=50 per treatment group). Asterisks denote significant lifespan extension (p<0.05; Kaplan Meier 
log-rank test) from control in 75% or more (***) and 60% or more (**) of 4-6 independent trials. Bars represent mean ± standard error 
of the mean between all replicates of a treatment dose.
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Figure 3.2 Lifespan-extending Alaskan berry and fungus treatments improve wildtype C. elegans motility late in life.
Percent per motility class of middle age (day 5 adults; A-C) and old age (day 11 adults; D-F) for lifespan-extending Alaskan blueberry 
(A, D), lowbush cranberry (B, E), and chaga (C, F) are shown. Class A animals (green bars) moved normally and spontaneously, 
class B animals (yellow bars) moved abnormally and may have required prodding, and class C animals (red bars) were unable to 
translocate. N=28-58 animals from at least 3 separate biological replicates per treatment group.
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Figure 3.3 Lifespan-extending Alaskan berry and fungus treatments improve wildtype C. elegans gentle touch response late in life.
Anterior (A-C) and posterior (D-F) mean touch score for each treatment group is shown. Asterisks denote significance from age- 
matched control (p<0.05; Poisson log linear model). Bars represent mean ± standard error of the mean. N=28-58 animals from at 
least 3 separate biological replicates per treatment group.
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Figure 3.4 Lifespan-extending Alaskan berry and fungus treatments change endogenous reactive oxygen species (ROS) levels in 
young wildtype C. elegans.
(A) The change in endogenous ROS measured by DCF-DA after treating young adults for 48h with selected lifespan-extending 
Alaskan berry and fungus treatments is shown. The percent change on a logarithmic scale of hsp16.2::GFP expression in the 
pharynx region of young adults treated for 48h with selected berry and fungus treatments relative to untreated control (B) and 
representative images (C-G) are also shown. Note the extreme increase in hsp16.2::GFP expression in response to heat shock. Bars 
represent mean ± standard error of the mean of each replicate, each with 2 or 3 technical replicates for the DCF-DA assay. Hashtag 
(p=0.085) and asterisks (p<0.06; one-way ANOVA with Tukey post-hoc) denote significance from 0^g/mL control.
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Figure 3.5 Alaskan blueberry treatments alter the accumulation of aberrations in aging anterior 
touch receptor neurons.
Animals from control and lifespan-extending blueberry treatments (60 and 200^g/mL) were 
imaged for touch receptor neuron aberrations at days 5, 7, 9, and 11 of adulthood. A schematic 
of the locations of the 6 GFP-labeled touch receptor neurons (A) is shown. Neuron aging 
markers in order of broad to more specific effects are shown: Mean number of total aberrations
(B), soma outgrowths (of all lengths) (C), extended outgrowths (>2x longer than soma diameter) 
per anterior (ALM) neuron (D) are shown along with representative images of ALM somas free 
of aberrations (E) and with extended outgrowth (F). Percent of all anterior cells imaged with 
abnormal somas (G) is shown along with example ALM neurons with abnormal somas (H-K). 
Bars represent mean ± standard error of the mean. Asterisks (p<0.05) and hashtags (p<0.08) 
denote significance from age-matched control. Nworms= 28-62 and Nanterior cells= 48-101 per 
bar. White arrowheads denote location of specific aberration. All images were collected at 20x 
magnification and were cropped to the same scale (no other image processing was performed). 
White scale bars are 10^m.
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Figure 3.6 Alaskan lowbush cranberry treatments increase occurrence of process branching in 
aging posterior touch receptor neurons.
Animals from control and lifespan-extending lowbush cranberry treatments (50 and 400|jg/ml_) 
were imaged for touch receptor neuron aberrations at days 5, 7, 9, and 11 of adulthood. Mean 
number of total aberrations (A) and branches observed on the dentrite/axon per posterior lateral 
touch receptor (PLM) neuron (B) are shown. Representative images of posterior neuron 
processes with no aberrations (C, D), with one process branch (E), and with multiple process 
branching events (F) are also shown. Bars represent mean ± standard error of the mean. 
Asterisks (p<0.05) and hashtags (p<0.085) denote significance from age-matched control. 
Nposterior cells= 48-73 per bar. In all images, the anterior end of the animal is to the right and 
posterior lateral touch receptor (PLM) neurons are shown. All images were collected at 20x 
magnification and were cropped to the same scale (no other image processing was performed). 
White scale bars are 10jm .
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Figure 3.7 Alaskan chaga treatments impact aging anterior and posterior touch receptor 
neurons.
Animals from control and lifespan-extending chaga treatments (50, 2, and 800^g/mL) were 
imaged for touch receptor neuron aberrations at days 5, 7, 9, and 11 of adulthood. The total 
number of anterior cell soma outgrowths was unchanged with chaga treatment (A), but the 
mean number of extended outgrowths (>2x longer than soma diameter) (B) and short soma 
outgrowths (<1x soma diameter) per anterior cell (C) were impacted. Posterior cell process 
outgrowths (D) represents branching or loop phenotypes observed from the axon and/dendrites 
of the two posterior lateral neurons (PLM). Representative images of short soma outgrowths 
(E), standard soma outgrowth (1x soma diameter; F), different length soma outgrowths (G) and 
extreme aberrations (H) are also shown. Bars represent mean ± standard error of the mean. 
Asterisks (p<0.05) denote significance from age-matched control. Nworms= 28-50, Nanterior 
cells= 50-95, and Nposterior cells= 56-100 per bar. . All images were collected at 20x 
magnification and were cropped to the same scale (no other image processing was performed). 
White scale bars are 10^m.
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Figure 3.8 Schematic summary of results.
Non-treated wildtype aging C. elegans touch receptor neurons exhibit increased extended 
outgrowths from the anterior neuron (ALM) soma and increased abnormal ALM soma by late life 
(day 11 of adulthood). Alaskan berry and fungus treatments impact this neuron aging trajectory 
by blocking accumulation of ALM aberrations (i.e. blueberry), increasing the incidence of 
posterior neuron (PLM) aberrations (i.e. lowbush cranberry), or both (i.e. chaga) when 
compared to age-matched controls. Nevertheless, all 3 treatments significantly increase lifespan 
and improve markers of healthspan (i.e. motility and touch response late in life).
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Supplemental Figure 3.1 Crowberry treatment does not affect wildtype C. elegans lifespan.
Treatment with 100, 200, and 800^g/mL crowberry mixed into NGM agar did not significantly 
affect mean or median lifespan at 25°C (0.13<p<0.78), Kaplan-Meier log-rank test; 3 replicates). 
Representative survival curves are shown (N=50 per treatment group).
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Supplemental Figure 3.2 Blueberry and lowbush cranberry treatments increase wildtype C. 
elegans lifespan even with UV killed bacterial food source.
Mean C. elegans lifespan cultured on UV killed bacteria increased from 10.2±0.3 to 11.4±0.6 
and 12.3±0.3 days (11.7% and 20.2% increase) upon treatment with 60 and 200^g/mL 
blueberry, respectively (p<0.05, Kaplan Meier log-rank test). 50 and 400^g/mL lowbush 
cranberry treatment increased lifespan to 12.6±0.5 and 13.2±0.7 days (14.2% and 19.9% 
increase), respectively, from 11.1 ±0.3 days in the presence of UV killed bacteria (p<0.01, 
Kaplan Meier log-rank test). Treatment with 50, 200, and 800^g/mL chaga did not significantly 
alter lifespan in the presence of UV killed bacteria (p>0.25, Kaplan Meier log-rank test, 3 
replicates). Asterisks represent significance from untreated control (p<0.05, Kaplan Meier log- 
rank test). Representative survival curves are shown (N=50 for each treatment group).
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Supplementary Figure 3.3 Lifespan-extending Alaskan berry and fungus treatments alter 
wildtype C. elegans daily progeny production, but not total progeny produced.
Blueberry (A), lowbush cranberry (B), and chaga (C) treatments differentially affected the 
number of progeny produced per adult per day on days 2, 3, and 1 of adulthood, respectively 
(p<0.05; Poisson log linear model), but did not alter the total number of progeny produced per 
adult (Table 3.3). Peak progeny production in all groups was observed at day 2 of adulthood 
(48h after treatment administration) and all animals ceased viable progeny production by day 6 
of adulthood.
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Table 3.1 Biochemical quantification of crude extracts.
Total phenolic content (quantified by Folin-Ciocalteu assay with gallic acid equivalent), flavonoid 
content (quantified by NaNO2/Al/NaOH assay with catechin equivalent), and anthocyanin 
content (quantified by pH-differential with cyanidin-3-glucoside) ± standard error of the mean for 
each berry and fungus extract is reported.
Total Phenolic 
Content 
(mg GAE g-1 FW)
Flavonoid 
Content 
(mg CAE 100g-1 FW)
Anthocyanin 
Content 
(mg C3G L-1 FW)
Blueberry 190.4 ± 4.0 202.3 ± 1.4 217.4 ± 5.3
Lowbush cranberry 219.6 ± 6.4 896.2 ± 8.6 158.4 ± 5.3
Chaga 74.9 ± 3.3 125.9 ± 3.1 5.5 ± 2.6
Crowberry 365.3 ± 9.2 453.2 ± 30.1 713.9 ± 45.2
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Table 3.2 Alaskan berry and fungus treatments extend wildtype C. elegans lifespan.
Percent change in lifespan relative to control, significance from the representative survival 
curves shown in Figure 3.1A-C. The highest and lowest percent increase in lifespan relative to 
control in all replicates is also reported. Experiments were repeated in multiple independent 
trials (>3), all with the same directional effect and similar magnitude of effect. Statistical 
significance (p value) calculated with Kaplan-Meier log-rank test.
Treatment N
Mean 
Lifespan ± 
S.E.M.
Percent
of
Control
p value
Highest
Increase
Observed
Lowest
Increase
Observed
Blueberry dose ( i^g/mL)
0 60 9.48±0.31
60 66 12.4±0.56 156% <0.0001 128% 107%
100 60 11.2±0.59 147% <0.0001 144% 111%
200 51 12.4±0.73 146% 0.001 147% 120%
400 58 11.2±0.58 139% <0.0001 139% 120%
800 60 9.31±0.28 109% 0.341 117% 109% (n.s.)
Lowbush cranberry dose (^g/mL)
0 50 11.3±0.58
50 50 13.9±0.91 122% 0.012 122% 116%
100 51 11.1±0.50 102% 0.868 116% 104% (n.s.)
200 50 12.5±0.49 110% 0.123 119% 106%
400 50 13.9±0.89 122% 0.016 122% 108%
800 50 12.5±0.28 107% 0.229 119% 108% (n.s)
Chaga dose (^g/mL)
0 50 10.7±0.50
50 49 13.1±0.60 122% 0.002 122% 113%
200 50 12.9±0.55 121% 0.005 124% 117%
800 47 12.9±0.65 121% 0.003 121% 116%
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Table 3.3 Alaskan berry and fungus treatments do not alter total progeny produced by wildtype 
C. elegans.
Experiments were repeated in 3 independent trials each with N=8 parents per treatment group, 
all with no significant effect observed.
Treatment
Total Progeny Produced 
per Adult 
(Mean ± S.E.M.)
Blueberry dose 
(ug/ml)
0 190.7±27.5
60 198.2±13.9
200 195.2±38.0
Lowbush 
cranberry dose 
(ug/ml)
0 183.4±19.3
50 201.7±10.2
400 198.3±7.2
Chaga dose 
(ug/ml)
0 173.4±7.47
50 174.9±14.7
200 188.1±4.6
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Chapter 4
Neuronal Aging in Caenorhabditis elegans is Modulated via Distinct Cellular Signaling and 
Genetic Mechanisms: Insights from Alaskan Berry and Fungal Treatments1
4.1 Abstract
We previously described the beneficial effects of three commonly consumed and 
culturally relevant Interior Alaskan plant and fungus species (bog blueberry, lowbush cranberry, 
and chaga fungus) on the decline in Caenorhabditis elegans overall health, mechanosensation, 
and touch receptor (mechanosensory) neuron morphology associated with aging. Here, we 
describe the cellular and molecular mechanisms underlying these health effects. Only lowbush 
cranberry treatment caused marked activation of the central aging-related transcription factor 
DAF-16/FOXO. Further, DAF-16 activity is required for the observed lowbush cranberry 
treatment-mediated lifespan extension and touch receptor neuron functional improvements and 
morphological changes. We then utilized next generation sequencing to conduct a non-biased 
comparison of gene expression in control, blueberry-treated, and chaga-treated young adults 
(day 3), with the goal of testing the involvement of genes differentially regulated early in life in 
the aging processes of touch receptor neurons. Of the nearly 40,000 transcripts in C. elegans, 
we detected 206 genes with significant changes between control and treatments and between 
the two treatments. From these 206 genes, we selected 12 genes with known neuron-related 
functions (e.g. axon guidance, cytoskeleton regulation, metabolism) and tested the impact of 
these genes on touch receptor neuron morphology and function in aged animals (day 11) using 
RNA interference. Of the 12 selected candidate genes, 8 (max-1, pck-1, stn-1, ttx-1, tub-1, unc- 
115, unc-44, ZK418.3) have roles in aging touch receptor neurons. These results indicate that
1 Authorship for this paper is as follows: Courtney Scerbak, Elena Vayndorf, Alicia Hernandez, Colin 
McGill, and Barbara Taylor. In preparation for submission.
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the different touch receptor neuron phenotypes observed with Alaskan nutraceutical treatments 
reflect distinct cellular and molecular mechanisms. We demonstrate that multiple, novel cellular 
signaling pathways are involved in aging, specifically touch receptor neuron aberration 
development. Furthermore, we demonstrate that nutritional interventions may be used to 
discover and describe novel genes important in the biology of aging.
4.2 Introduction
Aging and nutrient consumption are tightly linked; the cellular signals and gene 
expression changes following the ingestion of nutrients impact biomarkers of aging. 
Epidemiological studies consistently show that dietary patterns rich in plant food sources are 
correlated with increased lifespan, decreased incidence of age-related diseases, or both 
(reviewed in Fleming et al., 2013). In model organisms, such as worms, flies, and rodents, many 
nutrients are studied for their impact on various biomarkers of aging (examples reviewed in 
Spencer, 2008; Zafra-Stone et al., 2007; Liu, 2004; Vayndorf et al., 2013). Alaskan traditional 
knowledge holds that a diverse collection of local plants and fungi benefit health and wellness 
(Garabaldi, 1999; Kari, 1995). Additionally, Alaskan plant and fungus species have adapted to 
extreme environments, in part by producing a wide variety of secondary metabolites (Elks et al.,
2013), indicating that the molecular action of these food sources may provide novel insights into 
the aging process.
High-thoroughput RNA sequencing (RNAseq) is a widely applicable, non-biased 
technique used to sequence, align, and quantify gene expression levels using RNA sequences 
isolated from a biological sample. This non-biased approach also allows for the detection of 
candidate genes for specific functional studies that might otherwise not be selected. RNAseq 
has been used to further our understanding of molecular biology and genetics in a variety of 
complex biological scenarios: uncovering the heterogeneity of cancerous tumors (Patel et al.,
2014); describing developmental differences in Caenorhabditis elegans gene expression (Li et
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al., 2014; Spencer et al., 2011); and discovering cell specific gene expression networks 
regulated by transcription factors, such as DAF-16/FOXO in C. elegans (Kaletsky et al., 2016). 
RNAseq is a descriptive approach to discerning complex treatment effects at the molecular 
level.
In both humans and the model organism, C. elegans, neurons are known to change 
shape and function with age (rather than dying), which, due to the communication and 
integration function of the nervous system, impacts aging of the entire organism. One class of 
C. elegans neurons known to change shape and function with age are the mechanosensory or 
touch receptor neurons, which sense soft touch. These neurons develop novel outgrowths from 
the soma, additional branching on the axon/dentrites, and abnormal soma shapes with age 
(Toth et al., 2012; Pan et al., 2011; Tank et al., 2011). The age-related development of these 
morphologies are regulated, in part, by two signaling pathways central to the regulation of 
lifespan and healthspan: the insulin/IGF and Jun kinase pathways (Scerbak et al., 2014; Toth et 
al., 2012; Pan et al., 2011; Tank et al., 2011). However, the cellular mechanisms by which these 
pathways (and likely others) regulate aging-related changes in the morphology of touch receptor 
neurons have yet to be fully described.
We previously described the beneficial effects of commonly consumed and culturally 
relevant Interior Alaskan plant and fungus species (bog blueberry, lowbush cranberry and chaga 
fungus) on the decline in overall health, neuronal function, and touch receptor neuron 
morphology associated with aging. Here, we tested the involvement of the central aging-related 
transcription factor in the insulin signaling pathway, DAF-16/FOXO, in the development of the 
observed effects (e.g. lifespan, aging neuron morphologies). We also performed RNAseq on 
young adult C. elegans treated with lifespan-extending doses of Alaskan blueberry (Vaccinium 
uliginosum) and chaga (Inonotus obliquus) extracts to inform subsequent genetic screens of 
aging neuron morphology and function. Through the RNAseq results, we uncovered previously 
undescribed candidate neuron morphology modulators. Our findings support the growing
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evidence that C. elegans touch receptor neuron aging is regulated via multiple mechanisms, 
including well-studied (e.g. insulin/IGF signaling) and novel pathways.
4.3 Materials and methods
4.3.1 C. elegans strains and maintenance
The C. elegans strains N2 (Bristol wildtype), TJ356 (DAF-16::GFP (zIs356 IV [daf- 
16p::daf-16a/b::GFP + rol-6])), OG497 (HSF-1::GFP (drSi13 II [hsf-1p::hsf-1::GFP::unc-54 
3'UTR + Cbr-unc-119(+)]; unc-119(ed3) III)), GR1307 (daf-16(mgdf50)), ZB154 (zdIs5 [Pmec- 
4GFP; lin-15(+)]), and ZB4064 (zdIs5 [Pmec-4 GFP; lin-15(+)]; uls57 [Punc-ngSID-1, Punc-ngYFP, 
Pmec-6mec-6]) were used in this study. Both ZB154 and ZB4064 exhibit GFP-labeled touch 
receptor neurons (Toth et al., 2012), and ZB4064 overexpresses the SID-1 transmembrane 
channel in all neurons (Calixto et al., 2010), rendering neurons susceptible to RNA interference 
treatment.
We used standard methods to maintain and manipulate C. elegans populations 
(Brenner, 1974). Stock populations were cultured at room temperature (about 22°C) on 
Nematode Growth Media agar plates (1L NGM: 2.5g peptone, 17g agar, 3g NaCl, 975mL 
double distilled water, 1mL 5mg/mL Cholesterol, 1mL 1M CaCl2, 1mL 1M MgSO4, 25mL 1M 
KHPO4, and 0.5mL 100mg/mL streptomycin) seeded with live bacteria (E. coli strain OP50-1 
cultured in Luria Broth) that was allowed to form a lawn for 2 days at room temperature and then 
stored at 4°C until use.
4.3.2 Berry and fungus extract preparation and treatment administration
The Alaskan blueberry and chaga extract preparation and treatment administration 
herein are the same as described in Chapter 3. Briefly, extracts of wild Alaskan specimens of 
blueberry (Vaccinium uliginosum) and chaga (Inonotus obliquus) were prepared with 80% 
aqueous acetone and rotaevaporation (blueberry) or boiling water and straining (chaga).
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Freeze thaw cycles were limited to one (thawed from -80°C then aliquoted and frozen at -20°C 
until use) to ensure maximal preservation of bioactive components. To administer berry and 
fungus treatments to C. elegans populations, we cultured synchronous, day 1 adult populations 
of the appropriate strain on NGM agar plates mixed with the appropriate concentration of extract 
and seeded with live OP50-1 E. coli at 25°C. Control populations were cultured on standard 
NGM plates without extract. For experiments involving aged populations, animals were hand 
transferred to fresh treatment plates to maintain synchrony and to avoid starvation and 
crowding.
4.3.3 Transcription factor activation assays
To visualize the activation of transcription factors, we utilized two previously described 
C. elegans strains: TJ356 (DAF-16::GFP; Henderson and Johnson, 2001) and OG497 (HSF- 
1::GFP; Morton and Lamitina, 2013). Synchronous populations were allowed to develop on 
NGM plates for 72h at 20°C and cultured on appropriate treatment plates until imaging (days 3 
and 9 of adulthood). For animals expressing DAF-16::GFP, we imaged at 10x magnification to 
visualize the entire animal. Positive controls were heat shocked for 30min at 37°C on agar 
plates and imaged immediately thereafter. Each DAF-16::GFP animal was classified into 3 
groups based on the nuclear foci observed: nuclear animals had foci seen throughout the 
animal with very little diffuse fluorescence (Figure 4.1C and 4.1 D), and intermediate animals 
had at least three distinct DAF-16::GFP foci with mostly diffuse fluorescence (Figures 4.1E and 
4.1G) (Oh et al., 2005). For animals expressing HSF-1::GFP, only 5 individuals were prepared 
for imaging at once, the epithelial cell layer in the bottom third of each animal was imaged at 
40x and positive controls were heat shocked for 30min at 35°C after preparing for imaging. To 
detect treatment effects, we used an ordinal logistic statistics model.
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4.3.4 RNA extraction and sample preparation
We collected total RNA from large, synchronous populations of day 3 adult C. elegans 
(2-3 100x20mm plates; >600 individuals) initiated via bleaching (i.e. isolation of embryos from 
healthy adults using a 5M NaOH and Chlorox 5% sodium hypochlorite solution and vortexing) 
and cultured 48h with 200^g/mL Alaskan blueberry extract, 200^g/mL Alaskan chaga extract, or 
no treatment. On the designated day, each adult population was isolated from their progeny by 
washing through a 50^m filter with M9 (autoclaved 3g KH2PO4, 5g NaCl, 6g Na2HPO4*7H2O and 
sterile 1mL 1M MgSO4 in 1L H2O) and allowed to settle by gravity and form a pellet before 
proceeding (<2 min). The pellet was then pipetted into a ceramic pestle pre-chilled with liquid 
nitrogen, immediately crushed with a mortar to a fine powder, transferred to RNAase free 2mL 
eppendorf tubes (filling up to 1.3mL), and placed on ice. Liquid nitrogen was added to the pestle 
as needed to keep the sample frozen. After all populations had been crushed and frozen, we 
proceeded with the RNA Purification step of the PureLink RNA Mini Kit (Ambion; catalog 
number 12183025), which involves binding, washing, and elution of the RNA. We then aliquoted 
2^L of each sample for prompt quality control analysis and immediately froze (-80°C) two 10^L 
aliquots of the remaining sample. Only samples determined to have a concentration >25^g/^L, 
RNA integrity value >7.0, and A260/A280 ratio >1.6 using a NanoDrop ND-1000 
Spectrophotometer and Aligent 2100 Bioanalyzer were sequenced. This extraction procedure 
was repeated in three independent trials, each with all three treatments (i.e. control, blueberry, 
chaga) prepared and cultured in parallel.
4.3.5 RNA sequencing and analysis
RNA samples were sent to Expression Analysis (EA; Durham, NC) for sequencing and 
analysis. EA created the library and performed 50bp paired end sequencing using an Illumina 
next generation sequencing platform. Specifically, total RNA samples were converted into cDNA 
libraries using the TruSeq Stranded mRNA Sample Prep Kit (Illumina, #RS-122-2103). Starting
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with 100ng of total RNA, polyadenylated RNA (primarily mRNA) was selected and purified using 
oligo-dT conjugated magnetic beads. This mRNA was chemically fragmented and converted 
into single-stranded cDNA using reverse transcriptase and random hexamer primers, with the 
addition of Actinomycin-D to suppress DNA-dependent synthesis of the second strand. Double­
stranded cDNA was created by removing the RNA template and synthesizing the second strand 
in the presence of dUTP in place of dTTP. A single A base was added to the 3’ end to facilitate 
ligation of sequencing adapters, which contain a single T base overhang. Adapter-ligated cDNA 
was amplified by polymerase chain reaction to increase the amount of sequence-ready library. 
Final cDNA libraries were analyzed for size distribution and using an Agilent Bioanalyzer (DNA 
1000 kit, Agilent # 5067-1504), quantitated by qPCR (KAPA Library Quant Kit, KAPA 
Biosystems # KK4824), then normalized to 2 nM in preparation for sequencing.
17.4-28.8 million reads were generated per sample and were aligned to the C. elegans 
genome (Ensemble Caenorhabditis_elegans version 80). These reads were the processed and 
analyzed using the EA RNA analysis pipeline, version 9. Pairs of treatment groups (e.g. control 
vs. blueberry or chaga vs. blueberry) were then compared to determine differential expression 
by calculating fold change, unadjusted p-value, and false discovery rate (Supplementary Tables 
4.1-4.3). Detected transcripts (>5 counts in at least one group) with an FDR of <0.30 and 
unadjusted p value <0.01 were considered significantly impacted by treatment (Supplemental 
Table 4.4). Gene ontology analysis was performed on significantly impacted transcripts with the 
publically available DAVID Bioinformatics Resources (version 6.7; Huang et al., 2009).
4.3.6 RNA interference treatment
To administer RNA interference (RNAi) treatment, we cultured age-synchronous 
populations of C. elegans on RNAi agar plates (2.5g peptone, 17g agar, 3g NaCl, 1mL 5mg/mL 
cholesterol, 1mL 1M CaCl2, 1mL 1M MgSO4, 25mL 1M KHPO4, 1mL 1M isopropyl beta-D-1- 
thiogalactopyranoside [IPTG], and 0.5mL 50mg/mL carbenicillin per 1L) seeded with 4x
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concentrated L4440 (empty vector) HT115 E. coli protected from light at 25°C. All animals 
began RNAi (and berry or fungus treatment, if required) after normal development - 48h after 
egg lay at 25°C. All subsequent treatment and control plates consisted of RNAi plates mixed 
with varying concentrations of the appropriate extract as described above, seeded with 4x 
concentrated live HT115 bacteria from the Ahringer Library. Bacterial dsRNA production was 
induced by growing the HT115 bacterial lawn at room temperature (~22°C) for two days, 
allowing us to target the desired C. elegans mRNA for degradation. The experimenter was 
always blinded to the RNAi and extract treatment regimens until statistical analysis. To verify the 
RNAi treatment conditions for each experiment, we performed control experiments measuring 
fluorescence knockdown following GFP RNAi treatment (Supplemental Figure 4.2). RNAi clone 
identity was verified by sequencing (Macrogen Corp.; primer M13F) after plasmid extraction 
(QIA Spin Miniprep Kit; Qiagen; cat num 27104).
4.3.7 Touch receptor neuron morphology and touch response analysis
On day 11 of adulthood (10 days after beginning RNAi/extract treatment), ZB4064 
individuals were randomly selected from a synchronous population and tested for motility, touch 
sensitivity, and touch receptor neuron aberrations. We assigned individuals into three classes 
based on their motility: Class A individuals moved normally and spontaneously; Class B 
individuals moved in markedly non-sinusoidal manner and, often, non-spontaneously; and Class 
C individuals were alive but unable to translocate (Herndon et al., 2002). We measured soft 
touch sensitivity by counting the number of positive responses an individual had to five 
alternating touches at each the anterior and posterior (10 total touches; Toth et al., 2012). 
Finally, to visualize the fluorescently labeled touch receptor neurons, we mounted individuals to 
a coverslip with 36% Pluronic solution and imaged the neurons with an Olympus FSX100 
inverted fluorescent microscope at 20x magnification. We quantified the occurrence of abnormal 
morphologies in the anterior and posterior lateral touch receptor neurons (ALM and PLM) of
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each individual and collected reference images. The neuron morphologies observed included 
those previously described (Scerbak et al., 2014; Toth et al., 2012; Pan et al., 2011; Tank et al., 
2011), such as various lengths of outgrowths from the soma (e.g. short or extended), branches 
from the process, abnormally shaped soma, punctae on the process, and soma in the wrong 
location. Additional morphologies were also observed and included branches from the process 
that connect back to the process (i.e. loops) and deformed process sections (i.e. tangles). We 
performed Poisson log linear (for count data, i.e. touch response) or logistic regression (for 
bimodal data, i.e. presence of abnormal cell soma) statistical models to test for treatment and 
age effects on touch sensitivity and neuron morphologies using SPSS (version 20) statistical 
software. Pairwise comparisons with p<0.05 were considered significant. We repeated this 
experiment in at least three independent trials for each combination of RNAi and extract 
treatment, each with a parallel empty vector L4440 no treatment control.
4.4 Results
4.4.1 Alaskan lowbush cranberry activates DAF-16/FOXO late in life
The well-studied DAF-16/FOXO and HSF-1 transcription factors are involved in longevity 
and stress response (reviewed in Hsu et al., 2003). Because of this, we tested the involvement 
of these central transcription factors in the Alaskan berry- and fungus-mediated effects we 
previously observed, namely lifespan extension and aging touch receptor neuron morphological 
and functional changes. C. elegans strains with GFP-tagged DAF-16 (strain TJ356) or HSF-1 
(strain OG497) are available to visualize activation of these transcription factors in response to 
stress (Morton and Lamitina, 2013; Henderson and Johnson, 2001). In the DAF-16::GFP 
animals, DAF-16 can be visualized in the nuclei of cells as distinct foci in response to stressors, 
such as heat shock (Figures 4.1C and 4.1D). After 48 hours of treatment with lifespan- 
extending Alaskan berry and fungus treatments (day 3 of adulthood), we did not detect 
activation of DAF-16 into nuclear foci with any treatment (Supplemental Figure 4.1). However, at
111
day 9 of adulthood (after 8 days of treatment), we observed formation of DAF-16 nuclear foci in 
both lifespan-extending lowbush cranberry treatments (Figure 4.1; Table 4.1). Blueberry and 
chaga treatments did not lead to detectable DAF-16 nuclear foci early (Supplemental Figure 
4.1) or late in life (data not shown).
In the HSF-1::GFP strain, HSF-1 is observed in nuclei under normal conditions and upon 
exposure to stress, forms distinct granules within nuclei, representing HSF-1 binding to DNA 
(Morton and Lamitina, 2013). We were unable to detect formation of HSF-1::GFP granules 
within nuclei following 48 hours of any lifespan-extending Alaskan berry and fungus treatment 
(Supplemental Figure 4.1). Interestingly, HSF-1::GFP animals had granules in all groups 
(including untreated control) later in adulthood (day 9), making it unfeasible for this method to 
determine whether HSF-1 is activated later in life due to Alaskan berry and fungus treatments.
4.4.2 Alaskan lowbush cranberry modulates DAF-16 to extend lifespan and influences
touch receptor neuron aging
To examine whether the DAF-16::GFP nuclear foci observed after lowbush cranberry 
treatment reflect a requirement for functional DAF-16 in lowbush cranberry-mediated lifespan 
extension, we treated C. elegans DAF-16 mutant populations (strain GR1307; daf-16(mgdf50); 
Ogg et al., 1997) with lowbush cranberry doses that extended wildtype lifespan (shown in 
Chapter 2 for the doses of 50 and 400|jg/mL). These DAF-16 mutants did not respond with 
increased lifespan to lowbush cranberry treatment, which suggests that the requirement of a 
functional DAF-16/FOXO transcription factor is needed for lifespan extension via lowbush 
cranberry treatment (Figure 4.2A; Table 4.2).
In young adults, the two posterior lateral (PLM) and two anterior lateral (ALM) touch 
receptor neurons consist of a spherical cell soma with axon projections towards the head of the 
animal. With age, these neurons exhibit decreased function (i.e. touch response) and altered 
morphology; ALM neurons develop additional outgrowths from the soma and abnormal (non-
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spherical) cell soma and PLM neurons develop addition growths on the axon (i.e. branches; 
Toth et al., 2012; Pan et al., 2011; Tank et al., 2011). We previously reported that lifespan- 
extending lowbush cranberry treatment increased the incidence of axon branching in posterior 
touch receptor neurons and improved touch response late in life. Thus, we also evaluated the 
involvement of DAF-16 in these lowbush cranberry-mediated touch receptor neuron aging 
effects. To do this, we compared the effects of lowbush cranberry, daf-16(RNAi), and lowbush 
cranberry-daf-16(RNAi) combination treatments on touch receptor neuron morphology and 
touch response in old (day 11) ZB154 animals (6 GFP-labeled touch receptor neurons). These 
experiments specifically tested the involvement of non-neuronal DAF-16 in the observed 
lowbush cranberry-induced increase in posterior cell branching events (as wildtype C. elegans 
neurons are not susceptible to RNAi; Calixto et al., 2010). We observed that daf-16(RNAi) 
completely blocked the observed increase in posterior touch response with empty vector 
lowbush cranberry treatments (p>0.8; Poisson log linear model; Figure 4.2B). daf-16(RNAi) and 
resulted in the same occurrence of posterior neuron process branching events as untreated 
empty vector control animals (p>0.1 Poisson log linear model; Figure 4.2C). Also, daf-16(RNAi) 
untreated and lowbush cranberry treated groups were not significantly different from untreated 
empty vector control in anterior touch response and most anterior neuron aberrations (p>0.1, 
Poisson log linear model). DAF-16 treatment did somewhat increase the number of anterior 
soma outgrowths observed at day 11 in all lowbush cranberry treatment groups; however, the 
change did not reach significance (111% of empty vector controls; 0.09>p>0.06 Poisson log 
linear model), suggesting that DAF-16 may be involved in the development of these aberrations 
through a mechanism not impacted by lowbush cranberry treatment (Figure 4.2D).
Others have observed that blueberry polyphenol-mediated lifespan extension does not 
require DAF-16 (Wilson et al., 2006). To test whether this is also the case with Alaskan 
blueberry treatments, we measured the lifespan of DAF-16 mutants (strain GR1307; daf- 
16(mgdf50)) with lifespan-extending blueberry treatments (60 and 200^g/mL). DAF-16 mutants
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maintained blueberry-mediated lifespan extension similar to that of wildtype (p<0.05; Kaplan 
Meier log-rank test; Table 4.5), indicating that DAF-16 is most likely not required for lifespan 
extension from blueberry treatment. Interestingly, chaga-mediated lifespan extension did 
require DAF-16 (Table 4.2), but we were unable to detect DAF-16 activation in live animals early 
or late in life (Supplemental Figure 4.1).
4.4.3 Alaskan blueberry and chaga treatments differentially impact the transcriptome
To further describe the molecular role Alaskan blueberry and chaga treatments play in 
the aging process, we used whole animal RNA sequencing to quantify differential transcript 
expression following treatment with lifespan-extending Alaskan extracts. Specifically, we 
collected total RNA from three independent biological replicates of young adult C. elegans 
populations each treated with 200^g/mL blueberry extract, 200^g/mL chaga extract, or nothing 
(control) for 48 hours. We obtained 17.4-29.1 million reads per sample with 32.1-37.9% and 
98.9-99.2% of those reads mapping to the current definition of the C. elegans transcriptome and 
genome, respectively, (Table 4.3).
We performed two separate pairwise statistical analyses to compare the transcriptome 
of control versus treatment (i.e. blueberry or chaga treated) populations (Figure 4.3A and 4.3B). 
The blueberry treatment induced small changes in the transcriptome when compared to control: 
11 transcripts were significantly up-regulated and 6 were significantly down-regulated (FDR<0.3 
and unadjusted p<0.0001; Figure 4.3A; Supplementary Table 4.1). Treatment with chaga 
resulted in the up-regulation of 86 transcripts and the down-regulation of 22 transcripts 
(FDR<0.3 and unadjusted p<0.001; Figure 4.3B; Supplementary Table 4.2). We then compared 
the transcripts significantly impacted by either blueberry or chaga treatment and found that only 
5 transcripts were up-regulated in both treatments and there was no overlap in the down- 
regulated genes of either treatment (Figure 4.3C and 4.3D). To examine the molecular and 
biological function of transcripts regulated by each treatment, we used the gene ontology (GO;
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gene function/description) functional annotation tool in the DAVID Bioinformatics Resources 
program (Huang et al., 2009). Blueberry treatment again impacted a small number of gene 
ontology terms, related to cellular membranes but with little to no functional descriptions (Figure 
4.1E; blue bars). Of the transcripts significantly impacted by blueberry treatment, only 29% (5 of 
17 transcripts) have a known or predicted GO molecular function and only 41% (7 of 17 
transcripts) have a known or predicted GO biological function (PANTHER analysis; Huaiyu et 
al., 2013). Chaga treatment not only similarly impacted the same membrane GO terms as 
blueberry but also exhibited enriched (i.e. statistically overrepresented) GO terms in sensory 
perception of chemical stimulus, receptor activity, and molecular transducer activity (Figure 
4.3E; orange bars). A high proportion of the transcripts regulated by chaga treatment had known 
functions: 60% (64 of 106 transcripts) had a known or predicted GO molecular function and 98% 
(104 of 106 transcripts) had known or predicted GO biological function (PANTHER analysis; 
Huaiyu et al., 2013).
To further compare the effects of Alaskan blueberry and chaga treatments on the 
transcriptome, we performed an additional pairwise statistical analysis to compare the 
transcriptomes of chaga-treated populations relative to blueberry-treated populations (Figure 
4.4A; Supplemental Table 4.3). This comparison yielded 133 up-regulated and 22 down- 
regulated transcripts, relative to blueberry expression levels (FDR<0.3 and unadjusted p<0.001; 
Supplemental Table 4.3). A large number of GO terms were enriched in this comparison 
(N=65), many of which fall into DAVID functional annotation clusters, which group GO terms 
based on the genes that are shared between them (Figure 4.4B and 4.4C). Enriched GO terms 
in this comparison again included membrane, sensory perception, and molecular transducer 
activity terms. Additional signaling (e.g. cell communication and zinc finger domain) and 
behavior (e.g. locomotion and response to nutrients) GO terms were enriched in this chaga- 
versus blueberry-treated population comparison that were not uncovered in the comparisons 
with control groups. DAVID functional annotation clustering highlights important GO annotation
115
groups by their overrepresentation in a gene list (i.e. transcripts significantly impacted in the 
chaga- versus blueberry-treatment comparison), allowing the GO terms to be explored in groups 
(Huang et al., 2009). This analysis revealed several neuron-related, enriched clusters of GO 
terms: behavior and response to stimuli (10 GO terms; Cluster 2; purple bars) and neuron 
development and morphology (13 GO terms; Cluster 6; orange bars; Figure 4.4B and 4.4C).
4.4.4 Cytoskeleton- and metabolism-mediating candidate genes impact aging touch
receptor neuron morphology and function
To relate gene expression changes early in life with aging touch receptor neuron 
morphology and function, we selected significantly impacted candidate genes from all three 
comparisons with enriched DAVID functional annotation clusters expressed in neurons and with 
homlogy to human genes (Supplemental Table 4.4). Genes selected included those known to 
be involved in neurotransmission, actin-binding processes, neuron differentiation and 
morphogenesis, and behavioral responses to stimuli (Table 4.4). To examine the effects of 
these genes on touch receptor neuron aging, we knocked down neuronal expression of the 
candidate genes after normal development with RNAi and examined neuronal aging phenotypes 
late in life (day 11) in ZB4064 animals (with GFP-labeled touch receptor neurons and neurons 
susceptible to RNAi treatment).
We previously demonstrated that lifespan- and healthspan-extending Alaskan 
nutraceutical treatments differentially impact touch receptor neuron morphology with age and 
our control treatments in this study replicate those results (even under RNAi treatment 
conditions: RNAi plates, HT115 E. coli, different C. elegans strain, ZB154). Briefly, blueberry 
treatment decreases the occurrence of anterior neuron extended soma outgrowths (>2x soma 
diameter; 44±0.1% versus 41 ±0.1 % occurrence; p<0.05; binary logistic model; data not shown) 
and abnormal anterior cell somas (non-spherical shape; Figure 4.7D; second bar), which is 
again reflected in these data. Chaga treatment resulted in decreased occurrence of extended
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soma outgrowth on anterior neurons (44±0.1% versus 19±0.1% occurrence; p<0.05; binary 
logistic model; data not shown) and increased process branching in posterior neurons (Figure 
4.7B; third bar).
Only one gene significantly impacted by blueberry treatment had both a known or 
predicted function homologous to humans and RNAi clones available through the Ahringer 
library (ZK418.3; Table 4.4; Figure 4.5). This neuron-specific knockdown not only increased the 
proportion of mobile (Class A) relative to immobile (Class C) aged animals (day 11) when 
compared to no treatment control (p<0.05 ordinal logistic model; Figure 4.5A), it also specifically 
increased the accumulation of posterior touch receptor neuron aberrant morphologies, namely 
process branching (p<0.01 binary logistic model; Figure 4.5B) and loop events (p<0.05 binary 
logistic model; Figure 4.5C). The anterior touch response of ZK418.3(RNAi) animals was also 
increased over control levels, to the same extent as blueberry treatment (2.2±0.01 versus 
2.6±0.1; <0.05 Poisson log-linear model; data not shown). Posterior touch response (p>0.05 
Poisson log-linear model) and anterior neuron morphology (p>0.05 binary logistic model for all 
observed morphologies) of these animals were unaffected (data not shown).
We selected two candidate neuron morphology modulators from genes significantly 
impacted by chaga treatment: nhr-35 and pck-1 (Table 4.4; Figure 4.6). Neuronal knockdown of 
both genes improved motility of old (day 11) treated animals to equal that of chaga-treatment 
levels (p<0.05 ordinal logistic model; Figure 4.6A). However, only pck-l(RNAi) resulted in 
increased posterior neuron branching events when compared to control levels (p<0.01 binary 
logistic model; Figure 4.6B). These RNAi treatments did not impact any other tested 
phenotypes, including anterior and posterior touch response (p>0.05 Poisson log-linear model) 
and anterior neuron morphology (p>0.05 binary logistic model for all observed morphologies; 
data not shown).
We selected 9 genes for follow-up from the blueberry versus chaga treatment 
comparison (Figure 4.4): F44A2.5, max-1, snt-1, stn-1, ttx-3, tub-1, unc-115, unc-2, and unc-44
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(Table 4.4; Figure 4.7). Motility and soft touch response were impacted by these RNAi 
treatments, but their effects (improvement versus regression) did not directly correlate with the 
neuron morphologies observed. 5 of the 9 neuronal RNAi treatments resulted in improved 
motility late in life (day 11), either similar to lifespan-extending blueberry (ttx-3) or chaga (snt-1, 
stn-1, tub-1, unc-44) treatments (Figure 4.7A). Anterior touch response was increased over 
control (2.1 ±0.1) in 6 treatments in a highly significant (stn-1 [2.7±0.1]; p<0.01; Poisson log 
linear model) or significant manner (max-1 [2.5±0.1], snt-1 [2.5±0.1], ttx-3 [2.5±0.1], tub-1 
[2.4±0.1], unc-115 [2.5±0.1]; p<0.05; Poisson log linear model; data not shown). No treatments 
significantly improved posterior touch response (p>0.05; Poisson log linear model), but max-1 
treatment did significantly decrease posterior touch response relative to control (0.8±0.1 versus 
0.5±0.1; p<0.05; Poisson log linear model; data not shown).
Although all 9 genes were upregulated with chaga treatment (compared to blueberry 
treatment), neuronal RNAi knockdown resulted in wide ranging effects on touch receptor neuron 
morphology. Many RNAi treatments increased the occurrence of posterior touch receptor 
neuron process branching to a similar extent as blueberry and chaga treatments (ttx-3, tub-1, 
unc-115) and to even statistically higher levels (max-1, stn-1, unc-44; p<0.05; binary logistic 
model; Figure 4.7B). Only stn-1(RNAi) increased the occurrence of anterior neuron soma 
outgrowths (between 1x and 2x soma diameter; p<0.05; binary logistic model) and only tub- 
1(RNAi) decreased soma outgrowths (p<0.01; binary logistic model; Figure 4.7C). No RNAi 
treatments significantly decreased the occurrence abnormal cell soma (p>0.05; binary logistic 
model; Figure 4.7E). However, two RNAi treatments (ttx-3, unc-44) resulted in drastically 
increased occurrence of abnormal cell somas (p<0.05; binary logistic model; Figure 4.7D). 
There is no direct correlation between occurrence of types of aberrations and touch response 
(e.g. improved touch response/motility is correlated with both increased and decreased 
incidence of anterior soma outgrowths), further supporting the idea that neuron morphologies 
have different biological consequences.
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Only 4 candidate genes (F44A2.5, snt-1, unc-2; nhr-35) had no effect on touch receptor 
neuron morphology. F44A2.5 and unc-2 RNAi treatments also had no effect on motility and 
touch response. However, snt-l(RNAi) induced a highly significant improvement in anterior 
touch response in old adults (2.1 ±0.1 versus 2.5±0.1; p<0.01; Poisson log linear model) and 
nhr-35(RNAi) improved motility of old adults relative to control (Figure 4.6A), suggesting that 
these genes may play other roles in aging touch receptor neurons.
4.5 Discussion
Through the application of transcriptional activity screening tools and a non-biased 
approach to uncovering cellular transcriptional activity (i.e. RNAseq), we uncovered (1) a 
specific mechanism for lowbush cranberry treatment effects (i.e. DAF-16/FOXO activation) and
(2) novel genes involved in the development of age-related touch receptor neuron aberrations. 
After observing DAF-16 nuclear foci in aged (day 9) lowbush cranberry-treated populations, we 
examined lifespan and touch receptor neuron aging following DAF-16 knockdown with RNA 
interference (RNAi). We demonstrated that DAF-16 is required both for the lifespan extension 
and the increased posterior touch receptor neuron (PLM) branching caused by lowbush 
cranberry treatments (Figure 4.2). To examine cellular processes impacted by blueberry and 
chaga treatments with a non-biased experimental design, we measured changes in whole 
organism gene expression using RNAseq. Interestingly, chaga induced differential expression of 
a group of well-described transcripts (60-98% known or predicted GO functions), while 
blueberry treatment affected less understood transcripts (29-41% predicted GO functions; 
Figure 4.3). Whole organism transcriptome changes in young adults treated with lifespan- 
extending blueberry and chaga extracts are more different from each other than either is from 
the control transcriptome (Figures 4.3 and 4.4), supporting our original hypothesis that the two 
extracts exert their effects through distinct mechanisms. Also, the comparison of chaga- versus 
blueberry-treated transcriptomes resulted in more descriptive gene ontology enrichment than
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either treatment versus control comparison and in enriched gene ontology terms particularly 
relevant to neuron development, maintenance, and aging, despite analyzing whole organism 
(versus neuron-specific) transcriptomes (Figure 4.2B). We then tested the hypothesis that 
candidate genes impacted by blueberry and/or chaga treatment early in life regulate aging touch 
receptor morphology and function, uncovering a role for several novel genes in touch receptor 
neuron aging with potential implications in the aging of the human nervous system (Figures 4.5­
4.8 and Table 4.5).
The size and distribution of DAF-16::GFP foci observed (Figure 4.1) and the results of 
the systemic (vs. neuron-specific) DAF-16 RNAi experiments (Figure 4.2) suggest that, at least 
in part, a non-neuron specific pathway induces posterior neuron process branching. DAF-16, 
orthologous to human FOXO, is well known to operate in multiple tissues downstream of various 
cellular signaling pathways (e.g. insulin signaling) regulating the expression of genes that 
promote longevity, proteostasis, and stress response (Mukhopadhyay et al., 2006; Neri, 2012). 
The neuroprotective role of DAF-16 in healthy, untreated touch receptor neuron aging has also 
been explored (Scerbak et al., 2014; Toth et al., 2012; Tank et al., 2011). Toth et al. (2012) 
demonstrated that increased DAF-16 activity due to decreased insulin signaling (daf-2(e1370) 
mutant background) resulted in increased PLM process branching in otherwise untreated 
animals by late in life (day 10 of adulthood). Conversely, Tank et al. (2011) observed 
decreased posterior cell branching in the same genetic background. However, consistent with 
our results (Figure 4.2), removal of DAF-16 via genetic mutation and RNAi does not drastically 
disrupt aging touch receptor neuron morphologies, but does decrease touch response when 
compared to wildtype aging (Scerbak et al., 2014; Toth et al., 2012; Tank et al., 2011). While the 
involvement of DAF-16 in lifespan extension is well explored (albeit complex), our correlation of 
specific touch receptor neuron morphology (posterior neuron process branching) with berry- and 
fungus-induced DAF-16 activation is novel. What remains to be determined is whether PLM
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process branching is a stimulatory response that actively promotes healthy aging or whether 
this phenotype occurs as a consequence of good health and aging.
The involvement of DAF-16 in the improved health with age upon Alaskan lowbush 
cranberry treatment is consistent with other work demonstrating that C. elegans lifespan 
extension upon American lowbush cranberry treatment requires DAF-16 (Guha et al., 2012). 
That we did not detect a requirement for DAF-16 for blueberry-mediated lifespan extension is 
not surprising; others have shown that DAF-16 is not required in lifespan extension in other 
species of wild blueberry (Wilson et al., 2006). Given that DAF-16 is a known modulator of hsp-
16.2 expression, it is interesting that we previously detected a significant increase in hsp- 
16.2::GFP expression but no detectable fluorescent DAF-16::GFP foci following blueberry 
treatment in young adults (Supplemental Figure 4.1). This supports the idea that hsp-16.2 is 
regulated by additional signaling pathways and may be used as a general biomarker of aging 
(Rea et al., 2005). An alternative explanation is that our transcription factor activation assay only 
detects strong activation of DAF-16; however, given the assay’s consistency and rapid time 
course, we remain convinced that it is a powerful preliminary screening tool when combined 
with additional bioassays.
Given the described involvement of DAF-16 in the development of lowbush cranberry 
treatment-induced posterior neuron process branching, it is somewhat surprising that we did not 
observe DAF-16 nuclear foci formation nor a requirement for DAF-16 in lifespan extension upon 
treatment with chaga. None of the differentially regulated transcripts in treatment versus control 
comparisons are known to be directly regulated by the aging-central transcription factors we 
previously explored, DAF-16/FOXO or HSF-1, supporting the robust nature of techniques that 
allow of the visualization of such transcription factors with GFP (Morton and Lamitina, 2013; 
Henderson and Johnson, 2001). Also, chaga treatment caused an additional phenotype among 
posterior neurons not observed with lowbush cranberry treatments -  process loops. The 
mechanisms driving posterior touch receptor branching events versus posterior branch and loop
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events may be distinct. We believe that the lack of detection of DAF-16 involvement in chaga 
treatments may also be due to the following: (1) chaga treatments specifically activate neuronal 
DAF-16, causing branching while escaping detection in the aging DAF-16::GFP model and 
whole organism RNAseq; (2) DAF-16 is activated at a time point other than the two we tested 
(day 3 and day 9); or (3) an additional, as of yet undescribed pathway exists to regulate PLM 
process branching (and loops).
By comparing the transcriptomes of young adult (day 3) blueberry- and chaga-treated 
populations to control and to each other, we unveiled and screened candidate aging touch 
receptor neuron modulators. This approach uncovered 8 previously undescribed aging touch 
receptor neuron modulators: max-1, pck-1, stn-1, ttx-1, tub-1, unc-115, unc-44, ZK418.3 (Figure 
4.8; Table 4.4). When knocked down with neuronal RNAi, all of these modulators differentially 
impacted mechanosensory neuron morphology while increasing motility and/or touch response 
late in life (Figure 4.8). While all of these genes have functions related to metabolism or neuron 
differentiation and morphogenesis and are expressed in neurons, most have not been 
extensively studied in the context of aging. We only identified previous aging-related work on 
two modulators: pck-1 and tub-1, both of which fall into our “metabolism” general function 
classification (Figure 4.8). pck-1 (phosphoenolpyruvate carboxykinase, an enzyme in 
gluconeogenesis) exhibits decreased function with age in C. elegans (Yuan et al., 2016), 
supporting a model of altered cellular metabolism as a factor in aging (Feng et al., 2016). tub-1 
(a homolog of the vertebrate tubby gene) was shown to regulate two biological processes 
through different signaling processes: lifespan via DAF-16/FOXO signaling and fat storage via 
RGB-3 signaling in ciliated neurons (Mukhopadhyay et al., 2005). Many of these modulators 
have known or predicted interactions with the neuronal cytoskeleton (max-1; stn-1; tub-1; unc- 
115; unc-44; ZK418.3; Table 4.5) and are involved in developmental processes (max-1; unc- 
115; unc-44; ZK418.3; ttx-1; Table 4.5). The known interactions of these gene products with the
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cytoskeleton and axonal transport suggest that these genes may be involved in the underlying 
structural mechanisms of touch receptor neuron phenotype development.
ZK418.3 was the only aging touch receptor neuron modulator uncovered in this study 
that had decreased expression in the treatment (i.e. blueberry) versus control transcriptome 
comparison. Interestingly, its experimental knockdown in neurons resulted in somewhat different 
effects when compared to blueberry treatment alone: occurrence of extended soma outgrowths 
was not impacted (as it was in Chapter 3 with blueberry treatment alone), occurrence of 
posterior process branching and ratio of Class A/B animals was increased over blueberry alone, 
and occurrence of posterior process loops was increased (which was not impacted by blueberry 
alone; Figure 4.5). These findings suggest that ZK418.3 is not the only gene modified by 
blueberry treatment effects and suggest an intricate relationship between networks of genes for 
the maintenance mechanosensory neuron morphology and function.
Somewhat surprisingly, we found relatively small early (day 3) whole animal 
transcriptome-level changes when comparing controls with either Alaskan blueberry (17 
transcripts differentially regulated) or chaga treatments (118 transcripts; Figure 4.3), despite 
their striking effects on wildtype lifespan, healthspan, and touch receptor neuron aging. Other 
research groups have observed both very large and relatively small gene expression effects in 
whole C. elegans: developmental stage impacts 8606 transcripts on average (Spencer et al., 
2011), bacterial and fungal infection impacted ~2000-3000 transcripts (Engelmann et al., 2011), 
and mutations in the xenobiotic-responsive transcription factor aryl hydrocarbon receptor (AHR- 
1) impacted ~120 genes (Aarnio et al., 2014). However, while the number of genes impacted by 
blueberry and chaga treatment was small, the genes’ impact on aging touch receptor neurons is 
striking (Figures 4.5-4.6, Figure 4.8). Other, non-genetic factors (i.e. microRNA translational 
regulation, pH-induced functional changes) may also impact the blueberry- and chaga-mediated 
aging of whole animals and touch receptor neurons.
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We have shown here that the increased incidence of age-related mechanosensory 
neuron morphologies is not directly correlated with poorer health: both decreased incidence of 
ALM aberrations (i.e. soma outgrowths, abnormal soma shape) and increased incidence of PLM 
aberrations (i.e. process branching and loops) correlate with increased lifespan, improved 
motility, and improved touch response. This lack of direct association between increased 
morphological changes and function is also described in Chapters 2 and 3. To further 
complicate an understanding of the damaging versus protective roles of neuronal aberrations 
with respect to aging, our findings provided evidence that increased incidence of ALM 
aberrations can be correlated with improved motility and/or touch response (i.e. ttx-l(RNAi), 
unc-44(RNAi), and stn-7(RNAi)). The ALM and PLM pairs of touch receptor neurons 
consistently respond to the aging process different manners; thus, age-related changes in 
neuron morphology cannot be interpreted wholesale as biomarkers of detrimental effects of 
aging.
The cellular and molecular mechanisms behind the health benefits of nutritional 
interventions can be complex and challenging to uncover. Here, we described a requirement for 
DAF-16/FOXO in Alaskan lowbush cranberry-mediated lifespan extension and altered touch 
receptor neuron aging (i.e. posterior process branching development), but not in Alaskan 
blueberry and chaga treatment effects. Early transcriptome changes (day 3) revealed modest 
numerical genetic changes with blueberry and chaga treatment, but did reveal novel candidate 
touch receptor neuron morphology modulators. Many of these candidate modulators do indeed 
impact aged (day 11) touch receptor neuron morphology and function, and their interactions 
with the cytoskeleton suggest a direct mechanism for development of morphological changes. 
These results demonstrate the different molecular mechanisms of the Alaskan nutraceuticals’ 
effects and support a model in which specific changes in touch receptor neuron morphology 
correspond to specific changes in intra- and intercellular signaling pathways.
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BFigure 4.1 Alaskan lowbush cranberry activates DAF-16/FOXO nuclear translocation later in life.
Representative images of GFP-labeled DAF-16 (strain TJ356) day 9 adult untreated negative 
(A-B) and positive (C-D) controls and treatment with lifespan-extending Alaskan lowbush 
cranberry treatments (E-H) are shown. Notice the presence of foci or punctae in the positive 
controls and both lowbush cranberry treatment groups. Yellow boxes on images to the left mark 
the magnified area in corresponding panels on the right. All images were collected at constant 
image exposure and 10x magnification. Positive control effects were induced by 30min at 37°C. 
Scale bars represent 60^m for all images in each column.
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Figure 4.2 Alaskan lowbush cranberry requires DAF-16 for lifespan extension and posterior 
neuron branching events late in life.
(A) Lowbush cranberry treatments that extend wildtype C. elegans lifespan (50 and 400^g/mL) 
do not extend the lifespan of DAF-16 mutant animals (daf-16)mgdf50)). Representative Kaplan 
Meier curve is shown (N=50 per treatment group) and results were replicated in 3 independent 
trials. DAF-16 RNAi treatment blocks lowbush cranberry treatment-mediated improvement in 
posterior touch response (B) and increased posterior process branching (C). Asterisks denote 
significant difference (p<0.05; Poisson log linear model) from untreated control in each RNAi 
treatment group. (D) DAF-16 impacts anterior cell soma outgrowth development in all lowbush 
cranberry treatment groups somewhat significantly. Hashtags denote slight significance 
(0.09<p<0.06; Poisson log linear model) compared to treatment matched empty vector control. 
Insets in C and D are representative images of touch receptor neurons with the appropriate 
neuron morphology marker (anterior of each individual oriented to the left). Bars represent mean 
± standard error of the mean. Nworms=17-31, Nanterior cells=22-40 cells, Nposterior cells= 26-51 per bar.
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Figure 4.3 Gene expression is differentially regulated following treatment with Alaskan blueberry 
and chaga extracts.
Volcano scatter plots of mean fold change in transcript expression levels (log2(fold change)) 
versus significance in gene expression change (-log10(p value)) in control relative to blueberry 
treatment (A) or chaga treatment (B) calculated from N=3 transcriptomes from each group are 
shown. The red line represents - lo g 10(0.05), to aid in determining significance (false discovery 
rate was also considered in the analysis). The 10 transcripts with the lowest false discovery rate 
(FDR) are listed for each group and identified on the volcano scatter plot. Venn diagrams of up- 
regulated (C) and down-regulated (D) by blueberry (blue circles) and chaga (orange circles) 
treatments are also shown. Note that neither treatment down-regulated the same genes. (E) 
Gene ontology terms with significant overrepresentation in treatment-induced transcriptome 
changes (fold enrichment; DAVID analysis) following blueberry (blue bars) and chaga (orange 
bars) treatments is shown.
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Figure 4.4 Transcriptome comparison between blueberry and chaga treatment yields more 
effects.
(A) Volcano scatter plot of fold change in transcript expression levels (log2(fold change)) versus 
significance in gene expression change (-log10(p value)) in blueberry relative to chaga groups. 
The red line represents - lo g 10(0.05), to aid in determining significance (false discovery rate was 
also considered in the analysis). The 10 transcripts with the lowest false discovery rate (FDR) 
are listed for each group and identified on the volcano scatter plot. (B) Gene ontology terms 
with significant overrepresentation in chaga- versus blueberry-treated transcriptomes (fold 
enrichment; DAVID analysis). Bar colors in chart B denote DAVID functional annotation cluster, 
described in C. (C) Functional annotation clustering results of chaga- versus blueberry-treated 
transcriptome changes (DAVID analysis). Enrichment score (-log scale) ranks cluster groups by 
overrepresentation, highlighting important GO annotation groups.
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Figure 4.5 The impacts of Alaskan blueberry-mediated candidate gene on aging neuron 
morphology.
Proportion of adults per motility class (A; detailed description in Methods section) and exhibiting 
posterior touch receptor neuron morphologies (B, branching; C, loops) in control (black bars), 
blueberry treatment (blue bars), and neuronal RNAi knockdown of ZK418.3 (green bars) are 
shown. Greek letters above bars designate statistically homogenous subsets (p<0.05; ordinal 
logistic model [A] or binary logistic model [B-C]). Insets show representative image of affected 
neuron morphology. N=31-40 animals from at least 3 separate biological replicates per 
treatment group.
130
Figure 4.6 The impacts of Alaskan chaga-mediated candidate gene on aging neuron 
morphology.
Proportion of adults per motility class (A) and exhibiting posterior neuron process branching (B) 
in control (black bar), chaga treatment (orange bar), and neuronal RNAi knockdown of 
candidate genes (green bars) are shown. Greek letters above bars designate statistically 
homogenous subsets (p<0.05; ordinal logistic model [A] or binary logistic model [B]). Inset 
shows representative image of affected neuron morphology. N=28-39 animals from at least 3 
separate biological replicates per treatment group.
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Figure 4.7 The impacts of candidate neuron morphology modulators on aging neuron 
morphology.
Proportion of adults per motility class (A), exhibiting posterior process branching (B), and 
exhibiting anterior neuron morphologies (outgrowths from the soma; C and abnormal cell 
somas; D) in control (black bars), chaga-treated (orange bars), blueberry treated (blue bars), 
and neuronal RNAi treatment of candidate genes (green bars) groups are shown. Greek letters 
above bars designate statistically homogenous subsets (p<0.05; ordinal logistic model [A] or 
binary logistic model [B-D]). Insets show representative image of affected neuron morphology. 
N=28-50 animals from at least 3 separate biological replicates per treatment group.
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Figure 4.8 Summary of touch receptor neuron aging modulators detected with Alaskan 
nutraceutical treatment.
A diverse group of C. elegans neuronal genes impacted by Alaskan blueberry and chaga 
treatments modulate touch receptor neuron aging. From outer circle inwards: general gene 
function; specific gene function; gene name; touch receptor neuron morphology impacted at day 
11 following RNAi (with cartoon of impacted morphology); posterior neuron branching impacted 
by all genes at day 11 following neuronal RNAi; all neuronal phenotype modifications result in 
improved motility and touch response (i.e. improved touch response and/or motility). More 
detailed results for each gene found in Figure 5 (blue gene name), Figure 6 (orange gene 
name), and Figure 7 (green gene names). Abbreviations: PLM - posterior lateral touch receptor 
neuron; ALM - anterior lateral touch receptor neuron; TR -  touch response.
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Supplemental Figure 4.1 DAF-16 and HSF-1 nuclear translocation are not induced after 48h 
treatment with Alaskan berry or fungus.
Representative images of age-matched, GFP-labeled DAF-16 (strain TJ356) or HSF-1 (strain 
OG497) day 3 adult untreated positive and negative controls and 48-h treatment with lifespan- 
extending Alaskan berry and fungus treatments are shown. Notice the striking appearance of 
the positive controls for each strain when compared with other treatment groups. DAF-16::GFP 
images (left panels) were collected at 10x and HSF-1::GFP images (right panels) were collected 
at 40x magnification. Positive control effects were induced by 30min at 37°C (DAF-16) or 35°C 
(HSF-1). Scale bars represent 60^m for the images in each column.
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Supplemental Figure 4.2 GFP RNAi treatment blocks GFP expression.
(A) Mean fluorescence (arbitrary fluorescent units; AFU) of the pharynx region following 
treatment with empty vector and GFP RNAi at day 11 of adulthood using a strain previously 
genetically modified to be susceptible to neuronal RNAi (ZB064 (zdIs5 [Pmec-4GFP, lin-15(+)]; 
uls57 [Punc-119SID-1, Punc-n 9y/p, Pmec-6rnec-6])). Representative images of a pharynx region from 
a day 11 adult treated with empty vector (B) and GFP (C) RNAi are also shown. Asterisks 
denote significance from empty vector control (p<0.05; unpaired t-test). N=8 animals per bar. All 
images analyzed and shown were collected using the same fluorescent imaging parameters 
(i.e. 20x magnification, 1/20s exposure, no additional image processing). This experiment was 
repeated with similar significant results for each experimental replicate involving RNAi (Figure 2; 
Figures 5-7).
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Animals were classified based on the presence of DAF-16::GFP nuclear foci at day 9 of 
adulthood following treatment. Animals with cytosolic DAF-16 had diffuse GFP expression 
throughout the animal (example in Figure 1A), nuclear DAF-16 foci seen throughout the animal 
with very little diffuse fluorescence (example in Figure 1C), and intermediate DAF-16 had at 
least three distinct DAF-16::GFP foci with mostly diffuse fluorescence (examples in Figures 1E 
and 1G). Treatments were grouped into statistically homogenous subsets (p<0.05, ordinal 
logistic model). Data and sample size represent all individuals examined from 3 independent 
trials, each with a significant effect.
Table 4.1 Alaskan lowbush cranberry treatments cause DAF-16::GFP nuclear foci formation
later in life.
Treatment (ug/ml)
Percent (%) Animals Tested Total
Sample
Size
Statistical
GroupCytosolic Intermediate Nuclear
0 Positive Control 
(Heat Shock) 0 0 100 20 a
0 Negative Control 72.7 27.3 0 33 b
50 Lowbush 
cranberry 38.7 61.3 0 31 c
400 Lowbush 
cranberry 19.3 80.6 0 31 c
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Mean lifespan for Alaskan blueberry-, lowbush cranberry-, and chaga-treated mutant DAF-16 C. 
elegans (daf-16(mgdf50)) from representative trials are shown. Untreated mutants had 
significantly decreased mean lifespan compared to untreated wildtype control, as expected. 
Significance from appropriate control (p value) calculated using Kaplan-Meier log-rank test.
Table 4.2 The effect of Alaskan berry and fungus treatments on daf-16(m gdf50) mutant lifespan.
Treatment Dose
(pg/mL)
Lifespan 
(mean days ± S.E.M.)
N p  value
Blueberry
0 9.85±0.50 50
60 13.4±0.49 48 <0.001
200 15.8±0.83 41 <0.001
Lowbush cranberry
0 7.17±0.33 50
50 6.97±0.31 50 0.608
400 7.65±0.44 50 0.560
Chaga
0 8.36±0.68 50
50 7.43±0.39 50 0.131
200 8.27±0.48 50 0.674
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Table 4.3 Summary of alignments from RNA library.
Control Blueberry Treatment Chaga Treatment
Sample
1
Sample
2
Sample
3
Sample
1
Sample
2
Sample
3
Sample
1
Sample
2
Sample
3
Total Number of 
Reads (millions) 18.25 29.05 17.44 18.75 28.84 25.65 19.25 25.79 26.56
Number of Reads 
Filtered on Quality 230254 277897 210010 245506 476239 492313 252872 355482 382463
Percent Reads 
Filtered on Quality 1.26 0.96 1.20 1.31 1.65 1.92 1.31 1.38 1.44
Number of Genes 
Detected Above 
Threshold
15658 17373 14980 15464 17408 15424 16834 17328 17727
Percent of Genes 
Detected based on 
Current 
Transcriptome 
Definition
33.49 37.16 32.04 33.08 37.24 32.99 36.01 37.07 37.92
Percent of Reads 
Mapped Either to the 
Transcriptome or the 
Genome
99.08 99.15 99.04 99.07 99.22 99.32 99.16 99.03 98.98
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Table 4.4 Candidate touch receptor neuron morphology regulators selected for follow-up.
Table lists the candidate genes selected selected for neuron morphology follow-up from the 
three transcriptome comparisons: control versus blueberry treatment, control versus chaga 
treatment, or blueberry versus chaga treatments. The fold change in gene expression relative to 
the indicated treatment (log2FC & FC), false discovery rate (FDR), relevant biological process 
and cellular component gene ontology terms (GO), and human homolog for each candidate 
gene are also listed.
Candidate
Gene log2FC FDR GO Human Homolog
Candidate Gene Impacted in Blueberry Treatment versus Control Comparison
ZK418.3 -6.5 0.01 vulval development; neurons
TMEM17; 
cillia membrane transport
Candidate Genes Impacted in Chaga Treatment versus Control Comparison
nhr-35 -0.59 0.14 DNA binding; transcription
Hepatocyte nuclear factor 
4A/4G; 
transcription
pck-1 1.1 0.14 gluconeogenesis Phosphoenolpyruvatecarboxykinase
Candidate Genes Impacted in Blueberry versus Chaga Comparison
F44A2.5 0.51 0.18 RNA binding, sarcoplasmic reticulum
CTIF;
CPB80/20-dependent 
translation initiation factor
max-1 0.52 0.29 cytoskeleton PLEKHH1;cytoskeleton
snt-1 1.23 0.21 synaptic vesicle exocytosis
synaptotagmin; 
pre-synaptic Ca2+ sensor
stn-1 0.5 0.28 neurotransmitter (acetylcholine) transport
a- and p-syntrophins; 
neuromuscular junction
ttx-3 1.45 0.16 axon guidance; associative learning
LIM/homeobox protein Lhx2; 
transcriptional activator in 
cell differentiation
tub-1 0.97 0.22 lipid storage; chemotaxis; axon
TUBBY; 
transcription/signaling factor
unc-115 0.39 0.108 neuron projection morphogenesis
ABLIM1; 
actin binding
unc-2 0.81 0.21 regulation of neurotransmitter levels
CACNA1A; 
P/Q-type calcium channel
unc-44 0.21 0.26 axon guidance & extension
Ankyrin-1 isoform Br21; 
integral adapter protein
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Table 4.5 Known interactions of the aging C. elegans touch receptor neuron aging modulators 
detected with Alaskan nutraceutical treatment with the cytoskeleton, axon transport, and 
developmental processes.
Table lists each of the 8 aging touch receptor neuron morphology modulators (gene), its level of 
interaction with the cytoskeleton (yes/no/predicted/unknown), and previous neuron-related 
functional studies of the gene and its homolog in C. elegans and vertebrates.
Gene Interacts with Cytoskeleton? Functional studies in C. elegans Functional studies in Vertebrates
max-1 Yes
GABA motor neurons 
developmental cell guidance 
(Huang et al., 2002)
Zebrafish motor neurons and 
epithelial cells developmental cell 
guidance (Zhong et al., 2006)
Mediates endocytosis in lysosomes 
(PLEKHM1; McEwan et al., 2015)
pck-1 No(kinase)
Energy metabolism 
(gluconeogenesis)
Energy metabolism 
(gluconeogenesis)
stn-1 Indirectly(predicted)
Linked to dystrophin function (Kim 
et al., 2004)
Interacts with the SNF-6 
acetylcholine receptor at 
neuromuscular junctions (Kim et al., 
2004)
Scaffolding proteins in 
neuromuscular synapses (a- and p- 
syntrophins; Grisoni et al., 2003; 
Albrecht and Froehner, 2002)
ttx-1
No
(transcription
factor)
Differentiation of AFD 
thermosensory neurons (Satterlee 
et al., 2001)
Brain embryogenesis (otd/Otx 
homeodomain transcription factors; 
Acampora et al., 2001)
tub-1 Predicted
Fat deposition and chemosensation 
through signaling in ciliated neurons 
(via RBG-3; Mukhopadhyay et al., 
2005)
Regulates lifespan (via DAF- 
16/FOXO; Mukhopadhyay et al., 
2005)
neuron function during and after 
development (Ikeda et al., 2002)
Associated with retinal dystrophy 
and obesity (Borman et al., 2014)
unc-115 Yes
Neuron class (e.g. VD and DD 
motor neurons) developmental cell 
guidance (Lundquist et al., 1998)
Binds action in many cell types 
(including neurons) and predicted to 
regulate cell morphology (ABLIM1; 
Roof et al., 1997)
unc-44 Yes
Axon guidance (Otsuka et al, 1995) Adapter protein with a variety of 
structural applications (Ankryin-1)
ZK418.3 Unknown
Expressed in amphid and labial 
head neurons (Phirke et al., 2011)
Involved in the development of 
ciliated neurons and vuval 
development (Phirke et al., 2011)
Part of a complex required for 
normal primary cilia development 
and function (TMEM17; Chih et al., 
2012)
Implicated in trafficking regulation to 
and from the cilia (TMEM17; Chih et 
al., 2012)
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Supplemental Table 4.1 Comparison of control versus blueberry treatment transcriptomes.
Supplemental Table 4.2 Comparison of control versus chaga treatment transcriptomes.
Supplemental Table 4.3 Comparison of blueberry versus chaga treatment transcriptomes.
Supplemental Tables 4.1-4.3 show expression level (log2mean) for each group and fold change 
(log2mean), unadjusted p value, and false discovery rate (FDR) for all transcripts detected 
during sequencing (>5). Transcripts with an FDR of <0.30 and unadjusted p value <0.01 were 
considered significantly impacted by treatment.
Supplemental Table 4.4 Selection of candidate touch receptor neuron morphology regulators.
Supplemental table 4.4 lists genes chosen through each round of selection: (1) all genes 
significantly impacted (FDR<0.3 and p value <0.05) in any of the three described comparisons 
with duplicates (N=92) removed for clarity; (2) genes from 1 with known functions relevant to the 
current study (i.e. neuron function and development, known connection to the aging process);
(3) genes from 2 with known human homologs.
Tables are oversized and included in supplementary CD/archive.
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Chapter 5
General Conclusions
5.1 Summary of findings
Aging is a ubiquitous process affecting the health of increasing numbers of individuals 
throughout the world. Here, we studied the molecular mechanisms driving touch receptor 
neuron aging in the model nematode, Caenorhabditis elegans, with the goal of further 
describing the intricate relationship between genetics and diet in the aging process. In the 
experiments described in Chapter 2, we tested the effects of components of the insulin signaling 
pathway on aging mechanosensory neurons expressing a neurotoxic expanded polyglutamine 
transgene (polyQ128; model of Huntington’s disease) or lacking this proteotoxicity stressor 
(polyQ0). We found that genetic manipulations that mimic decreased insulin signaling (i.e. DAF- 
2/insulin receptor knockdown with RNA interference (RNAi)) improved biomarkers of aging (e.g. 
lifespan, touch response) when compared to those that mimic insulin availability (DAF-16/FOXO 
transcription factor knockdown) in both the neurodegenerative and natural aging models. As 
reported in Chapter 3, we also evaluated the in vivo anti-aging characteristics of four medicinal 
Alaskan berry and fungal species (Vaccinium uliginosum, blueberry; Vaccinium vitis-idaea, 
lowbush cranberry; Empetrum nigrum, crowberry; and Innonotus obliquus, chaga). Blueberry, 
lowbush cranberry, and chaga treatments increased wildtype Caenorhabditis elegans lifespan 
and improved markers of healthspan (e.g. motility) while crowberry treatment did not affect 
wildtype lifespan. We then tested the hypothesis that the lifespan-extending treatments 
influence touch receptor neuron aging by modulating age-related morphological changes and 
functional decline. Interestingly, each of these treatments improved the age-related decline in 
touch response and motility but differentially impacted touch receptor neuron aging trajectories: 
the development of aberrant neuron morphologies was either slowed (blueberry; decreased
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anterior neuron soma outgrowths at day 11), amplified (lowbush cranberry; increased posterior 
neuron process branching at day 11), or both (chaga; decreased anterior soma outgrowths and 
increased posterior process branching). Lastly, as reported in Chapter 4, we tested the 
hypothesis that lifespan-extending Alaskan berry and fungal treatments modify the aging 
process via specific, distinct cellular and molecular mechanisms. Only lowbush cranberry 
treatment effects were specifically modulated by DAF-16/FOXO activity, a well-studied, aging- 
related component of the insulin signaling pathway. Interestingly, we observed the same 
morphological phenotype (i.e. posterior neuron process branching) with daf-2(RNAi) (see 
Chapter 2) and lowbush cranberry treatment, both of which appear to increase the activity of 
DAF-16/FOXO. RNA sequencing revealed modest genetic changes early in life with blueberry 
and chaga treatments, but allowed us to uncover a novel role for a group of neuronal 
morphogenesis and metabolism genes that interact with the cytoskeleton in the development of 
touch receptor neuron morphologies. These results demonstrate for the first time that culturally 
valued Alaskan nutraceuticals exhibit in vivo anti-aging properties. Importantly, the results 
herein demonstrate that although an accumulation of abnormal neuron morphologies is 
associated with aging and decreased health, not all of these morphologies are detrimental to 
neuronal and organismal health and may in fact be defense or protective mechanisms. These 
results also support the large body of knowledge positing that there are multiple cellular 
strategies (e.g. cellular signaling, gene expression) and interventions (e.g. nutrition) for 
promoting health with age.
5.2 Proteostasis in aging neurons
In healthy cells, proteins are monitored for proper folding and misfolded proteins are 
corrected or degraded in order to maintain protein homeostasis ("proteostasis”) within the cell. 
Dysregulation of proteostasis is a hallmark of neurodegenerative diseases. One such disease, 
Huntington’s disease, is characterized by polyglutamine (polyQ)-expanded huntingtin protein
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that aggregates within neurons. Introduction of mutated huntingtin (polyQ128) into C. elegans 
neurons results in deficient mechanosensation and development of neuronal aberrations (e.g. 
process bumps; Parker et al., 2001). Insulin signaling is implicated in the progression of 
neurodegenerative diseases, in part because of its regulation of stress response genes (e.g. 
protein chaperones, which regulate protein folding; reviewed in Dillin and Cohen, 2011). The 
study reported in Chapter 2 aimed to explore the link between healthy and diseased insulin 
signaling processes in touch receptor neurons. Indeed, insulin signaling regulation of touch 
receptor neuron form and function are somewhat distinct between the healthy and polyQ128 
models: insulin receptor knockdown (daf-2(RNAi)) increases morphological aberrations in 
healthy animals and decreases aberrations in polyQ128 animals. However, the central aging 
transcription factor, DAF-16/FOXO, is neuroprotective in both models. The addition of a 
proteostatic imbalance (polyQ128 transgene) altered the response of touch receptor neurons to 
insulin signaling disruption, highlighting the importance of protein balance in cellular function 
and the aging process.
Our research group recently demonstrated that maintaining neuron proteostasis is a 
critical step in the touch receptor neuron aging process (Vayndorf et a l. 2016). Both toxic 
polygluatamine-expanded huntingtin and neuronal RNAi of proteostatsis pathway components 
(e.g. proteosome, ubiquitin pathway) modified the age-related morphological aging trajectory of 
touch receptor neurons. These specific genetic interventions did not result in specific 
morphological changes, unlike the Alaskan nutraceutical interventions employed in the studies 
described in Chapters 3 and 4, suggesting that (1) proteostasis has wide-ranging cellular 
impacts on the aging process and (2) proteostasis dysregulation is not a mechanism of our 
Alaskan nutraceutical treatment effects (which is also supported in our RNAseq results).
Loss of proteostasis within cells is also an accepted marker of the normal, non-diseased 
aging process (reviewed in Lopez-Otin et al., 2013). For example, wildtype aged C. elegans 
have lower protein expression of proteins involved in proteostasis processes (e.g. translation,
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proteosomal function; Copes et al., 2015) and accumulate widespread, insoluble protein 
aggregates (David et al., 2010). Maintenance of proteostasis within neurons (and other cells) is 
critical to the health of the cell and the organism. Future work will continue to describe strategies 
to maintaining proteostasis with age, but must consider the source of proteostasis dysregulation 
(i.e. aging versus neurodegeneration).
5.3 Nutritional impacts on insulin signaling and DAF-16/FOXO activity
Changes in nutrient sensing at the organismal (e.g. olfaction) and cellular level (e.g. 
insulin signaling) are known to be associated with aging (reviewed in Lopez-Otin et al., 2013). In 
C. elegans, various mutations in components of the insulin signaling pathway (e.g. DAF-2 
receptor, AGE-1/P13K kinase, DAF-16/FOXO transcription factor), a key nutrient sensing 
pathway, consistently regulate lifespan, response to stress, and neuron aging (reviewed in 
Fontana et al., 2010; Broughton and Partridge, 2009). Similarly, decreasing insulin signaling in 
rodents increases lifespan and improves neurodegenerative phenotypes (reviewed in Broughton 
and Partridge, 2009). Several epidemiological studies have indicated that genetic variation in 
the FOXO transcription factor (homolog to C. elegans DAF-16 and central to the insulin 
signaling pathway) is involved in human lifespan (Deelen et al., 2014; Beekman et al., 2013; 
Newman and Murabito, 2013). Interestingly, levels of human growth hormone and IGF-1 (that 
bind to and activate human insulin receptors) decrease with age, which is thought to represent a 
defensive response to the damage associated with aging (reviewed in Lopez-Otin et al., 2013). 
The idea that food intake and nutrition influences the activity of this central signaling pathway 
and transcription factor is a very interesting one. Given the known genetic differences in human 
FOXO, the potential for individual variation in the response (e.g. inactivate/activate, speed and 
duration of response) of this transcription factor in response to nutrients and/or bioactive 
compounds should be investigated.
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Due to its known interactions with the aging process, we chose to screen for DAF- 
16/FOXO activation upon treatment with Alaskan nutraceuticals (Chapter 4). We found that 
DAF-16/FOXO was activated in aged (day 9) animals treated with Alaskan lowbush cranberry 
(but not treatment with blueberry or chaga), mimicking low insulin receptor (DAF-2) activation 
and, thus, low nutrient availability. Although the C. elegans insulin signaling pathway is well 
known to regulate development, metabolism, and stress response, the regulation of C. elegans 
insulin peptide levels (of which there are 40) and their interactions with the DAF-2 receptor is 
not completely described (reviewed in Gami and Wolkow, 2006). To further describe the 
relationship of DAF-16/FOXO with other broadly acting cellular signaling pathways, it would be 
interesting to test the involvement of Alaskan lowbush cranberry treatment on insulin peptide 
availability and the activity of other conserved upstream regulators of DAF-16/FOXO (e.g. heat 
shock factor [HSF-1] and JNK signaling).
5.4 Aging phenotypes of anterior versus posterior touch receptor neurons
The anterior (ALM) and posterior (PLM) mechanosensory (or touch receptor) neurons 
respond to aging and aging manipulations with different morphological changes: ALM neurons 
exhibit increased soma outgrowths and abnormal soma shapes while PLM neurons exhibit 
increased process outgrowths (i.e. branching, loops; Vayndorf et al., 2016; Toth et al., 2012; 
Pan et al., 2011; Tank et al., 2011). Additionally, we have shown here that the increased 
incidence of these age-related morphologies is not directly correlated with poorer health: both 
decreased incidence of ALM aberrations (i.e. soma outgrowths, abnormal soma shape) and 
increased incidence of PLM aberrations (i.e. process branching and loops) correlate with 
increased lifespan, improved motility, and improved touch response. To further complicate an 
understanding of the damaging versus protective roles of neuronal aberrations with respect to 
aging, our findings provided evidence that increased incidence of ALM aberrations can be 
correlated with improved motility and/or touch response (i.e. ttx-1 (RNAi), unc-44(RNAi), and stn-
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f(RNAi)). What remains to be determined is whether increased incidence of morphological 
aberrations (e.g. PLM process branching) is a stimulatory response that actively promotes 
healthy aging or whether this phenotype occurs as a consequence of good health and aging. 
The ALM and PLM pairs of touch receptor neurons consistently respond to the aging process 
different manners; thus, age-related changes in neuron morphology cannot be interpreted 
wholesale as biomarkers of detrimental effects of aging.
The heterogeneity in morphological responses to aging between ALM and PLM neurons 
may be due to their particular neural networks and, thus, activity levels. In general terms, the 
touch receptor neurons (including the pairs of ALM and PLM neurons) synapse on interneurons, 
which then synapse on motor neurons, resulting in forward or backward movement (reviewed in 
Goodman, 2006). Specifically, the PLM neurons have stimulatory gap junctions with the 
AVB/PVC interneurons (which regulate forward movement) and inhibitory chemical synapses on 
the AVA/AVD interneurons (which regulate backward movement). Thus, PLM activation by 
posterior touch stimulates forward movement. ALM neurons are involved in opposing neuronal 
interactions (inhibitory chemical synapses on AVB/PVC and stimulatory gap junctions with 
AVA/AVD), stimulating backward movement upon anterior touch (reviewed in Goodman, 2006). 
As they age, the three anterior touch receptor neurons (ALML, ALMR, AVM) form their own 
neural network via gap junctions, a characteristic not shared with the posterior touch receptor 
neurons (Chalfie et al., 1985). Additionally, only ALM neurons (not PLM) sensitize to high salt, 
hypoxia, dauer, and prolonged vibration, which prevents the animal from repeatedly changing 
direction in response to non-localized stressors (Chen and Chalfie, 2014). Toth et al. (2012) 
proposed that the age-related morphological differences between neurons of the same class 
(e.g. PLM and ALM neurons) and between classes of neurons (e.g. touch receptor versus 
dopamine neurons) may also be due to neuronal position (i.e. space to grow) or cell-specific 
gene expression. Taken together, the functional differences in the ALM and PLM neurons likely
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have consequences for their age-related morphological changes and, thus, their responses to 
the aging process.
5.5 Environmental factors in medicinal food efficacy
The relationship between plant and fungal species’ biochemical composition, in vivo 
medicinal action, and ecology is an area of research that warrants further study. Plant and 
fungus species adapt to extreme environments (such as Alaska’s extreme photoperiods) by 
producing a wide variety of secondary metabolites (Elks et al., 2013), chemicals known to 
interact with health- and aging-related cellular processes (e.g. quercitin impacts insulin 
signaling; Youl et al., 2010), perhaps via xenohormesis. It is well accepted in agricultural 
chemistry that the biochemical composition of food sources may be detected (i.e. by flavor), and 
even preferred, upon consumption by consumers. For example, grape ripening is regulated by 
environmentally-responsive hormones, and the particular molecular basis of ripening directly 
influences secondary metabolite production and, thus, aroma and taste (reviewed in Kuhn et al., 
2013). One study found that blueberry tasters discern flavor biochemical profiles (which were 
determined by genetics and environment), validating approaches to breed for flavor (Gilbert et 
al., 2015). However, studying the effects of environment-induced (e.g. variations in temperature, 
precipitation, and/or soil composition) intraspecies variation in biochemical composition and on 
subsequent in vivo health metrics (e.g. neuronal aging in C. elegans) would offer an 
interdisciplinary approach to understanding the basic biology of aging and to promoting healthy 
aging.
5.6 Final conclusions
C. elegans touch receptor neurons exhibit changes in morphology and a decline in 
function with age (Toth et al., 2012; Pan et al., 2011; Tank et al., 2011). Here, we demonstrate 
that these age-related changes can be modulated by both genetic (e.g. insulin signaling) and
155
nutritional (e.g. Alaskan nutraceuticals) interventions. We also uncovered a novel role for a 
group of genes in touch receptor neuron aging by studying Alaskan nutraceutical treatment- 
induced transcriptome changes. The cellular and molecular aging processes (e.g. insulin 
signaling, cytoskeletal regulations) are impacted by both intrinsic (e.g. genetic determinants of 
aging) and extrinsic (e.g. nutrition) factors. This supports the large body of knowledge positing 
that there are multiple, interrelated cellular strategies and mechanisms promoting health with 
age. Finally, studying the impact of culturally valued foods, such as Alaskan berries and fungi, 
not only supports the traditional ecological knowledge that these foods are healthy, but provides 
novel insights into the mechanisms of neuronal aging and aging in general.
5.7 References cited
Beekman, M., Blanche, H., Perola, M., Hervonen, A., Bezrukov, V., Sikora, E., Flachsbart, F., 
Christiansen, L., De Craen, A.J.M., Kirkwood, T.B.L., Rea, I.A., Poulain, M., Robine, 
J.M., Valensin, S., Stazi, M.A., Passarino, G., Deiana, L., Gonos, E.S., Paternoster, L., 
S0rensen, T.I.A., Tan, Q., Helmer, Q., van den Akker, E.B., Deelen, J., Martella, F., 
Cordell, H.J., Ayers, K.L., Vaupel, J.W., Teornwall, O., Johnson, T.E., Schreiber, S., 
Lathrop, M., Skytthe A., Westendorp, R.G.J., Christensen, K., Gampe, J., Nebel, A., 
Houwing-Duistermaat, J.J., Slagboom, P.E., and Franceschi, C. (2013). Genome-wide 
linkage analysis for human longevity: Genetics of healthy aging study. Aging Cell 12, 
184-193.
Broughton, S. and Partridge, L. (2009). Insulin/IGF-like signaling, the central nervous system 
and aging. Biochem J 418, 1-12.
Chalfie, M., Sulston, J.E., White, J.G., Southgate, E., Thomson, N., and Brenner, S. (1985). The 
neural circuit for touch sensitivity in Caenorhabditis elegans. J Neurosci 5(4), 956-964. 
Chen, X. and Chalfie, M. (2014). Modulation of C. elegans touch sensitivity is integrated at 
multiple levels. J Neurosci 34(19), 6522-6536.
156
Copes, N., Edwards, C., Chaput, D., Saifee, M., Barjuca, I., Nelson, D., Paraggio A., Saad, P., 
Lipps, D., Stevens, S.M. Jr., and Bradshaw, P.C. (2015) Metabolome and proteosome 
changes with aging in Caenorhabditis elegans. Exp Geron 72, 67-84.
David, D.C., Ollikainen, N., Trinidad, J.C., Cary, M.P., Bulingame, A.L., and Kenyon, C. (2010). 
Protein aggregation as an inherent part of aging in C. elegans. PLoS Biol 8(8), 
e1000450.
Deelen, J., Beekman, M., Uh, H.W., Broer, L., Ayers, K.L., Tan, Q., Kamatani, Y., Bennet, A.M., 
Tamm, R., Trompet, S., Guobjartsson, D.F., Flachsbart, F., Rose, G.,Viktorin, A., 
Fischer, K., Nygaard, M., Cordell, H.J., Crocco, P., van den Akker, E.B., Bohringer, S., 
Helmer, Q., Nelson, C.P., Saunders, G.I., Alver, M., Andersen-Ranberg, K., Breen, M.E., 
van der Breggen, R., Caliebe, A., Capri, M., Cevenini, E.,Collerton, J.C., Dato, S., 
Davies, K., Ford, I., Gampe, J., Garagnani, P., de Geus, E.J., Harrowo, J., van Heemst,
D., Heijmans, B.T., Heinsen, F.A., Hottenga, J.J.,Hofman, A., Jeune, B., Jonsson, P.V., 
Lathrop, M., Lechner, D., Martin-Ruiz, C.,McNerlan, S.E., Mihailov, E., Montesanto, A., 
Mooijaart, S.P., Murphy, A., Nohr, E.A., Patemoster, L., Postmus, I., Rivadeneira, F., 
Ross, O.A., Salvioli, S., Sattar, N.,Schreiber, S., Stefansson, H., Stott, D.J., Tiemeier, H., 
Uitterlinden, A.G., Westen-dorp, R.G., Willemsen, G., Samani, N.J., Galan, P., 
S0rensen, T.I., Boomsma, D.I.,Jukema, J.W., Rea, I.M., Passarino, G., de Graen, A.J., 
Christensen, K., Nebel, A., Stefansson, K., Metspalu, A., Magnusson, P., Blanche, H., 
Christiansen, L., Kirkwood,T.B., van Duijn, C.M., Franceschi, C., Houwing-Duistermaat, 
J.J., Slagboom, P.E., 2014. Genome-wide association meta-analysis of human longevity 
identifies a novel locus conferring survival beyond 90 years of age. Hum Mol Genet 23, 
4420-4432.
Dillin, A., and Cohen, E. (2011). Ageing and protein aggregation-mediate disorders: from 
invertebrates to mammals. Philos Trans R Soc Lond B Biol Sci 366, 94-98.
157
Elks, C. M., Francis, J., Stull, A. J., Cefalu, W. T., Shukitt-Hale, B., & Ingram, D. K. (2013). 
Overview of the health properties of blueberries. In M. Skinner & D. Hunter (Eds.), 
Bioactives in fruit: Health benefits and functional foods (1st ed., pp. 251-271). John 
Wiley & Sons.
Fontana, L., Partridge, L., and Longo, V.D. (2010). Extending healthy lifespan—from yeast to 
humans. Science 328, 321-326.
Gami, M.S. and Wolkow, C.A. (2006). Studies of Caenorhabditis elegans DAF-2/insulin 
signaling reveal targets for pharmacological manipulation of lifespan. Aging Cell 5(1), 31­
37.
Gilbert, J.L., Guthart, M.J., Gezan, S.A., de Carvalho, M.P., Schwieterman, M.L., Colquhoun, 
T.A., Bartoshuk, L.M., Sims, C.A., Clark, D.G., and Olmstead, J.W. (2015). Identifying 
breeding priorities for blueberry flavor using biochemical, sensory, and genotype by 
environment analyses. PLoS ONE 10(9): e0138494.
Goodman, M.B. Mechanosensation (2006), WormBook, ed. The C. elegans Research 
Community, WormBook,
Kuhn, N., Guan, L., Dai, Z.W., Wu, B.H., Lauvergeat, V., Gomes, E., Li, S.H., Godoy, F., Arce- 
Johnson, P., and Deirot, S. (2013). Berry ripening: recently heard through the grapevine. 
J Exp Botany, 65(15), 4543-4559.
Lopez-Otin, C., Blasco, M.A., Partridge, L., Serrano, M., and Kroemer, G. (2013). The hallmarks 
of aging. Cell 153, 1194-1217
Newman, A.B. and Murabito, J.M. (2013). The epidemiology of longevity and exceptional 
survival. Epidemiology Rev 35, 181-197.
Pan, C.L., Peng, C.Y., Chen, C.H., and Mclntire, S. (2011). Genetic analysis of age-dependent 
defects of the Caenorhabditis elegans touch receptor neurons. PNAS 108, 9274-9279.
158
Parker, J.A., Connolly, J.B., Wellington, C., Hayden, M., Dausset, J., and Neri, C. (2001) 
Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and 
severe dysfunction of PLM mechanosensory neurons without cell death. PNAS 
98(23):13318-13323.
Tank, E., Rodgers, K., and Kenyon, C. (2011). Spontaneous Age-Related Neurite Branching in 
Caenorhabditis elegans. J Neurosci 31, 9279-9288.
Toth, M., Melentijevic, I., Shah, L., Bhatia, A., Lu, K., Talwar, A., Naji, H., Ibanez-Ventoso, C., 
Ghose, P., Jevince, A., Xue, J., Herndon, L.A., Bhanot, G. Rongo, C., Hall, D.H., and 
Driscoll, M. (2012). Neurite sprouting and synapse deterioration in the aging 
Caenorhabditis elegans nervous system. J Neurosci 32, 8778-8790.
Vayndorf, E.M., Scerbak, C., Hunter, S., Neuswanger, J.R., Toth, M., Parker, A.J., Neri, C., 
Driscoll, M., and Taylor, B.E. (2016). Morphological remodeling of C. elegans neurons 
during aging is modified by compromised protein homeostasis. NPJ Aging Mech Dis 2, 
e16001.
Youl, E., Bardy, G., Magous, R., Cros, G., Sejalon, F., Virsolvy, A., Richard, S., Quignard, J.F., 
Gross, R., Petit, P., Bataille, D., and Oiry, C. (2010). Quercetin potentiates insulin 
secretion and protects INS-1 pancreatic p-cells against oxidative damage via the 
ERK1/2 pathway. Br J Pharmacol. 161, 799-814.
159
